id	sid	tid	token	lemma	pos
dpc-4927	1	1	dermatology	dermatology	NOUN
dpc-4927	1	2	:	:	PUNCT
dpc-4927	1	3	practical	practical	ADJ
dpc-4927	1	4	and	and	CCONJ
dpc-4927	1	5	conceptual	conceptual	ADJ
dpc-4927	1	6	original	original	ADJ
dpc-4927	1	7	article	article	NOUN
dpc-4927	1	8	|	|	ADV
dpc-4927	1	9	dermatol	dermatol	ADJ
dpc-4927	1	10	pract	pract	NOUN
dpc-4927	1	11	concept	concept	NOUN
dpc-4927	1	12	.	.	PUNCT
dpc-4927	2	1	2025;15(1):4927	2025;15(1):4927	NUM
dpc-4927	2	2	1	1	NUM
dpc-4927	2	3	a	a	DET
dpc-4927	2	4	window	window	NOUN
dpc-4927	2	5	into	into	ADP
dpc-4927	2	6	the	the	DET
dpc-4927	2	7	vascular	vascular	ADJ
dpc-4927	2	8	endothelium	endothelium	NOUN
dpc-4927	2	9	in	in	ADP
dpc-4927	2	10	covid-19	covid-19	PROPN
dpc-4927	2	11	:	:	PUNCT
dpc-4927	2	12	nails	nails	PROPN
dpc-4927	2	13	ozge	ozge	PROPN
dpc-4927	2	14	sevil	sevil	PROPN
dpc-4927	2	15	karstarli	karstarli	PROPN
dpc-4927	2	16	bakay1	bakay1	PROPN
dpc-4927	2	17	,	,	PUNCT
dpc-4927	2	18	niyazi	niyazi	PROPN
dpc-4927	2	19	cetin1	cetin1	PROPN
dpc-4927	2	20	,	,	PUNCT
dpc-4927	2	21	umut	umut	PROPN
dpc-4927	2	22	bakay2	bakay2	PROPN
dpc-4927	2	23	,	,	PUNCT
dpc-4927	2	24	gokhan	gokhan	PROPN
dpc-4927	2	25	cinar3	cinar3	PROPN
dpc-4927	2	26	,	,	PUNCT
dpc-4927	2	27	sule	sule	PROPN
dpc-4927	2	28	goksin1	goksin1	PROPN
dpc-4927	2	29	1	1	NUM
dpc-4927	2	30	pamukkale	pamukkale	PROPN
dpc-4927	2	31	university	university	NOUN
dpc-4927	2	32	faculty	faculty	NOUN
dpc-4927	2	33	of	of	ADP
dpc-4927	2	34	medicine	medicine	NOUN
dpc-4927	2	35	,	,	PUNCT
dpc-4927	2	36	department	department	NOUN
dpc-4927	2	37	of	of	ADP
dpc-4927	2	38	dermatology	dermatology	NOUN
dpc-4927	2	39	,	,	PUNCT
dpc-4927	2	40	denizli	denizli	PROPN
dpc-4927	2	41	,	,	PUNCT
dpc-4927	2	42	turkey	turkey	PROPN
dpc-4927	2	43	2	2	NUM
dpc-4927	2	44	denizli	denizli	PROPN
dpc-4927	2	45	state	state	NOUN
dpc-4927	2	46	hospital	hospital	NOUN
dpc-4927	2	47	,	,	PUNCT
dpc-4927	2	48	department	department	NOUN
dpc-4927	2	49	of	of	ADP
dpc-4927	2	50	rheumatology	rheumatology	NOUN
dpc-4927	2	51	,	,	PUNCT
dpc-4927	2	52	denizli	denizli	PROPN
dpc-4927	2	53	,	,	PUNCT
dpc-4927	2	54	turkey	turkey	NOUN
dpc-4927	2	55	3	3	NUM
dpc-4927	2	56	agrı	agrı	NOUN
dpc-4927	2	57	training	training	NOUN
dpc-4927	2	58	and	and	CCONJ
dpc-4927	2	59	research	research	NOUN
dpc-4927	2	60	hospital	hospital	NOUN
dpc-4927	2	61	,	,	PUNCT
dpc-4927	2	62	department	department	NOUN
dpc-4927	2	63	of	of	ADP
dpc-4927	2	64	dermatology	dermatology	NOUN
dpc-4927	2	65	,	,	PUNCT
dpc-4927	2	66	agrı	agrı	NOUN
dpc-4927	2	67	,	,	PUNCT
dpc-4927	2	68	turkey	turkey	NOUN
dpc-4927	2	69	key	key	NOUN
dpc-4927	2	70	words	word	NOUN
dpc-4927	2	71	:	:	PUNCT
dpc-4927	2	72	proximal	proximal	ADJ
dpc-4927	2	73	nailfold	nailfold	ADJ
dpc-4927	2	74	dermoscopy	dermoscopy	NOUN
dpc-4927	2	75	,	,	PUNCT
dpc-4927	2	76	covid-19	covid-19	PROPN
dpc-4927	2	77	,	,	PUNCT
dpc-4927	2	78	capillaroscopy	capillaroscopy	ADJ
dpc-4927	2	79	citation	citation	NOUN
dpc-4927	2	80	:	:	PUNCT
dpc-4927	2	81	karstarli	karstarli	PROPN
dpc-4927	2	82	bakay	bakay	PROPN
dpc-4927	3	1	os	os	PROPN
dpc-4927	3	2	,	,	PUNCT
dpc-4927	3	3	cetin	cetin	NOUN
dpc-4927	3	4	n	n	CCONJ
dpc-4927	3	5	,	,	PUNCT
dpc-4927	3	6	bakay	bakay	PROPN
dpc-4927	3	7	u	u	NOUN
dpc-4927	3	8	,	,	PUNCT
dpc-4927	3	9	cinar	cinar	PROPN
dpc-4927	3	10	g	g	PROPN
dpc-4927	3	11	,	,	PUNCT
dpc-4927	3	12	goksin	goksin	PROPN
dpc-4927	3	13	s.	s.	PROPN
dpc-4927	3	14	beyond	beyond	ADP
dpc-4927	3	15	the	the	DET
dpc-4927	3	16	virus	virus	NOUN
dpc-4927	3	17	:	:	PUNCT
dpc-4927	3	18	proximal	proximal	ADJ
dpc-4927	3	19	nailfold	nailfold	NOUN
dpc-4927	3	20	dermoscopy	dermoscopy	VERB
dpc-4927	3	21	in	in	ADP
dpc-4927	3	22	covid-19	covid-19	PROPN
dpc-4927	3	23	patients	patient	NOUN
dpc-4927	3	24	.	.	PUNCT
dpc-4927	4	1	dermatol	dermatol	NOUN
dpc-4927	4	2	pract	pract	PROPN
dpc-4927	4	3	concept	concept	NOUN
dpc-4927	4	4	.	.	PUNCT
dpc-4927	5	1	2025;15(1):4927	2025;15(1):4927	NUM
dpc-4927	5	2	.	.	PUNCT
dpc-4927	6	1	doi	doi	NOUN
dpc-4927	6	2	:	:	PUNCT
dpc-4927	6	3	https://doi.org/10.5826/dpc.1501a4927	https://doi.org/10.5826/dpc.1501a4927	PROPN
dpc-4927	6	4	accepted	accept	VERB
dpc-4927	6	5	:	:	PUNCT
dpc-4927	6	6	november	november	PROPN
dpc-4927	6	7	10	10	NUM
dpc-4927	6	8	,	,	PUNCT
dpc-4927	6	9	2024	2024	NUM
dpc-4927	6	10	;	;	PUNCT
dpc-4927	6	11	published	publish	VERB
dpc-4927	6	12	:	:	PUNCT
dpc-4927	6	13	january	january	PROPN
dpc-4927	6	14	2025	2025	NUM
dpc-4927	6	15	copyright	copyright	NOUN
dpc-4927	6	16	:	:	PUNCT
dpc-4927	6	17	©	©	PROPN
dpc-4927	6	18	2024	2024	NUM
dpc-4927	6	19	karstarli	karstarli	NOUN
dpc-4927	6	20	bakay	bakay	PROPN
dpc-4927	6	21	et	et	PROPN
dpc-4927	6	22	al	al	PROPN
dpc-4927	6	23	.	.	PUNCT
dpc-4927	7	1	this	this	PRON
dpc-4927	7	2	is	be	AUX
dpc-4927	7	3	an	an	DET
dpc-4927	7	4	open	open	ADJ
dpc-4927	7	5	-	-	PUNCT
dpc-4927	7	6	access	access	NOUN
dpc-4927	7	7	article	article	NOUN
dpc-4927	7	8	distributed	distribute	VERB
dpc-4927	7	9	under	under	ADP
dpc-4927	7	10	the	the	DET
dpc-4927	7	11	terms	term	NOUN
dpc-4927	7	12	of	of	ADP
dpc-4927	7	13	the	the	DET
dpc-4927	7	14	creative	creative	ADJ
dpc-4927	7	15	commons	common	NOUN
dpc-4927	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4927	7	17	license	license	NOUN
dpc-4927	7	18	(	(	PUNCT
dpc-4927	7	19	by	by	ADP
dpc-4927	7	20	-	-	PUNCT
dpc-4927	7	21	nc-4.0	nc-4.0	NOUN
dpc-4927	7	22	)	)	PUNCT
dpc-4927	7	23	,	,	PUNCT
dpc-4927	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4927	7	25	,	,	PUNCT
dpc-4927	7	26	which	which	PRON
dpc-4927	7	27	permits	permit	VERB
dpc-4927	7	28	unrestricted	unrestricted	ADJ
dpc-4927	7	29	noncommercial	noncommercial	ADJ
dpc-4927	7	30	use	use	NOUN
dpc-4927	7	31	,	,	PUNCT
dpc-4927	7	32	distribution	distribution	NOUN
dpc-4927	7	33	,	,	PUNCT
dpc-4927	7	34	and	and	CCONJ
dpc-4927	7	35	reproduction	reproduction	NOUN
dpc-4927	7	36	in	in	ADP
dpc-4927	7	37	any	any	DET
dpc-4927	7	38	medium	medium	NOUN
dpc-4927	7	39	,	,	PUNCT
dpc-4927	7	40	provided	provide	VERB
dpc-4927	7	41	the	the	DET
dpc-4927	7	42	original	original	ADJ
dpc-4927	7	43	authors	author	NOUN
dpc-4927	7	44	and	and	CCONJ
dpc-4927	7	45	source	source	NOUN
dpc-4927	7	46	are	be	AUX
dpc-4927	7	47	credited	credit	VERB
dpc-4927	7	48	.	.	PUNCT
dpc-4927	8	1	funding	funding	NOUN
dpc-4927	8	2	:	:	PUNCT
dpc-4927	8	3	none	none	NOUN
dpc-4927	8	4	.	.	PUNCT
dpc-4927	9	1	competing	compete	VERB
dpc-4927	9	2	interests	interest	NOUN
dpc-4927	9	3	:	:	PUNCT
dpc-4927	9	4	none	none	NOUN
dpc-4927	9	5	.	.	PUNCT
dpc-4927	10	1	authorship	authorship	NOUN
dpc-4927	10	2	:	:	PUNCT
dpc-4927	10	3	oskb	oskb	NOUN
dpc-4927	10	4	and	and	CCONJ
dpc-4927	10	5	sg	sg	AUX
dpc-4927	10	6	designed	design	VERB
dpc-4927	10	7	and	and	CCONJ
dpc-4927	10	8	coordinated	coordinate	VERB
dpc-4927	10	9	the	the	DET
dpc-4927	10	10	study	study	NOUN
dpc-4927	10	11	.	.	PUNCT
dpc-4927	11	1	n.c	n.c	PROPN
dpc-4927	11	2	and	and	CCONJ
dpc-4927	11	3	g.c	g.c	PROPN
dpc-4927	11	4	collected	collect	VERB
dpc-4927	11	5	the	the	DET
dpc-4927	11	6	data	datum	NOUN
dpc-4927	11	7	and	and	CCONJ
dpc-4927	11	8	took	take	VERB
dpc-4927	11	9	dermoscopic	dermoscopic	ADJ
dpc-4927	11	10	images	image	NOUN
dpc-4927	11	11	.	.	PUNCT
dpc-4927	12	1	oskb	oskb	NOUN
dpc-4927	12	2	and	and	CCONJ
dpc-4927	12	3	ub	ub	NOUN
dpc-4927	12	4	were	be	AUX
dpc-4927	12	5	involved	involve	VERB
dpc-4927	12	6	in	in	ADP
dpc-4927	12	7	data	datum	NOUN
dpc-4927	12	8	interpretation	interpretation	NOUN
dpc-4927	12	9	and	and	CCONJ
dpc-4927	12	10	drafted	draft	VERB
dpc-4927	12	11	the	the	DET
dpc-4927	12	12	manuscript	manuscript	NOUN
dpc-4927	12	13	.	.	PUNCT
dpc-4927	13	1	all	all	DET
dpc-4927	13	2	authors	author	NOUN
dpc-4927	13	3	proofread	proofread	VERB
dpc-4927	13	4	and	and	CCONJ
dpc-4927	13	5	approved	approve	VERB
dpc-4927	13	6	the	the	DET
dpc-4927	13	7	final	final	ADJ
dpc-4927	13	8	version	version	NOUN
dpc-4927	13	9	of	of	ADP
dpc-4927	13	10	the	the	DET
dpc-4927	13	11	manuscript	manuscript	NOUN
dpc-4927	13	12	.	.	PUNCT
dpc-4927	14	1	corresponding	correspond	VERB
dpc-4927	14	2	author	author	NOUN
dpc-4927	14	3	:	:	PUNCT
dpc-4927	14	4	ozge	ozge	PROPN
dpc-4927	14	5	sevil	sevil	PROPN
dpc-4927	14	6	karstarli	karstarli	PROPN
dpc-4927	14	7	bakay	bakay	PROPN
dpc-4927	14	8	,	,	PUNCT
dpc-4927	14	9	md	md	PROPN
dpc-4927	14	10	;	;	PUNCT
dpc-4927	14	11	department	department	NOUN
dpc-4927	14	12	of	of	ADP
dpc-4927	14	13	dermatology	dermatology	NOUN
dpc-4927	14	14	,	,	PUNCT
dpc-4927	14	15	pamukkale	pamukkale	PROPN
dpc-4927	14	16	university	university	NOUN
dpc-4927	14	17	faculty	faculty	NOUN
dpc-4927	14	18	of	of	ADP
dpc-4927	14	19	medicine	medicine	NOUN
dpc-4927	14	20	,	,	PUNCT
dpc-4927	14	21	kinikli	kinikli	PROPN
dpc-4927	14	22	street	street	PROPN
dpc-4927	14	23	,	,	PUNCT
dpc-4927	14	24	20070	20070	NUM
dpc-4927	14	25	.	.	PUNCT
dpc-4927	15	1	phone	phone	NOUN
dpc-4927	15	2	:	:	PUNCT
dpc-4927	15	3	+905376755441	+905376755441	NUM
dpc-4927	15	4	e	e	X
dpc-4927	15	5	-	-	NOUN
dpc-4927	15	6	mail	mail	NOUN
dpc-4927	15	7	:	:	PUNCT
dpc-4927	16	1	ozgekarstarli@hotmail.com	ozgekarstarli@hotmail.com	X
dpc-4927	16	2	introduction	introduction	NOUN
dpc-4927	16	3	:	:	PUNCT
dpc-4927	16	4	endothelial	endothelial	ADJ
dpc-4927	16	5	damage	damage	NOUN
dpc-4927	16	6	is	be	AUX
dpc-4927	16	7	associated	associate	VERB
dpc-4927	16	8	with	with	ADP
dpc-4927	16	9	acute	acute	ADJ
dpc-4927	16	10	and	and	CCONJ
dpc-4927	16	11	long	long	ADJ
dpc-4927	16	12	-	-	PUNCT
dpc-4927	16	13	term	term	NOUN
dpc-4927	16	14	coronavirus	coronavirus	NOUN
dpc-4927	16	15	disease	disease	NOUN
dpc-4927	16	16	2019	2019	NUM
dpc-4927	16	17	(	(	PUNCT
dpc-4927	16	18	covid-19	covid-19	PROPN
dpc-4927	16	19	)	)	PUNCT
dpc-4927	16	20	complications	complication	NOUN
dpc-4927	16	21	.	.	PUNCT
dpc-4927	17	1	proximal	proximal	ADJ
dpc-4927	17	2	nailfold	nailfold	NOUN
dpc-4927	17	3	capillaries	capillary	NOUN
dpc-4927	17	4	and	and	CCONJ
dpc-4927	17	5	nail	nail	NOUN
dpc-4927	17	6	beds	bed	NOUN
dpc-4927	17	7	give	give	VERB
dpc-4927	17	8	important	important	ADJ
dpc-4927	17	9	clues	clue	NOUN
dpc-4927	17	10	to	to	PART
dpc-4927	17	11	microvascular	microvascular	VERB
dpc-4927	17	12	changes	change	NOUN
dpc-4927	17	13	associated	associate	VERB
dpc-4927	17	14	with	with	ADP
dpc-4927	17	15	endothelial	endothelial	ADJ
dpc-4927	17	16	dysfunction	dysfunction	NOUN
dpc-4927	17	17	.	.	PUNCT
dpc-4927	18	1	objective	objective	NOUN
dpc-4927	18	2	:	:	PUNCT
dpc-4927	19	1	we	we	PRON
dpc-4927	19	2	aimed	aim	VERB
dpc-4927	19	3	to	to	PART
dpc-4927	19	4	use	use	VERB
dpc-4927	19	5	dermoscopy	dermoscopy	NOUN
dpc-4927	19	6	to	to	PART
dpc-4927	19	7	examine	examine	VERB
dpc-4927	19	8	the	the	DET
dpc-4927	19	9	proximal	proximal	ADJ
dpc-4927	19	10	nailfold	nailfold	NOUN
dpc-4927	19	11	capillaries	capillary	NOUN
dpc-4927	19	12	and	and	CCONJ
dpc-4927	19	13	nail	nail	NOUN
dpc-4927	19	14	bed	bed	NOUN
dpc-4927	19	15	of	of	ADP
dpc-4927	19	16	covid-19	covid-19	PROPN
dpc-4927	19	17	patients	patient	NOUN
dpc-4927	19	18	and	and	CCONJ
dpc-4927	19	19	identify	identify	VERB
dpc-4927	19	20	microvascular	microvascular	ADJ
dpc-4927	19	21	changes	change	NOUN
dpc-4927	19	22	.	.	PUNCT
dpc-4927	20	1	methods	method	NOUN
dpc-4927	20	2	:	:	PUNCT
dpc-4927	20	3	a	a	DET
dpc-4927	20	4	prospective	prospective	ADJ
dpc-4927	20	5	study	study	NOUN
dpc-4927	20	6	was	be	AUX
dpc-4927	20	7	designed	design	VERB
dpc-4927	20	8	to	to	PART
dpc-4927	20	9	evaluate	evaluate	VERB
dpc-4927	20	10	the	the	DET
dpc-4927	20	11	dermoscopic	dermoscopic	ADJ
dpc-4927	20	12	features	feature	NOUN
dpc-4927	20	13	of	of	ADP
dpc-4927	20	14	proximal	proximal	ADJ
dpc-4927	20	15	nail	nail	NOUN
dpc-4927	20	16	fold	fold	NOUN
dpc-4927	20	17	capillaries	capillary	NOUN
dpc-4927	20	18	and	and	CCONJ
dpc-4927	20	19	nail	nail	NOUN
dpc-4927	20	20	bed	bed	NOUN
dpc-4927	20	21	in	in	ADP
dpc-4927	20	22	mild	mild	ADJ
dpc-4927	20	23	-	-	PUNCT
dpc-4927	20	24	to	to	ADP
dpc-4927	20	25	-	-	PUNCT
dpc-4927	20	26	moderate	moderate	ADJ
dpc-4927	20	27	covid-19	covid-19	PROPN
dpc-4927	20	28	patients	patient	NOUN
dpc-4927	20	29	and	and	CCONJ
dpc-4927	20	30	healthy	healthy	ADJ
dpc-4927	20	31	controls	control	NOUN
dpc-4927	20	32	between	between	ADP
dpc-4927	20	33	june	june	PROPN
dpc-4927	20	34	2022	2022	NUM
dpc-4927	20	35	and	and	CCONJ
dpc-4927	20	36	december	december	PROPN
dpc-4927	20	37	2023	2023	NUM
dpc-4927	20	38	.	.	PUNCT
dpc-4927	21	1	the	the	DET
dpc-4927	21	2	patients	patient	NOUN
dpc-4927	21	3	underwent	undergo	VERB
dpc-4927	21	4	their	their	PRON
dpc-4927	21	5	initial	initial	ADJ
dpc-4927	21	6	dermoscopic	dermoscopic	ADJ
dpc-4927	21	7	examination	examination	NOUN
dpc-4927	21	8	two	two	NUM
dpc-4927	21	9	weeks	week	NOUN
dpc-4927	21	10	after	after	ADP
dpc-4927	21	11	the	the	DET
dpc-4927	21	12	onset	onset	NOUN
dpc-4927	21	13	of	of	ADP
dpc-4927	21	14	symptoms	symptom	NOUN
dpc-4927	21	15	,	,	PUNCT
dpc-4927	21	16	followed	follow	VERB
dpc-4927	21	17	by	by	ADP
dpc-4927	21	18	a	a	DET
dpc-4927	21	19	follow	follow	VERB
dpc-4927	21	20	-	-	PUNCT
dpc-4927	21	21	up	up	NOUN
dpc-4927	21	22	evaluation	evaluation	NOUN
dpc-4927	21	23	10	10	NUM
dpc-4927	21	24	-	-	SYM
dpc-4927	21	25	14	14	NUM
dpc-4927	21	26	months	month	NOUN
dpc-4927	21	27	later	later	ADV
dpc-4927	21	28	.	.	PUNCT
dpc-4927	22	1	results	result	NOUN
dpc-4927	22	2	:	:	PUNCT
dpc-4927	22	3	the	the	DET
dpc-4927	22	4	study	study	NOUN
dpc-4927	22	5	included	include	VERB
dpc-4927	22	6	46	46	NUM
dpc-4927	22	7	patients	patient	NOUN
dpc-4927	22	8	with	with	ADP
dpc-4927	22	9	mild	mild	ADJ
dpc-4927	22	10	-	-	PUNCT
dpc-4927	22	11	to	to	ADP
dpc-4927	22	12	-	-	PUNCT
dpc-4927	22	13	moderate	moderate	ADJ
dpc-4927	22	14	covid-19	covid-19	PROPN
dpc-4927	22	15	and	and	CCONJ
dpc-4927	22	16	62	62	NUM
dpc-4927	22	17	healthy	healthy	ADJ
dpc-4927	22	18	controls	control	NOUN
dpc-4927	22	19	.	.	PUNCT
dpc-4927	23	1	the	the	DET
dpc-4927	23	2	presence	presence	NOUN
dpc-4927	23	3	of	of	ADP
dpc-4927	23	4	avascular	avascular	ADJ
dpc-4927	23	5	areas	area	NOUN
dpc-4927	23	6	(	(	PUNCT
dpc-4927	23	7	p	p	X
dpc-4927	23	8	<	<	X
dpc-4927	23	9	0.001	0.001	NUM
dpc-4927	23	10	)	)	PUNCT
dpc-4927	23	11	,	,	PUNCT
dpc-4927	23	12	meandering	meander	VERB
dpc-4927	23	13	capillaries	capillary	NOUN
dpc-4927	23	14	(	(	PUNCT
dpc-4927	23	15	p	p	X
dpc-4927	23	16	=	=	NOUN
dpc-4927	23	17	0.016	0.016	NUM
dpc-4927	23	18	)	)	PUNCT
dpc-4927	23	19	,	,	PUNCT
dpc-4927	23	20	microhemorrhages	microhemorrhage	VERB
dpc-4927	23	21	(	(	PUNCT
dpc-4927	23	22	p	p	X
dpc-4927	23	23	=	=	NOUN
dpc-4927	23	24	0.007	0.007	NUM
dpc-4927	23	25	)	)	PUNCT
dpc-4927	23	26	,	,	PUNCT
dpc-4927	23	27	and	and	CCONJ
dpc-4927	23	28	enlarged	enlarge	VERB
dpc-4927	23	29	capillaries	capillary	NOUN
dpc-4927	23	30	(	(	PUNCT
dpc-4927	23	31	p	p	NOUN
dpc-4927	23	32	=	=	NOUN
dpc-4927	23	33	0.009	0.009	NUM
dpc-4927	23	34	)	)	PUNCT
dpc-4927	23	35	in	in	ADP
dpc-4927	23	36	the	the	DET
dpc-4927	23	37	proximal	proximal	ADJ
dpc-4927	23	38	nail	nail	NOUN
dpc-4927	23	39	fold	fold	NOUN
dpc-4927	23	40	was	be	AUX
dpc-4927	23	41	significantly	significantly	ADV
dpc-4927	23	42	higher	high	ADJ
dpc-4927	23	43	in	in	ADP
dpc-4927	23	44	covid-19	covid-19	PROPN
dpc-4927	23	45	patients	patient	NOUN
dpc-4927	23	46	than	than	ADP
dpc-4927	23	47	in	in	ADP
dpc-4927	23	48	healthy	healthy	ADJ
dpc-4927	23	49	controls	control	NOUN
dpc-4927	23	50	.	.	PUNCT
dpc-4927	24	1	the	the	DET
dpc-4927	24	2	capillary	capillary	ADJ
dpc-4927	24	3	architecture	architecture	NOUN
dpc-4927	24	4	was	be	AUX
dpc-4927	24	5	disorganized	disorganized	ADJ
dpc-4927	24	6	(	(	PUNCT
dpc-4927	24	7	p	p	X
dpc-4927	24	8	=	=	NOUN
dpc-4927	24	9	0.002	0.002	NUM
dpc-4927	24	10	)	)	PUNCT
dpc-4927	24	11	and	and	CCONJ
dpc-4927	24	12	density	density	NOUN
dpc-4927	24	13	reduced	reduce	VERB
dpc-4927	24	14	(	(	PUNCT
dpc-4927	24	15	p	p	X
dpc-4927	24	16	<	<	X
dpc-4927	24	17	0.001	0.001	NUM
dpc-4927	24	18	)	)	PUNCT
dpc-4927	24	19	in	in	ADP
dpc-4927	24	20	covid-19	covid-19	PROPN
dpc-4927	24	21	patients	patient	NOUN
dpc-4927	24	22	compared	compare	VERB
dpc-4927	24	23	to	to	ADP
dpc-4927	24	24	healthy	healthy	ADJ
dpc-4927	24	25	controls	control	NOUN
dpc-4927	24	26	.	.	PUNCT
dpc-4927	25	1	in	in	ADP
dpc-4927	25	2	the	the	DET
dpc-4927	25	3	follow	follow	NOUN
dpc-4927	25	4	-	-	PUNCT
dpc-4927	25	5	up	up	ADP
dpc-4927	25	6	examination	examination	NOUN
dpc-4927	25	7	,	,	PUNCT
dpc-4927	25	8	microvascular	microvascular	ADJ
dpc-4927	25	9	changes	change	NOUN
dpc-4927	25	10	were	be	AUX
dpc-4927	25	11	observed	observe	VERB
dpc-4927	25	12	to	to	PART
dpc-4927	25	13	have	have	AUX
dpc-4927	25	14	regressed	regress	VERB
dpc-4927	25	15	.	.	PUNCT
dpc-4927	26	1	conclusions	conclusion	NOUN
dpc-4927	26	2	:	:	PUNCT
dpc-4927	26	3	proximal	proximal	ADJ
dpc-4927	26	4	nailfold	nailfold	ADJ
dpc-4927	26	5	dermoscopy	dermoscopy	NOUN
dpc-4927	26	6	is	be	AUX
dpc-4927	26	7	an	an	DET
dpc-4927	26	8	effective	effective	ADJ
dpc-4927	26	9	,	,	PUNCT
dpc-4927	26	10	low	low	ADJ
dpc-4927	26	11	-	-	PUNCT
dpc-4927	26	12	cost	cost	NOUN
dpc-4927	26	13	,	,	PUNCT
dpc-4927	26	14	easily	easily	ADV
dpc-4927	26	15	accessible	accessible	ADJ
dpc-4927	26	16	method	method	NOUN
dpc-4927	26	17	that	that	PRON
dpc-4927	26	18	enables	enable	VERB
dpc-4927	26	19	observation	observation	NOUN
dpc-4927	26	20	of	of	ADP
dpc-4927	26	21	microvascular	microvascular	ADJ
dpc-4927	26	22	changes	change	NOUN
dpc-4927	26	23	in	in	ADP
dpc-4927	26	24	covid-19	covid-19	PROPN
dpc-4927	26	25	patients	patient	NOUN
dpc-4927	26	26	.	.	PUNCT
dpc-4927	27	1	abstract	abstract	ADJ
dpc-4927	27	2	2	2	NUM
dpc-4927	27	3	original	original	ADJ
dpc-4927	27	4	article	article	NOUN
dpc-4927	27	5	|	|	ADV
dpc-4927	27	6	dermatol	dermatol	ADJ
dpc-4927	27	7	pract	pract	NOUN
dpc-4927	27	8	concept	concept	NOUN
dpc-4927	27	9	.	.	PUNCT
dpc-4927	28	1	2025;15(1):4927	2025;15(1):4927	NUM
dpc-4927	28	2	introduction	introduction	NOUN
dpc-4927	28	3	coronavirus	coronavirus	NOUN
dpc-4927	28	4	disease	disease	NOUN
dpc-4927	28	5	2019	2019	NUM
dpc-4927	28	6	(	(	PUNCT
dpc-4927	28	7	covid-19	covid-19	PROPN
dpc-4927	28	8	)	)	PUNCT
dpc-4927	28	9	,	,	PUNCT
dpc-4927	28	10	caused	cause	VERB
dpc-4927	28	11	by	by	ADP
dpc-4927	28	12	severe	severe	ADJ
dpc-4927	28	13	acute	acute	ADJ
dpc-4927	28	14	respiratory	respiratory	ADJ
dpc-4927	28	15	syndrome	syndrome	NOUN
dpc-4927	28	16	coronavirus-2	coronavirus-2	NUM
dpc-4927	28	17	(	(	PUNCT
dpc-4927	28	18	sars	sar	NOUN
dpc-4927	28	19	-	-	PUNCT
dpc-4927	28	20	cov-2	cov-2	NOUN
dpc-4927	28	21	)	)	PUNCT
dpc-4927	28	22	,	,	PUNCT
dpc-4927	28	23	has	have	VERB
dpc-4927	28	24	a	a	DET
dpc-4927	28	25	broad	broad	ADJ
dpc-4927	28	26	range	range	NOUN
dpc-4927	28	27	of	of	ADP
dpc-4927	28	28	clinical	clinical	ADJ
dpc-4927	28	29	manifestations	manifestation	NOUN
dpc-4927	28	30	,	,	PUNCT
dpc-4927	28	31	from	from	ADP
dpc-4927	28	32	mild	mild	ADJ
dpc-4927	28	33	flulike	flulike	NOUN
dpc-4927	28	34	illness	illness	NOUN
dpc-4927	28	35	to	to	ADP
dpc-4927	28	36	severe	severe	ADJ
dpc-4927	28	37	,	,	PUNCT
dpc-4927	28	38	potentially	potentially	ADV
dpc-4927	28	39	fatal	fatal	ADJ
dpc-4927	28	40	outcomes	outcome	NOUN
dpc-4927	28	41	[	[	X
dpc-4927	28	42	1	1	NUM
dpc-4927	28	43	]	]	PUNCT
dpc-4927	28	44	.	.	PUNCT
dpc-4927	29	1	the	the	DET
dpc-4927	29	2	first	first	ADJ
dpc-4927	29	3	data	datum	NOUN
dpc-4927	29	4	providing	provide	VERB
dpc-4927	29	5	an	an	DET
dpc-4927	29	6	understanding	understanding	NOUN
dpc-4927	29	7	of	of	ADP
dpc-4927	29	8	the	the	DET
dpc-4927	29	9	pathogenesis	pathogenesis	NOUN
dpc-4927	29	10	of	of	ADP
dpc-4927	29	11	the	the	DET
dpc-4927	29	12	disease	disease	NOUN
dpc-4927	29	13	were	be	AUX
dpc-4927	29	14	obtained	obtain	VERB
dpc-4927	29	15	from	from	ADP
dpc-4927	29	16	autopsies	autopsy	NOUN
dpc-4927	29	17	of	of	ADP
dpc-4927	29	18	patients	patient	NOUN
dpc-4927	29	19	who	who	PRON
dpc-4927	29	20	died	die	VERB
dpc-4927	29	21	with	with	ADP
dpc-4927	29	22	severe	severe	ADJ
dpc-4927	29	23	disease	disease	NOUN
dpc-4927	29	24	.	.	PUNCT
dpc-4927	30	1	it	it	PRON
dpc-4927	30	2	has	have	AUX
dpc-4927	30	3	been	be	AUX
dpc-4927	30	4	reported	report	VERB
dpc-4927	30	5	that	that	SCONJ
dpc-4927	30	6	endothelial	endothelial	ADJ
dpc-4927	30	7	damage	damage	NOUN
dpc-4927	30	8	caused	cause	VERB
dpc-4927	30	9	by	by	ADP
dpc-4927	30	10	sars	sar	NOUN
dpc-4927	30	11	-	-	PUNCT
dpc-4927	30	12	cov-2	cov-2	NOUN
dpc-4927	30	13	cell	cell	NOUN
dpc-4927	30	14	invasion	invasion	NOUN
dpc-4927	30	15	and	and	CCONJ
dpc-4927	30	16	disturbance	disturbance	NOUN
dpc-4927	30	17	in	in	ADP
dpc-4927	30	18	inflammation	inflammation	NOUN
dpc-4927	30	19	and	and	CCONJ
dpc-4927	30	20	coagulation	coagulation	NOUN
dpc-4927	30	21	pathways	pathway	NOUN
dpc-4927	30	22	may	may	AUX
dpc-4927	30	23	lead	lead	VERB
dpc-4927	30	24	to	to	ADP
dpc-4927	30	25	microcirculatory	microcirculatory	ADJ
dpc-4927	30	26	disorders	disorder	NOUN
dpc-4927	30	27	and	and	CCONJ
dpc-4927	30	28	multiple	multiple	ADJ
dpc-4927	30	29	organ	organ	NOUN
dpc-4927	30	30	failure	failure	NOUN
dpc-4927	30	31	[	[	X
dpc-4927	30	32	2	2	NUM
dpc-4927	30	33	]	]	PUNCT
dpc-4927	30	34	.	.	PUNCT
dpc-4927	31	1	over	over	ADP
dpc-4927	31	2	time	time	NOUN
dpc-4927	31	3	,	,	PUNCT
dpc-4927	31	4	data	datum	NOUN
dpc-4927	31	5	showing	show	VERB
dpc-4927	31	6	that	that	SCONJ
dpc-4927	31	7	endothelial	endothelial	ADJ
dpc-4927	31	8	damage	damage	NOUN
dpc-4927	31	9	is	be	AUX
dpc-4927	31	10	present	present	ADJ
dpc-4927	31	11	not	not	PART
dpc-4927	31	12	only	only	ADV
dpc-4927	31	13	in	in	ADP
dpc-4927	31	14	severe	severe	ADJ
dpc-4927	31	15	disease	disease	NOUN
dpc-4927	31	16	but	but	CCONJ
dpc-4927	31	17	also	also	ADV
dpc-4927	31	18	in	in	SCONJ
dpc-4927	31	19	mild	mild	ADJ
dpc-4927	31	20	disease	disease	NOUN
dpc-4927	31	21	findings	finding	NOUN
dpc-4927	31	22	have	have	AUX
dpc-4927	31	23	been	be	AUX
dpc-4927	31	24	shared	share	VERB
dpc-4927	31	25	[	[	PUNCT
dpc-4927	31	26	3	3	NUM
dpc-4927	31	27	]	]	PUNCT
dpc-4927	31	28	.	.	PUNCT
dpc-4927	32	1	several	several	ADJ
dpc-4927	32	2	studies	study	NOUN
dpc-4927	32	3	have	have	AUX
dpc-4927	32	4	focused	focus	VERB
dpc-4927	32	5	on	on	ADP
dpc-4927	32	6	defining	define	VERB
dpc-4927	32	7	endothelial	endothelial	ADJ
dpc-4927	32	8	damage	damage	NOUN
dpc-4927	32	9	caused	cause	VERB
dpc-4927	32	10	by	by	ADP
dpc-4927	32	11	covid-19	covid-19	PROPN
dpc-4927	32	12	in	in	ADP
dpc-4927	32	13	patients	patient	NOUN
dpc-4927	32	14	of	of	ADP
dpc-4927	32	15	varying	vary	VERB
dpc-4927	32	16	severity	severity	NOUN
dpc-4927	32	17	[	[	X
dpc-4927	32	18	4	4	NUM
dpc-4927	32	19	-	-	SYM
dpc-4927	32	20	9	9	NUM
dpc-4927	32	21	]	]	PUNCT
dpc-4927	32	22	.	.	PUNCT
dpc-4927	33	1	it	it	PRON
dpc-4927	33	2	has	have	AUX
dpc-4927	33	3	been	be	AUX
dpc-4927	33	4	reported	report	VERB
dpc-4927	33	5	that	that	SCONJ
dpc-4927	33	6	some	some	DET
dpc-4927	33	7	biomarkers	biomarker	NOUN
dpc-4927	33	8	such	such	ADJ
dpc-4927	33	9	as	as	ADP
dpc-4927	33	10	von	von	PROPN
dpc-4927	33	11	willebrand	willebrand	PROPN
dpc-4927	33	12	factor	factor	NOUN
dpc-4927	33	13	(	(	PUNCT
dpc-4927	33	14	vwf	vwf	NOUN
dpc-4927	33	15	)	)	PUNCT
dpc-4927	33	16	,	,	PUNCT
dpc-4927	33	17	tissue	tissue	NOUN
dpc-4927	33	18	-	-	PUNCT
dpc-4927	33	19	type	type	NOUN
dpc-4927	33	20	plasminogen	plasminogen	NOUN
dpc-4927	33	21	activator	activator	NOUN
dpc-4927	33	22	(	(	PUNCT
dpc-4927	33	23	t	t	PROPN
dpc-4927	33	24	-	-	PUNCT
dpc-4927	33	25	pa	pa	PROPN
dpc-4927	33	26	)	)	PUNCT
dpc-4927	33	27	,	,	PUNCT
dpc-4927	33	28	plasminogen	plasminogen	NOUN
dpc-4927	33	29	activator	activator	NOUN
dpc-4927	33	30	inhibitor-1	inhibitor-1	PUNCT
dpc-4927	33	31	antigen	antigen	NOUN
dpc-4927	33	32	(	(	PUNCT
dpc-4927	33	33	pai-1	pai-1	X
dpc-4927	33	34	)	)	PUNCT
dpc-4927	33	35	antigen	antigen	ADJ
dpc-4927	33	36	,	,	PUNCT
dpc-4927	33	37	and	and	CCONJ
dpc-4927	33	38	soluble	soluble	ADJ
dpc-4927	33	39	thrombomodulin	thrombomodulin	PROPN
dpc-4927	33	40	(	(	PUNCT
dpc-4927	33	41	stm	stm	PROPN
dpc-4927	33	42	)	)	PUNCT
dpc-4927	33	43	can	can	AUX
dpc-4927	33	44	be	be	AUX
dpc-4927	33	45	used	use	VERB
dpc-4927	33	46	as	as	ADP
dpc-4927	33	47	indicators	indicator	NOUN
dpc-4927	33	48	of	of	ADP
dpc-4927	33	49	endothelial	endothelial	ADJ
dpc-4927	33	50	dysfunction	dysfunction	NOUN
dpc-4927	33	51	in	in	ADP
dpc-4927	33	52	covid-19	covid-19	PROPN
dpc-4927	33	53	patients	patient	NOUN
dpc-4927	33	54	[	[	X
dpc-4927	33	55	7	7	NUM
dpc-4927	33	56	-	-	SYM
dpc-4927	33	57	9	9	NUM
dpc-4927	33	58	]	]	PUNCT
dpc-4927	33	59	.	.	PUNCT
dpc-4927	34	1	these	these	DET
dpc-4927	34	2	biomarkers	biomarker	NOUN
dpc-4927	34	3	are	be	AUX
dpc-4927	34	4	challenging	challenge	VERB
dpc-4927	34	5	to	to	PART
dpc-4927	34	6	use	use	VERB
dpc-4927	34	7	routinely	routinely	ADV
dpc-4927	34	8	because	because	SCONJ
dpc-4927	34	9	they	they	PRON
dpc-4927	34	10	are	be	AUX
dpc-4927	34	11	not	not	PART
dpc-4927	34	12	readily	readily	ADV
dpc-4927	34	13	accessible	accessible	ADJ
dpc-4927	34	14	or	or	CCONJ
dpc-4927	34	15	cost	cost	NOUN
dpc-4927	34	16	-	-	PUNCT
dpc-4927	34	17	effective	effective	ADJ
dpc-4927	34	18	in	in	ADP
dpc-4927	34	19	daily	daily	ADJ
dpc-4927	34	20	practice	practice	NOUN
dpc-4927	34	21	.	.	PUNCT
dpc-4927	35	1	as	as	ADP
dpc-4927	35	2	an	an	DET
dpc-4927	35	3	alternative	alternative	NOUN
dpc-4927	35	4	to	to	ADP
dpc-4927	35	5	these	these	DET
dpc-4927	35	6	biomarkers	biomarker	NOUN
dpc-4927	35	7	,	,	PUNCT
dpc-4927	35	8	nailfold	nailfold	ADJ
dpc-4927	35	9	videocapillaroscopy	videocapillaroscopy	NOUN
dpc-4927	35	10	has	have	AUX
dpc-4927	35	11	been	be	AUX
dpc-4927	35	12	used	use	VERB
dpc-4927	35	13	to	to	PART
dpc-4927	35	14	demonstrate	demonstrate	VERB
dpc-4927	35	15	endotheliopathy	endotheliopathy	ADJ
dpc-4927	35	16	in	in	ADP
dpc-4927	35	17	covid-19	covid-19	PROPN
dpc-4927	35	18	patients	patient	NOUN
dpc-4927	35	19	[	[	X
dpc-4927	35	20	10	10	NUM
dpc-4927	35	21	-	-	SYM
dpc-4927	35	22	16	16	NUM
dpc-4927	35	23	]	]	PUNCT
dpc-4927	35	24	.	.	PUNCT
dpc-4927	36	1	nailfold	nailfold	PROPN
dpc-4927	36	2	video	video	PROPN
dpc-4927	36	3	capillaroscopy	capillaroscopy	PROPN
dpc-4927	36	4	(	(	PUNCT
dpc-4927	36	5	nvc	nvc	NOUN
dpc-4927	36	6	)	)	PUNCT
dpc-4927	36	7	providing	provide	VERB
dpc-4927	36	8	x	x	PUNCT
dpc-4927	36	9	200	200	NUM
dpc-4927	36	10	magnification	magnification	NOUN
dpc-4927	36	11	is	be	AUX
dpc-4927	36	12	the	the	DET
dpc-4927	36	13	gold	gold	ADJ
dpc-4927	36	14	standard	standard	NOUN
dpc-4927	36	15	for	for	ADP
dpc-4927	36	16	detecting	detect	VERB
dpc-4927	36	17	nailfold	nailfold	ADJ
dpc-4927	36	18	capillary	capillary	ADJ
dpc-4927	36	19	abnormalities	abnormality	NOUN
dpc-4927	36	20	.	.	PUNCT
dpc-4927	37	1	however	however	ADV
dpc-4927	37	2	,	,	PUNCT
dpc-4927	37	3	it	it	PRON
dpc-4927	37	4	requires	require	VERB
dpc-4927	37	5	special	special	ADJ
dpc-4927	37	6	equipment	equipment	NOUN
dpc-4927	37	7	and	and	CCONJ
dpc-4927	37	8	is	be	AUX
dpc-4927	37	9	not	not	PART
dpc-4927	37	10	easily	easily	ADV
dpc-4927	37	11	accessible	accessible	ADJ
dpc-4927	37	12	[	[	X
dpc-4927	37	13	17	17	NUM
dpc-4927	37	14	]	]	PUNCT
dpc-4927	37	15	.	.	PUNCT
dpc-4927	38	1	some	some	DET
dpc-4927	38	2	studies	study	NOUN
dpc-4927	38	3	have	have	AUX
dpc-4927	38	4	shown	show	VERB
dpc-4927	38	5	that	that	SCONJ
dpc-4927	38	6	the	the	DET
dpc-4927	38	7	dermoscope	dermoscope	NOUN
dpc-4927	38	8	,	,	PUNCT
dpc-4927	38	9	a	a	DET
dpc-4927	38	10	more	more	ADV
dpc-4927	38	11	widely	widely	ADV
dpc-4927	38	12	used	use	VERB
dpc-4927	38	13	,	,	PUNCT
dpc-4927	38	14	practical	practical	ADJ
dpc-4927	38	15	,	,	PUNCT
dpc-4927	38	16	and	and	CCONJ
dpc-4927	38	17	cheaper	cheap	ADJ
dpc-4927	38	18	tool	tool	NOUN
dpc-4927	38	19	,	,	PUNCT
dpc-4927	38	20	can	can	AUX
dpc-4927	38	21	be	be	AUX
dpc-4927	38	22	used	use	VERB
dpc-4927	38	23	instead	instead	ADV
dpc-4927	38	24	of	of	ADP
dpc-4927	38	25	nvc	nvc	NOUN
dpc-4927	38	26	in	in	ADP
dpc-4927	38	27	cases	case	NOUN
dpc-4927	38	28	that	that	PRON
dpc-4927	38	29	cause	cause	VERB
dpc-4927	38	30	microvascular	microvascular	ADJ
dpc-4927	38	31	damage	damage	NOUN
dpc-4927	38	32	such	such	ADJ
dpc-4927	38	33	as	as	ADP
dpc-4927	38	34	systemic	systemic	ADJ
dpc-4927	38	35	sclerosis	sclerosis	NOUN
dpc-4927	39	1	[	[	X
dpc-4927	39	2	17	17	NUM
dpc-4927	39	3	-	-	SYM
dpc-4927	39	4	19	19	NUM
dpc-4927	39	5	]	]	PUNCT
dpc-4927	39	6	.	.	PUNCT
dpc-4927	40	1	objective	objective	ADJ
dpc-4927	40	2	our	our	PRON
dpc-4927	40	3	study	study	NOUN
dpc-4927	40	4	aimed	aim	VERB
dpc-4927	40	5	to	to	PART
dpc-4927	40	6	describe	describe	VERB
dpc-4927	40	7	the	the	DET
dpc-4927	40	8	dermoscopic	dermoscopic	ADJ
dpc-4927	40	9	findings	finding	NOUN
dpc-4927	40	10	of	of	ADP
dpc-4927	40	11	the	the	DET
dpc-4927	40	12	proximal	proximal	ADJ
dpc-4927	40	13	nailfold	nailfold	NOUN
dpc-4927	40	14	and	and	CCONJ
dpc-4927	40	15	nail	nail	NOUN
dpc-4927	40	16	bed	bed	NOUN
dpc-4927	40	17	in	in	ADP
dpc-4927	40	18	covid-19	covid-19	PROPN
dpc-4927	40	19	patients	patient	NOUN
dpc-4927	40	20	.	.	PUNCT
dpc-4927	41	1	in	in	ADP
dpc-4927	41	2	addition	addition	NOUN
dpc-4927	41	3	,	,	PUNCT
dpc-4927	41	4	we	we	PRON
dpc-4927	41	5	aimed	aim	VERB
dpc-4927	41	6	to	to	PART
dpc-4927	41	7	identify	identify	VERB
dpc-4927	41	8	potential	potential	ADJ
dpc-4927	41	9	microvascular	microvascular	ADJ
dpc-4927	41	10	abnormalities	abnormality	NOUN
dpc-4927	41	11	through	through	ADP
dpc-4927	41	12	dermoscopic	dermoscopic	NOUN
dpc-4927	41	13	observations	observation	NOUN
dpc-4927	41	14	.	.	PUNCT
dpc-4927	42	1	methods	method	NOUN
dpc-4927	42	2	study	study	VERB
dpc-4927	42	3	population	population	NOUN
dpc-4927	42	4	the	the	DET
dpc-4927	42	5	study	study	NOUN
dpc-4927	42	6	involved	involve	VERB
dpc-4927	42	7	46	46	NUM
dpc-4927	42	8	mild	mild	ADJ
dpc-4927	42	9	-	-	PUNCT
dpc-4927	42	10	to	to	ADP
dpc-4927	42	11	-	-	PUNCT
dpc-4927	42	12	moderate	moderate	ADJ
dpc-4927	42	13	covid-19	covid-19	PROPN
dpc-4927	42	14	patients	patient	NOUN
dpc-4927	42	15	at	at	ADP
dpc-4927	42	16	pamukkale	pamukkale	PROPN
dpc-4927	42	17	university	university	PROPN
dpc-4927	42	18	between	between	ADP
dpc-4927	42	19	june	june	PROPN
dpc-4927	42	20	2022	2022	NUM
dpc-4927	42	21	and	and	CCONJ
dpc-4927	42	22	december	december	PROPN
dpc-4927	42	23	2023	2023	NUM
dpc-4927	42	24	,	,	PUNCT
dpc-4927	42	25	along	along	ADP
dpc-4927	42	26	with	with	ADP
dpc-4927	42	27	62	62	NUM
dpc-4927	42	28	healthy	healthy	ADJ
dpc-4927	42	29	controls	control	NOUN
dpc-4927	42	30	.	.	PUNCT
dpc-4927	43	1	patients	patient	NOUN
dpc-4927	43	2	who	who	PRON
dpc-4927	43	3	presented	present	VERB
dpc-4927	43	4	to	to	ADP
dpc-4927	43	5	the	the	DET
dpc-4927	43	6	emergency	emergency	NOUN
dpc-4927	43	7	services	service	NOUN
dpc-4927	43	8	with	with	ADP
dpc-4927	43	9	symptoms	symptom	NOUN
dpc-4927	43	10	suggestive	suggestive	ADJ
dpc-4927	43	11	of	of	ADP
dpc-4927	43	12	sars	sar	NOUN
dpc-4927	43	13	-	-	PUNCT
dpc-4927	43	14	cov-2	cov-2	PART
dpc-4927	43	15	infection	infection	NOUN
dpc-4927	43	16	,	,	PUNCT
dpc-4927	43	17	such	such	ADJ
dpc-4927	43	18	as	as	ADP
dpc-4927	43	19	fever	fever	NOUN
dpc-4927	43	20	,	,	PUNCT
dpc-4927	43	21	myalgia	myalgia	NOUN
dpc-4927	43	22	,	,	PUNCT
dpc-4927	43	23	or	or	CCONJ
dpc-4927	43	24	cough	cough	NOUN
dpc-4927	43	25	,	,	PUNCT
dpc-4927	43	26	and	and	CCONJ
dpc-4927	43	27	were	be	AUX
dpc-4927	43	28	diagnosed	diagnose	VERB
dpc-4927	43	29	with	with	ADP
dpc-4927	43	30	the	the	DET
dpc-4927	43	31	virus	virus	NOUN
dpc-4927	43	32	by	by	ADP
dpc-4927	43	33	real	real	ADJ
dpc-4927	43	34	-	-	PUNCT
dpc-4927	43	35	time	time	NOUN
dpc-4927	43	36	pcr	pcr	ADJ
dpc-4927	43	37	examination	examination	NOUN
dpc-4927	43	38	of	of	ADP
dpc-4927	43	39	nasopharyngeal	nasopharyngeal	ADJ
dpc-4927	43	40	swab	swab	NOUN
dpc-4927	43	41	samples	sample	NOUN
dpc-4927	43	42	were	be	AUX
dpc-4927	43	43	included	include	VERB
dpc-4927	43	44	in	in	ADP
dpc-4927	43	45	the	the	DET
dpc-4927	43	46	study	study	NOUN
dpc-4927	43	47	.	.	PUNCT
dpc-4927	44	1	patients	patient	NOUN
dpc-4927	44	2	were	be	AUX
dpc-4927	44	3	classified	classify	VERB
dpc-4927	44	4	as	as	ADP
dpc-4927	44	5	mild	mild	ADJ
dpc-4927	44	6	or	or	CCONJ
dpc-4927	44	7	moderate	moderate	ADJ
dpc-4927	44	8	based	base	VERB
dpc-4927	44	9	on	on	ADP
dpc-4927	44	10	the	the	DET
dpc-4927	44	11	world	world	PROPN
dpc-4927	44	12	health	health	PROPN
dpc-4927	44	13	organization	organization	NOUN
dpc-4927	44	14	’s	’s	PART
dpc-4927	44	15	definition	definition	NOUN
dpc-4927	44	16	of	of	ADP
dpc-4927	44	17	severity	severity	NOUN
dpc-4927	44	18	for	for	ADP
dpc-4927	44	19	cases	case	NOUN
dpc-4927	44	20	of	of	ADP
dpc-4927	44	21	covid-19	covid-19	PROPN
dpc-4927	44	22	.	.	PUNCT
dpc-4927	45	1	patients	patient	NOUN
dpc-4927	45	2	with	with	ADP
dpc-4927	45	3	mild	mild	ADJ
dpc-4927	45	4	cases	case	NOUN
dpc-4927	45	5	typically	typically	ADV
dpc-4927	45	6	present	present	ADJ
dpc-4927	45	7	with	with	ADP
dpc-4927	45	8	fever	fever	NOUN
dpc-4927	45	9	,	,	PUNCT
dpc-4927	45	10	cough	cough	NOUN
dpc-4927	45	11	,	,	PUNCT
dpc-4927	45	12	and	and	CCONJ
dpc-4927	45	13	fatigue	fatigue	NOUN
dpc-4927	45	14	,	,	PUNCT
dpc-4927	45	15	while	while	SCONJ
dpc-4927	45	16	those	those	PRON
dpc-4927	45	17	with	with	ADP
dpc-4927	45	18	moderate	moderate	ADJ
dpc-4927	45	19	cases	case	NOUN
dpc-4927	45	20	have	have	VERB
dpc-4927	45	21	difficulty	difficulty	NOUN
dpc-4927	45	22	breathing	breathing	NOUN
dpc-4927	45	23	or	or	CCONJ
dpc-4927	45	24	evidence	evidence	NOUN
dpc-4927	45	25	of	of	ADP
dpc-4927	45	26	pneumonia	pneumonia	NOUN
dpc-4927	45	27	[	[	X
dpc-4927	45	28	15	15	NUM
dpc-4927	45	29	]	]	PUNCT
dpc-4927	45	30	.	.	PUNCT
dpc-4927	46	1	in	in	ADP
dpc-4927	46	2	line	line	NOUN
dpc-4927	46	3	with	with	ADP
dpc-4927	46	4	these	these	DET
dpc-4927	46	5	criteria	criterion	NOUN
dpc-4927	46	6	,	,	PUNCT
dpc-4927	46	7	38	38	NUM
dpc-4927	46	8	patients	patient	NOUN
dpc-4927	46	9	exhibited	exhibit	VERB
dpc-4927	46	10	mild	mild	ADJ
dpc-4927	46	11	disease	disease	NOUN
dpc-4927	46	12	severity	severity	NOUN
dpc-4927	46	13	,	,	PUNCT
dpc-4927	46	14	while	while	SCONJ
dpc-4927	46	15	eight	eight	NUM
dpc-4927	46	16	demonstrated	demonstrate	VERB
dpc-4927	46	17	moderate	moderate	ADJ
dpc-4927	46	18	disease	disease	NOUN
dpc-4927	46	19	severity	severity	NOUN
dpc-4927	46	20	.	.	PUNCT
dpc-4927	47	1	healthy	healthy	ADJ
dpc-4927	47	2	controls	control	NOUN
dpc-4927	47	3	were	be	AUX
dpc-4927	47	4	individuals	individual	NOUN
dpc-4927	47	5	who	who	PRON
dpc-4927	47	6	had	have	VERB
dpc-4927	47	7	no	no	DET
dpc-4927	47	8	prior	prior	ADJ
dpc-4927	47	9	history	history	NOUN
dpc-4927	47	10	of	of	ADP
dpc-4927	47	11	covid-19	covid-19	PROPN
dpc-4927	47	12	infection	infection	NOUN
dpc-4927	47	13	.	.	PUNCT
dpc-4927	48	1	connective	connective	ADJ
dpc-4927	48	2	tissue	tissue	NOUN
dpc-4927	48	3	diseases	disease	NOUN
dpc-4927	48	4	and	and	CCONJ
dpc-4927	48	5	any	any	DET
dpc-4927	48	6	other	other	ADJ
dpc-4927	48	7	conditions	condition	NOUN
dpc-4927	48	8	affecting	affect	VERB
dpc-4927	48	9	microcirculation	microcirculation	NOUN
dpc-4927	48	10	(	(	PUNCT
dpc-4927	48	11	such	such	ADJ
dpc-4927	48	12	as	as	ADP
dpc-4927	48	13	smoking	smoking	NOUN
dpc-4927	48	14	,	,	PUNCT
dpc-4927	48	15	diabetes	diabetes	NOUN
dpc-4927	48	16	,	,	PUNCT
dpc-4927	48	17	obesity	obesity	NOUN
dpc-4927	48	18	,	,	PUNCT
dpc-4927	48	19	and	and	CCONJ
dpc-4927	48	20	hypertension	hypertension	NOUN
dpc-4927	48	21	)	)	PUNCT
dpc-4927	48	22	were	be	AUX
dpc-4927	48	23	considered	consider	VERB
dpc-4927	48	24	exclusion	exclusion	NOUN
dpc-4927	48	25	criteria	criterion	NOUN
dpc-4927	48	26	.	.	PUNCT
dpc-4927	49	1	the	the	DET
dpc-4927	49	2	ethics	ethics	PROPN
dpc-4927	49	3	committee	committee	PROPN
dpc-4927	49	4	of	of	ADP
dpc-4927	49	5	the	the	DET
dpc-4927	49	6	pamukkale	pamukkale	PROPN
dpc-4927	49	7	university	university	NOUN
dpc-4927	49	8	training	training	NOUN
dpc-4927	49	9	and	and	CCONJ
dpc-4927	49	10	research	research	NOUN
dpc-4927	49	11	hospital	hospital	NOUN
dpc-4927	49	12	,	,	PUNCT
dpc-4927	49	13	denizli	denizli	PROPN
dpc-4927	49	14	turkey	turkey	PROPN
dpc-4927	49	15	,	,	PUNCT
dpc-4927	49	16	approved	approve	VERB
dpc-4927	49	17	the	the	DET
dpc-4927	49	18	study	study	NOUN
dpc-4927	49	19	.	.	PUNCT
dpc-4927	50	1	written	write	VERB
dpc-4927	50	2	informed	informed	ADJ
dpc-4927	50	3	consent	consent	NOUN
dpc-4927	50	4	was	be	AUX
dpc-4927	50	5	obtained	obtain	VERB
dpc-4927	50	6	from	from	ADP
dpc-4927	50	7	all	all	DET
dpc-4927	50	8	patients	patient	NOUN
dpc-4927	50	9	.	.	PUNCT
dpc-4927	51	1	the	the	DET
dpc-4927	51	2	procedures	procedure	NOUN
dpc-4927	51	3	followed	follow	VERB
dpc-4927	51	4	were	be	AUX
dpc-4927	51	5	by	by	ADP
dpc-4927	51	6	the	the	DET
dpc-4927	51	7	declaration	declaration	NOUN
dpc-4927	51	8	of	of	ADP
dpc-4927	51	9	helsinki	helsinki	PROPN
dpc-4927	51	10	and	and	CCONJ
dpc-4927	51	11	institutional	institutional	ADJ
dpc-4927	51	12	guidelines	guideline	NOUN
dpc-4927	51	13	.	.	PUNCT
dpc-4927	52	1	dermoscopic	dermoscopic	NOUN
dpc-4927	52	2	examination	examination	NOUN
dpc-4927	52	3	the	the	DET
dpc-4927	52	4	proximal	proximal	ADJ
dpc-4927	52	5	fold	fold	NOUN
dpc-4927	52	6	and	and	CCONJ
dpc-4927	52	7	nail	nail	NOUN
dpc-4927	52	8	bed	bed	NOUN
dpc-4927	52	9	of	of	ADP
dpc-4927	52	10	all	all	DET
dpc-4927	52	11	nails	nail	NOUN
dpc-4927	52	12	except	except	SCONJ
dpc-4927	52	13	the	the	DET
dpc-4927	52	14	thumb	thumb	NOUN
dpc-4927	52	15	(	(	PUNCT
dpc-4927	52	16	which	which	PRON
dpc-4927	52	17	are	be	AUX
dpc-4927	52	18	often	often	ADV
dpc-4927	52	19	difficult	difficult	ADJ
dpc-4927	52	20	to	to	PART
dpc-4927	52	21	visualize	visualize	VERB
dpc-4927	52	22	capillaries	capillary	NOUN
dpc-4927	52	23	)	)	PUNCT
dpc-4927	52	24	of	of	ADP
dpc-4927	52	25	covid-19	covid-19	PROPN
dpc-4927	52	26	patients	patient	NOUN
dpc-4927	52	27	and	and	CCONJ
dpc-4927	52	28	healthy	healthy	ADJ
dpc-4927	52	29	controls	control	NOUN
dpc-4927	52	30	were	be	AUX
dpc-4927	52	31	evaluated	evaluate	VERB
dpc-4927	52	32	in	in	ADP
dpc-4927	52	33	polarized	polarize	VERB
dpc-4927	52	34	light	light	NOUN
dpc-4927	52	35	with	with	ADP
dpc-4927	52	36	contact	contact	NOUN
dpc-4927	52	37	mode	mode	NOUN
dpc-4927	52	38	using	use	VERB
dpc-4927	52	39	ultrasound	ultrasound	NOUN
dpc-4927	52	40	gel	gel	NOUN
dpc-4927	52	41	as	as	ADP
dpc-4927	52	42	an	an	DET
dpc-4927	52	43	interface	interface	NOUN
dpc-4927	52	44	with	with	ADP
dpc-4927	52	45	fotofinder	fotofinder	NOUN
dpc-4927	52	46	®	®	NOUN
dpc-4927	52	47	medicam	medicam	PROPN
dpc-4927	52	48	800	800	NUM
dpc-4927	52	49	dermatoscope	dermatoscope	NOUN
dpc-4927	52	50	(	(	PUNCT
dpc-4927	52	51	fotofinder	fotofinder	NOUN
dpc-4927	52	52	systems	system	NOUN
dpc-4927	52	53	gmbh	gmbh	PROPN
dpc-4927	52	54	)	)	PUNCT
dpc-4927	52	55	.	.	PUNCT
dpc-4927	53	1	participants	participant	NOUN
dpc-4927	53	2	were	be	AUX
dpc-4927	53	3	assessed	assess	VERB
dpc-4927	53	4	after	after	ADP
dpc-4927	53	5	resting	rest	VERB
dpc-4927	53	6	at	at	ADP
dpc-4927	53	7	room	room	NOUN
dpc-4927	53	8	temperature	temperature	NOUN
dpc-4927	53	9	(	(	PUNCT
dpc-4927	53	10	20	20	NUM
dpc-4927	53	11	-	-	SYM
dpc-4927	53	12	25	25	NUM
dpc-4927	53	13	°	°	PROPN
dpc-4927	53	14	c	c	NOUN
dpc-4927	53	15	)	)	PUNCT
dpc-4927	53	16	for	for	ADP
dpc-4927	53	17	at	at	ADV
dpc-4927	53	18	least	least	ADV
dpc-4927	53	19	15–20	15–20	NUM
dpc-4927	53	20	minutes	minute	NOUN
dpc-4927	53	21	before	before	ADP
dpc-4927	53	22	the	the	DET
dpc-4927	53	23	examination	examination	NOUN
dpc-4927	53	24	.	.	PUNCT
dpc-4927	54	1	two	two	NUM
dpc-4927	54	2	dermatologists	dermatologist	NOUN
dpc-4927	54	3	recorded	record	VERB
dpc-4927	54	4	dermoscopic	dermoscopic	NOUN
dpc-4927	54	5	images	image	NOUN
dpc-4927	54	6	using	use	VERB
dpc-4927	54	7	x	x	X
dpc-4927	54	8	20	20	NUM
dpc-4927	54	9	and	and	CCONJ
dpc-4927	54	10	x	x	SYM
dpc-4927	54	11	70	70	NUM
dpc-4927	54	12	magnification	magnification	NOUN
dpc-4927	54	13	.	.	PUNCT
dpc-4927	55	1	a	a	DET
dpc-4927	55	2	dermatologist	dermatologist	NOUN
dpc-4927	55	3	experienced	experience	VERB
dpc-4927	55	4	in	in	ADP
dpc-4927	55	5	dermoscopy	dermoscopy	NOUN
dpc-4927	55	6	and	and	CCONJ
dpc-4927	55	7	trained	train	VERB
dpc-4927	55	8	in	in	ADP
dpc-4927	55	9	capillaroscopy	capillaroscopy	NOUN
dpc-4927	55	10	(	(	PUNCT
dpc-4927	55	11	oskb	oskb	NOUN
dpc-4927	55	12	)	)	PUNCT
dpc-4927	55	13	and	and	CCONJ
dpc-4927	55	14	a	a	DET
dpc-4927	55	15	rheumatologist	rheumatologist	NOUN
dpc-4927	55	16	experienced	experience	VERB
dpc-4927	55	17	in	in	ADP
dpc-4927	55	18	capillaroscopy	capillaroscopy	NOUN
dpc-4927	55	19	(	(	PUNCT
dpc-4927	55	20	ub	ub	ADJ
dpc-4927	55	21	)	)	PUNCT
dpc-4927	55	22	evaluated	evaluate	VERB
dpc-4927	55	23	the	the	DET
dpc-4927	55	24	dermoscopic	dermoscopic	ADJ
dpc-4927	55	25	images	image	NOUN
dpc-4927	55	26	of	of	ADP
dpc-4927	55	27	the	the	DET
dpc-4927	55	28	nailfold	nailfold	NOUN
dpc-4927	55	29	capillaries	capillary	NOUN
dpc-4927	55	30	in	in	ADP
dpc-4927	55	31	terms	term	NOUN
dpc-4927	55	32	of	of	ADP
dpc-4927	55	33	their	their	PRON
dpc-4927	55	34	morphology	morphology	NOUN
dpc-4927	55	35	,	,	PUNCT
dpc-4927	55	36	diameter	diameter	NOUN
dpc-4927	55	37	,	,	PUNCT
dpc-4927	55	38	architecture	architecture	NOUN
dpc-4927	55	39	,	,	PUNCT
dpc-4927	55	40	and	and	CCONJ
dpc-4927	55	41	density	density	NOUN
dpc-4927	56	1	[	[	X
dpc-4927	56	2	1,2	1,2	NUM
dpc-4927	56	3	]	]	PUNCT
dpc-4927	56	4	.	.	PUNCT
dpc-4927	57	1	throughout	throughout	ADP
dpc-4927	57	2	the	the	DET
dpc-4927	57	3	evaluation	evaluation	NOUN
dpc-4927	57	4	,	,	PUNCT
dpc-4927	57	5	these	these	DET
dpc-4927	57	6	two	two	NUM
dpc-4927	57	7	authors	author	NOUN
dpc-4927	57	8	remained	remain	VERB
dpc-4927	57	9	blinded	blind	VERB
dpc-4927	57	10	.	.	PUNCT
dpc-4927	58	1	the	the	DET
dpc-4927	58	2	capillary	capillary	ADJ
dpc-4927	58	3	network	network	NOUN
dpc-4927	58	4	is	be	AUX
dpc-4927	58	5	loop	loop	NOUN
dpc-4927	58	6	-	-	PUNCT
dpc-4927	58	7	shaped	shape	VERB
dpc-4927	58	8	and	and	CCONJ
dpc-4927	58	9	runs	run	VERB
dpc-4927	58	10	parallel	parallel	ADJ
dpc-4927	58	11	to	to	ADP
dpc-4927	58	12	the	the	DET
dpc-4927	58	13	skin	skin	NOUN
dpc-4927	58	14	in	in	ADP
dpc-4927	58	15	healthy	healthy	ADJ
dpc-4927	58	16	people	people	NOUN
dpc-4927	58	17	(	(	PUNCT
dpc-4927	58	18	figure	figure	NOUN
dpc-4927	58	19	1	1	NUM
dpc-4927	58	20	)	)	PUNCT
dpc-4927	58	21	.	.	PUNCT
dpc-4927	59	1	capillary	capillary	ADJ
dpc-4927	59	2	density	density	NOUN
dpc-4927	59	3	is	be	AUX
dpc-4927	59	4	considered	consider	VERB
dpc-4927	59	5	decreased	decrease	VERB
dpc-4927	59	6	if	if	SCONJ
dpc-4927	59	7	it	it	PRON
dpc-4927	59	8	is	be	AUX
dpc-4927	59	9	less	less	ADJ
dpc-4927	59	10	than	than	ADP
dpc-4927	59	11	7	7	NUM
dpc-4927	59	12	per	per	ADP
dpc-4927	59	13	mm	mm	NOUN
dpc-4927	60	1	[	[	X
dpc-4927	60	2	2	2	NUM
dpc-4927	60	3	]	]	PUNCT
dpc-4927	60	4	.	.	PUNCT
dpc-4927	61	1	the	the	DET
dpc-4927	61	2	first	first	ADJ
dpc-4927	61	3	dermoscopic	dermoscopic	ADJ
dpc-4927	61	4	evaluation	evaluation	NOUN
dpc-4927	61	5	was	be	AUX
dpc-4927	61	6	conducted	conduct	VERB
dpc-4927	61	7	two	two	NUM
dpc-4927	61	8	weeks	week	NOUN
dpc-4927	61	9	after	after	ADP
dpc-4927	61	10	the	the	DET
dpc-4927	61	11	onset	onset	NOUN
dpc-4927	61	12	of	of	ADP
dpc-4927	61	13	symptoms	symptom	NOUN
dpc-4927	61	14	in	in	ADP
dpc-4927	61	15	covid-19	covid-19	PROPN
dpc-4927	61	16	patients	patient	NOUN
dpc-4927	61	17	.	.	PUNCT
dpc-4927	62	1	a	a	DET
dpc-4927	62	2	follow	follow	VERB
dpc-4927	62	3	-	-	PUNCT
dpc-4927	62	4	up	up	ADP
dpc-4927	62	5	dermoscopic	dermoscopic	ADJ
dpc-4927	62	6	evaluation	evaluation	NOUN
dpc-4927	62	7	of	of	ADP
dpc-4927	62	8	the	the	DET
dpc-4927	62	9	patient	patient	NOUN
dpc-4927	62	10	group	group	NOUN
dpc-4927	62	11	was	be	AUX
dpc-4927	62	12	performed	perform	VERB
dpc-4927	62	13	after	after	ADP
dpc-4927	62	14	10–14	10–14	NUM
dpc-4927	62	15	months	month	NOUN
dpc-4927	62	16	.	.	PUNCT
dpc-4927	63	1	statistical	statistical	ADJ
dpc-4927	63	2	analysis	analysis	NOUN
dpc-4927	63	3	data	datum	NOUN
dpc-4927	63	4	were	be	AUX
dpc-4927	63	5	analyzed	analyze	VERB
dpc-4927	63	6	using	use	VERB
dpc-4927	63	7	ibm	ibm	PROPN
dpc-4927	63	8	spss	spss	PROPN
dpc-4927	63	9	software	software	NOUN
dpc-4927	63	10	(	(	PUNCT
dpc-4927	63	11	version	version	NOUN
dpc-4927	63	12	26	26	NUM
dpc-4927	63	13	;	;	PUNCT
dpc-4927	63	14	ibm	ibm	PROPN
dpc-4927	63	15	,	,	PUNCT
dpc-4927	63	16	armonk	armonk	PROPN
dpc-4927	63	17	,	,	PUNCT
dpc-4927	63	18	new	new	PROPN
dpc-4927	63	19	york	york	PROPN
dpc-4927	63	20	,	,	PUNCT
dpc-4927	63	21	usa	usa	PROPN
dpc-4927	63	22	)	)	PUNCT
dpc-4927	63	23	.	.	PUNCT
dpc-4927	64	1	the	the	DET
dpc-4927	64	2	results	result	NOUN
dpc-4927	64	3	of	of	ADP
dpc-4927	64	4	categorical	categorical	ADJ
dpc-4927	64	5	measurements	measurement	NOUN
dpc-4927	64	6	are	be	AUX
dpc-4927	64	7	expressed	express	VERB
dpc-4927	64	8	as	as	ADP
dpc-4927	64	9	numbers	number	NOUN
dpc-4927	64	10	and	and	CCONJ
dpc-4927	64	11	percentages	percentage	NOUN
dpc-4927	64	12	.	.	PUNCT
dpc-4927	65	1	the	the	DET
dpc-4927	65	2	chi	chi	ADJ
dpc-4927	65	3	-	-	PUNCT
dpc-4927	65	4	square	square	ADJ
dpc-4927	65	5	test	test	NOUN
dpc-4927	65	6	was	be	AUX
dpc-4927	65	7	used	use	VERB
dpc-4927	65	8	for	for	ADP
dpc-4927	65	9	the	the	DET
dpc-4927	65	10	analysis	analysis	NOUN
dpc-4927	65	11	of	of	ADP
dpc-4927	65	12	two	two	NUM
dpc-4927	65	13	categorical	categorical	ADJ
dpc-4927	65	14	variables	variable	NOUN
dpc-4927	65	15	.	.	PUNCT
dpc-4927	66	1	the	the	DET
dpc-4927	66	2	numeric	numeric	ADJ
dpc-4927	66	3	measurements	measurement	NOUN
dpc-4927	66	4	are	be	AUX
dpc-4927	66	5	presented	present	VERB
dpc-4927	66	6	as	as	ADP
dpc-4927	66	7	mean	mean	NOUN
dpc-4927	66	8	±	±	NUM
dpc-4927	66	9	standard	standard	ADJ
dpc-4927	66	10	deviation	deviation	NOUN
dpc-4927	66	11	(	(	PUNCT
dpc-4927	66	12	sd	sd	NOUN
dpc-4927	66	13	)	)	PUNCT
dpc-4927	66	14	.	.	PUNCT
dpc-4927	67	1	a	a	DET
dpc-4927	67	2	p	p	NOUN
dpc-4927	67	3	-	-	PUNCT
dpc-4927	67	4	value	value	NOUN
dpc-4927	67	5	of	of	ADP
dpc-4927	67	6	<	<	NOUN
dpc-4927	67	7	0.05	0.05	NUM
dpc-4927	67	8	was	be	AUX
dpc-4927	67	9	considered	consider	VERB
dpc-4927	67	10	statistically	statistically	ADV
dpc-4927	67	11	significant	significant	ADJ
dpc-4927	67	12	.	.	PUNCT
dpc-4927	68	1	original	original	ADJ
dpc-4927	68	2	article	article	NOUN
dpc-4927	68	3	|	|	ADV
dpc-4927	68	4	dermatol	dermatol	ADJ
dpc-4927	68	5	pract	pract	NOUN
dpc-4927	68	6	concept	concept	NOUN
dpc-4927	68	7	.	.	PUNCT
dpc-4927	69	1	2025;15(1):4927	2025;15(1):4927	NUM
dpc-4927	69	2	3	3	NUM
dpc-4927	69	3	results	result	VERB
dpc-4927	69	4	the	the	DET
dpc-4927	69	5	study	study	NOUN
dpc-4927	69	6	included	include	VERB
dpc-4927	69	7	46	46	NUM
dpc-4927	69	8	patients	patient	NOUN
dpc-4927	69	9	with	with	ADP
dpc-4927	69	10	mild	mild	ADJ
dpc-4927	69	11	-	-	PUNCT
dpc-4927	69	12	to	to	ADP
dpc-4927	69	13	-	-	PUNCT
dpc-4927	69	14	moderate	moderate	ADJ
dpc-4927	69	15	covid-19	covid-19	PROPN
dpc-4927	69	16	and	and	CCONJ
dpc-4927	69	17	62	62	NUM
dpc-4927	69	18	healthy	healthy	ADJ
dpc-4927	69	19	controls	control	NOUN
dpc-4927	69	20	.	.	PUNCT
dpc-4927	70	1	there	there	PRON
dpc-4927	70	2	was	be	VERB
dpc-4927	70	3	no	no	DET
dpc-4927	70	4	statistically	statistically	ADV
dpc-4927	70	5	significant	significant	ADJ
dpc-4927	70	6	difference	difference	NOUN
dpc-4927	70	7	between	between	ADP
dpc-4927	70	8	the	the	DET
dpc-4927	70	9	patient	patient	ADJ
dpc-4927	70	10	and	and	CCONJ
dpc-4927	70	11	control	control	NOUN
dpc-4927	70	12	groups	group	NOUN
dpc-4927	70	13	regarding	regard	VERB
dpc-4927	70	14	age	age	NOUN
dpc-4927	70	15	,	,	PUNCT
dpc-4927	70	16	sex	sex	NOUN
dpc-4927	70	17	,	,	PUNCT
dpc-4927	70	18	and	and	CCONJ
dpc-4927	70	19	vaccination	vaccination	NOUN
dpc-4927	70	20	status	status	NOUN
dpc-4927	70	21	(	(	PUNCT
dpc-4927	70	22	p	p	X
dpc-4927	70	23	>	>	X
dpc-4927	70	24	0.05	0.05	NUM
dpc-4927	70	25	)	)	PUNCT
dpc-4927	70	26	.	.	PUNCT
dpc-4927	71	1	the	the	DET
dpc-4927	71	2	mean	mean	ADJ
dpc-4927	71	3	age	age	NOUN
dpc-4927	71	4	of	of	ADP
dpc-4927	71	5	the	the	DET
dpc-4927	71	6	patient	patient	NOUN
dpc-4927	71	7	group	group	NOUN
dpc-4927	71	8	was	be	AUX
dpc-4927	71	9	34.15	34.15	NUM
dpc-4927	71	10	±	±	NUM
dpc-4927	71	11	11.35	11.35	NUM
dpc-4927	71	12	and	and	CCONJ
dpc-4927	71	13	of	of	ADP
dpc-4927	71	14	the	the	DET
dpc-4927	71	15	control	control	NOUN
dpc-4927	71	16	group	group	NOUN
dpc-4927	71	17	,	,	PUNCT
dpc-4927	71	18	30.25	30.25	NUM
dpc-4927	71	19	±	±	NUM
dpc-4927	71	20	9.42	9.42	NUM
dpc-4927	71	21	years	year	NOUN
dpc-4927	71	22	.	.	PUNCT
dpc-4927	72	1	in	in	ADP
dpc-4927	72	2	the	the	DET
dpc-4927	72	3	patient	patient	NOUN
dpc-4927	72	4	group	group	NOUN
dpc-4927	72	5	,	,	PUNCT
dpc-4927	72	6	30	30	NUM
dpc-4927	72	7	(	(	PUNCT
dpc-4927	72	8	65.2	65.2	NUM
dpc-4927	72	9	%	%	NOUN
dpc-4927	72	10	)	)	PUNCT
dpc-4927	72	11	were	be	AUX
dpc-4927	72	12	female	female	ADJ
dpc-4927	72	13	,	,	PUNCT
dpc-4927	72	14	and	and	CCONJ
dpc-4927	72	15	in	in	ADP
dpc-4927	72	16	the	the	DET
dpc-4927	72	17	control	control	NOUN
dpc-4927	72	18	group	group	NOUN
dpc-4927	72	19	,	,	PUNCT
dpc-4927	72	20	39	39	NUM
dpc-4927	72	21	(	(	PUNCT
dpc-4927	72	22	63.9	63.9	NUM
dpc-4927	72	23	%	%	NOUN
dpc-4927	72	24	)	)	PUNCT
dpc-4927	72	25	were	be	AUX
dpc-4927	72	26	female	female	ADJ
dpc-4927	72	27	.	.	PUNCT
dpc-4927	73	1	out	out	ADP
dpc-4927	73	2	of	of	ADP
dpc-4927	73	3	108	108	NUM
dpc-4927	73	4	participants	participant	NOUN
dpc-4927	73	5	,	,	PUNCT
dpc-4927	73	6	six	six	NUM
dpc-4927	73	7	had	have	AUX
dpc-4927	73	8	never	never	ADV
dpc-4927	73	9	been	be	AUX
dpc-4927	73	10	vaccinated	vaccinate	VERB
dpc-4927	73	11	,	,	PUNCT
dpc-4927	73	12	46	46	NUM
dpc-4927	73	13	had	have	AUX
dpc-4927	73	14	been	be	AUX
dpc-4927	73	15	vaccinated	vaccinate	VERB
dpc-4927	73	16	with	with	ADP
dpc-4927	73	17	biontech	biontech	NOUN
dpc-4927	73	18	,	,	PUNCT
dpc-4927	73	19	8	8	NUM
dpc-4927	73	20	with	with	ADP
dpc-4927	73	21	coronavac	coronavac	PROPN
dpc-4927	73	22	(	(	PUNCT
dpc-4927	73	23	sinovac	sinovac	NOUN
dpc-4927	73	24	)	)	PUNCT
dpc-4927	73	25	,	,	PUNCT
dpc-4927	73	26	and	and	CCONJ
dpc-4927	73	27	48	48	NUM
dpc-4927	73	28	had	have	VERB
dpc-4927	73	29	both	both	CCONJ
dpc-4927	73	30	biontech	biontech	NOUN
dpc-4927	73	31	and	and	CCONJ
dpc-4927	73	32	coronavac	coronavac	VERB
dpc-4927	73	33	vaccines	vaccine	NOUN
dpc-4927	73	34	.	.	PUNCT
dpc-4927	74	1	the	the	DET
dpc-4927	74	2	patient	patient	ADJ
dpc-4927	74	3	cohort	cohort	NOUN
dpc-4927	74	4	exhibited	exhibit	VERB
dpc-4927	74	5	a	a	DET
dpc-4927	74	6	prevalence	prevalence	NOUN
dpc-4927	74	7	of	of	ADP
dpc-4927	74	8	fever	fever	NOUN
dpc-4927	74	9	(	(	PUNCT
dpc-4927	74	10	40	40	NUM
dpc-4927	74	11	%	%	NOUN
dpc-4927	74	12	)	)	PUNCT
dpc-4927	74	13	,	,	PUNCT
dpc-4927	74	14	fatigue	fatigue	NOUN
dpc-4927	74	15	(	(	PUNCT
dpc-4927	74	16	77	77	NUM
dpc-4927	74	17	%	%	NOUN
dpc-4927	74	18	)	)	PUNCT
dpc-4927	74	19	,	,	PUNCT
dpc-4927	74	20	cough	cough	NOUN
dpc-4927	74	21	(	(	PUNCT
dpc-4927	74	22	26	26	NUM
dpc-4927	74	23	%	%	NOUN
dpc-4927	74	24	)	)	PUNCT
dpc-4927	74	25	,	,	PUNCT
dpc-4927	74	26	headache	headache	NOUN
dpc-4927	74	27	(	(	PUNCT
dpc-4927	74	28	21.7	21.7	NUM
dpc-4927	74	29	%	%	NOUN
dpc-4927	74	30	)	)	PUNCT
dpc-4927	74	31	,	,	PUNCT
dpc-4927	74	32	and	and	CCONJ
dpc-4927	74	33	anosmia	anosmia	NOUN
dpc-4927	74	34	(	(	PUNCT
dpc-4927	74	35	2.1	2.1	NUM
dpc-4927	74	36	%	%	NOUN
dpc-4927	74	37	)	)	PUNCT
dpc-4927	74	38	.	.	PUNCT
dpc-4927	75	1	we	we	PRON
dpc-4927	75	2	detected	detect	VERB
dpc-4927	75	3	three	three	NUM
dpc-4927	75	4	cutaneous	cutaneous	ADJ
dpc-4927	75	5	symptoms	symptom	NOUN
dpc-4927	75	6	that	that	PRON
dpc-4927	75	7	may	may	AUX
dpc-4927	75	8	be	be	AUX
dpc-4927	75	9	associated	associate	VERB
dpc-4927	75	10	with	with	ADP
dpc-4927	75	11	covid-19	covid-19	PROPN
dpc-4927	75	12	:	:	PUNCT
dpc-4927	75	13	urticaria	urticaria	NOUN
dpc-4927	75	14	(	(	PUNCT
dpc-4927	75	15	n=1	n=1	PROPN
dpc-4927	75	16	)	)	PUNCT
dpc-4927	75	17	,	,	PUNCT
dpc-4927	75	18	telogen	telogen	NOUN
dpc-4927	75	19	effluvium	effluvium	NOUN
dpc-4927	75	20	(	(	PUNCT
dpc-4927	75	21	n=1	n=1	PROPN
dpc-4927	75	22	)	)	PUNCT
dpc-4927	75	23	,	,	PUNCT
dpc-4927	75	24	and	and	CCONJ
dpc-4927	75	25	erythema	erythema	ADJ
dpc-4927	75	26	multiforme	multiforme	NOUN
dpc-4927	75	27	(	(	PUNCT
dpc-4927	75	28	n=1	n=1	PROPN
dpc-4927	75	29	)	)	PUNCT
dpc-4927	75	30	.	.	PUNCT
dpc-4927	76	1	the	the	DET
dpc-4927	76	2	red	red	ADJ
dpc-4927	76	3	half	half	ADJ
dpc-4927	76	4	-	-	PUNCT
dpc-4927	76	5	moon	moon	NOUN
dpc-4927	76	6	nail	nail	NOUN
dpc-4927	76	7	sign	sign	NOUN
dpc-4927	76	8	was	be	AUX
dpc-4927	76	9	seen	see	VERB
dpc-4927	76	10	on	on	ADP
dpc-4927	76	11	one	one	NUM
dpc-4927	76	12	patient	patient	NOUN
dpc-4927	76	13	’s	’s	PART
dpc-4927	76	14	nail	nail	NOUN
dpc-4927	76	15	(	(	PUNCT
dpc-4927	76	16	figure	figure	NOUN
dpc-4927	76	17	2	2	NUM
dpc-4927	76	18	)	)	PUNCT
dpc-4927	76	19	.	.	PUNCT
dpc-4927	77	1	the	the	DET
dpc-4927	77	2	presence	presence	NOUN
dpc-4927	77	3	of	of	ADP
dpc-4927	77	4	avascular	avascular	ADJ
dpc-4927	77	5	areas	area	NOUN
dpc-4927	77	6	(	(	PUNCT
dpc-4927	77	7	p	p	X
dpc-4927	77	8	<	<	X
dpc-4927	77	9	0.001	0.001	NUM
dpc-4927	77	10	)	)	PUNCT
dpc-4927	77	11	(	(	PUNCT
dpc-4927	77	12	figure	figure	NOUN
dpc-4927	77	13	3a	3a	NUM
dpc-4927	77	14	)	)	PUNCT
dpc-4927	77	15	,	,	PUNCT
dpc-4927	77	16	meandering	meander	VERB
dpc-4927	77	17	capillaries	capillary	NOUN
dpc-4927	77	18	(	(	PUNCT
dpc-4927	77	19	p	p	X
dpc-4927	77	20	=	=	NOUN
dpc-4927	77	21	0.016	0.016	NUM
dpc-4927	77	22	)	)	PUNCT
dpc-4927	77	23	(	(	PUNCT
dpc-4927	77	24	figure	figure	NOUN
dpc-4927	77	25	4	4	NUM
dpc-4927	77	26	and	and	CCONJ
dpc-4927	77	27	figure	figure	NOUN
dpc-4927	77	28	5b	5b	NUM
dpc-4927	77	29	)	)	PUNCT
dpc-4927	77	30	,	,	PUNCT
dpc-4927	77	31	microhemorrhages	microhemorrhage	VERB
dpc-4927	77	32	(	(	PUNCT
dpc-4927	77	33	p	p	X
dpc-4927	77	34	=	=	NOUN
dpc-4927	77	35	0.007	0.007	NUM
dpc-4927	77	36	)	)	PUNCT
dpc-4927	77	37	(	(	PUNCT
dpc-4927	77	38	figure	figure	NOUN
dpc-4927	77	39	5	5	NUM
dpc-4927	77	40	)	)	PUNCT
dpc-4927	77	41	,	,	PUNCT
dpc-4927	77	42	and	and	CCONJ
dpc-4927	77	43	enlarged	enlarge	VERB
dpc-4927	77	44	capillaries	capillary	NOUN
dpc-4927	77	45	(	(	PUNCT
dpc-4927	77	46	p	p	NOUN
dpc-4927	77	47	=	=	NOUN
dpc-4927	77	48	0.009	0.009	NUM
dpc-4927	77	49	)	)	PUNCT
dpc-4927	77	50	(	(	PUNCT
dpc-4927	77	51	figure	figure	VERB
dpc-4927	77	52	5a	5a	NUM
dpc-4927	77	53	and	and	CCONJ
dpc-4927	77	54	figure	figure	VERB
dpc-4927	77	55	6	6	NUM
dpc-4927	77	56	)	)	PUNCT
dpc-4927	77	57	in	in	ADP
dpc-4927	77	58	the	the	DET
dpc-4927	77	59	proximal	proximal	ADJ
dpc-4927	77	60	nail	nail	NOUN
dpc-4927	77	61	fold	fold	NOUN
dpc-4927	77	62	was	be	AUX
dpc-4927	77	63	significantly	significantly	ADV
dpc-4927	77	64	higher	high	ADJ
dpc-4927	77	65	in	in	ADP
dpc-4927	77	66	covid-19	covid-19	PROPN
dpc-4927	77	67	patients	patient	NOUN
dpc-4927	77	68	than	than	ADP
dpc-4927	77	69	in	in	ADP
dpc-4927	77	70	healthy	healthy	ADJ
dpc-4927	77	71	controls	control	NOUN
dpc-4927	77	72	(	(	PUNCT
dpc-4927	77	73	table	table	NOUN
dpc-4927	77	74	1	1	NUM
dpc-4927	77	75	)	)	PUNCT
dpc-4927	77	76	.	.	PUNCT
dpc-4927	78	1	branched	branched	ADJ
dpc-4927	78	2	capillaries	capillary	NOUN
dpc-4927	78	3	were	be	AUX
dpc-4927	78	4	more	more	ADV
dpc-4927	78	5	common	common	ADJ
dpc-4927	78	6	in	in	ADP
dpc-4927	78	7	covid-19	covid-19	PROPN
dpc-4927	78	8	patients	patient	NOUN
dpc-4927	78	9	than	than	ADP
dpc-4927	78	10	in	in	ADP
dpc-4927	78	11	the	the	DET
dpc-4927	78	12	control	control	NOUN
dpc-4927	78	13	group	group	NOUN
dpc-4927	78	14	,	,	PUNCT
dpc-4927	78	15	but	but	CCONJ
dpc-4927	78	16	the	the	DET
dpc-4927	78	17	difference	difference	NOUN
dpc-4927	78	18	was	be	AUX
dpc-4927	78	19	not	not	PART
dpc-4927	78	20	statistically	statistically	ADV
dpc-4927	78	21	significant	significant	ADJ
dpc-4927	78	22	(	(	PUNCT
dpc-4927	78	23	p	p	X
dpc-4927	78	24	<	<	X
dpc-4927	78	25	0.05	0.05	NUM
dpc-4927	78	26	)	)	PUNCT
dpc-4927	78	27	.	.	PUNCT
dpc-4927	79	1	the	the	DET
dpc-4927	79	2	capillary	capillary	ADJ
dpc-4927	79	3	architecture	architecture	NOUN
dpc-4927	79	4	was	be	AUX
dpc-4927	79	5	disorganized	disorganized	ADJ
dpc-4927	79	6	(	(	PUNCT
dpc-4927	79	7	p	p	X
dpc-4927	79	8	=	=	NOUN
dpc-4927	79	9	0.002	0.002	NUM
dpc-4927	79	10	)	)	PUNCT
dpc-4927	79	11	and	and	CCONJ
dpc-4927	79	12	density	density	NOUN
dpc-4927	79	13	decreased	decrease	VERB
dpc-4927	79	14	(	(	PUNCT
dpc-4927	79	15	p	p	X
dpc-4927	79	16	<	<	X
dpc-4927	79	17	0.001	0.001	NUM
dpc-4927	79	18	)	)	PUNCT
dpc-4927	79	19	in	in	ADP
dpc-4927	79	20	covid-19	covid-19	PROPN
dpc-4927	79	21	patients	patient	NOUN
dpc-4927	79	22	compared	compare	VERB
dpc-4927	79	23	to	to	ADP
dpc-4927	79	24	healthy	healthy	ADJ
dpc-4927	79	25	controls	control	NOUN
dpc-4927	79	26	(	(	PUNCT
dpc-4927	79	27	figure	figure	NOUN
dpc-4927	79	28	3a	3a	NUM
dpc-4927	79	29	)	)	PUNCT
dpc-4927	79	30	.	.	PUNCT
dpc-4927	80	1	on	on	ADP
dpc-4927	80	2	the	the	DET
dpc-4927	80	3	other	other	ADJ
dpc-4927	80	4	hand	hand	NOUN
dpc-4927	80	5	,	,	PUNCT
dpc-4927	80	6	capillary	capillary	ADJ
dpc-4927	80	7	tortuosity	tortuosity	NOUN
dpc-4927	80	8	was	be	AUX
dpc-4927	80	9	detected	detect	VERB
dpc-4927	80	10	more	more	ADV
dpc-4927	80	11	frequently	frequently	ADV
dpc-4927	80	12	in	in	ADP
dpc-4927	80	13	the	the	DET
dpc-4927	80	14	healthy	healthy	ADJ
dpc-4927	80	15	control	control	NOUN
dpc-4927	80	16	group	group	NOUN
dpc-4927	80	17	than	than	ADP
dpc-4927	80	18	in	in	ADP
dpc-4927	80	19	the	the	DET
dpc-4927	80	20	patients	patient	NOUN
dpc-4927	80	21	with	with	ADP
dpc-4927	80	22	covid-19	covid-19	PROPN
dpc-4927	80	23	(	(	PUNCT
dpc-4927	80	24	table	table	NOUN
dpc-4927	80	25	1	1	NUM
dpc-4927	80	26	)	)	PUNCT
dpc-4927	80	27	.	.	PUNCT
dpc-4927	81	1	although	although	SCONJ
dpc-4927	81	2	a	a	DET
dpc-4927	81	3	higher	high	ADJ
dpc-4927	81	4	rate	rate	NOUN
dpc-4927	81	5	of	of	ADP
dpc-4927	81	6	dilated	dilated	ADJ
dpc-4927	81	7	nail	nail	NOUN
dpc-4927	81	8	bed	bed	NOUN
dpc-4927	81	9	capillaries	capillary	NOUN
dpc-4927	81	10	(	(	PUNCT
dpc-4927	81	11	figure	figure	NOUN
dpc-4927	81	12	7	7	NUM
dpc-4927	81	13	)	)	PUNCT
dpc-4927	81	14	was	be	AUX
dpc-4927	81	15	found	find	VERB
dpc-4927	81	16	in	in	ADP
dpc-4927	81	17	covid-19	covid-19	PROPN
dpc-4927	81	18	patients	patient	NOUN
dpc-4927	81	19	,	,	PUNCT
dpc-4927	81	20	the	the	DET
dpc-4927	81	21	difference	difference	NOUN
dpc-4927	81	22	was	be	AUX
dpc-4927	81	23	not	not	PART
dpc-4927	81	24	statistically	statistically	ADV
dpc-4927	81	25	significant	significant	ADJ
dpc-4927	81	26	(	(	PUNCT
dpc-4927	81	27	p	p	X
dpc-4927	81	28	>	>	X
dpc-4927	81	29	0.05	0.05	NUM
dpc-4927	81	30	)	)	PUNCT
dpc-4927	81	31	.	.	PUNCT
dpc-4927	82	1	we	we	PRON
dpc-4927	82	2	did	do	AUX
dpc-4927	82	3	not	not	PART
dpc-4927	82	4	find	find	VERB
dpc-4927	82	5	any	any	DET
dpc-4927	82	6	significant	significant	ADJ
dpc-4927	82	7	difference	difference	NOUN
dpc-4927	82	8	between	between	ADP
dpc-4927	82	9	the	the	DET
dpc-4927	82	10	evaluations	evaluation	NOUN
dpc-4927	82	11	carried	carry	VERB
dpc-4927	82	12	out	out	ADP
dpc-4927	82	13	at	at	ADP
dpc-4927	82	14	a	a	DET
dpc-4927	82	15	magnification	magnification	NOUN
dpc-4927	82	16	of	of	ADP
dpc-4927	82	17	x	x	PROPN
dpc-4927	82	18	20	20	NUM
dpc-4927	82	19	and	and	CCONJ
dpc-4927	82	20	a	a	DET
dpc-4927	82	21	magnification	magnification	NOUN
dpc-4927	82	22	of	of	ADP
dpc-4927	82	23	x	x	X
dpc-4927	82	24	70	70	NUM
dpc-4927	82	25	(	(	PUNCT
dpc-4927	82	26	p	p	X
dpc-4927	82	27	>	>	X
dpc-4927	82	28	0.05	0.05	NUM
dpc-4927	82	29	)	)	PUNCT
dpc-4927	82	30	.	.	PUNCT
dpc-4927	83	1	after	after	ADP
dpc-4927	83	2	10–14	10–14	NUM
dpc-4927	83	3	months	month	NOUN
dpc-4927	83	4	,	,	PUNCT
dpc-4927	83	5	we	we	PRON
dpc-4927	83	6	reconnected	reconnecte	VERB
dpc-4927	83	7	with	with	ADP
dpc-4927	83	8	27	27	NUM
dpc-4927	83	9	participants	participant	NOUN
dpc-4927	83	10	from	from	ADP
dpc-4927	83	11	the	the	DET
dpc-4927	83	12	covid-19	covid-19	PROPN
dpc-4927	83	13	patient	patient	NOUN
dpc-4927	83	14	group	group	NOUN
dpc-4927	83	15	for	for	ADP
dpc-4927	83	16	a	a	DET
dpc-4927	83	17	follow	follow	VERB
dpc-4927	83	18	-	-	PUNCT
dpc-4927	83	19	up	up	ADP
dpc-4927	83	20	dermoscopic	dermoscopic	NOUN
dpc-4927	83	21	examination	examination	NOUN
dpc-4927	83	22	conducted	conduct	VERB
dpc-4927	83	23	under	under	ADP
dpc-4927	83	24	identical	identical	ADJ
dpc-4927	83	25	conditions	condition	NOUN
dpc-4927	83	26	.	.	PUNCT
dpc-4927	84	1	of	of	ADP
dpc-4927	84	2	these	these	DET
dpc-4927	84	3	patients	patient	NOUN
dpc-4927	84	4	,	,	PUNCT
dpc-4927	84	5	25	25	NUM
dpc-4927	84	6	had	have	AUX
dpc-4927	84	7	had	have	VERB
dpc-4927	84	8	mild	mild	ADJ
dpc-4927	84	9	and	and	CCONJ
dpc-4927	84	10	two	two	NUM
dpc-4927	84	11	had	have	AUX
dpc-4927	84	12	had	have	VERB
dpc-4927	84	13	moderate	moderate	ADJ
dpc-4927	84	14	disease	disease	NOUN
dpc-4927	84	15	severity	severity	NOUN
dpc-4927	84	16	.	.	PUNCT
dpc-4927	85	1	during	during	ADP
dpc-4927	85	2	follow	follow	NOUN
dpc-4927	85	3	-	-	PUNCT
dpc-4927	85	4	up	up	NOUN
dpc-4927	85	5	,	,	PUNCT
dpc-4927	85	6	no	no	DET
dpc-4927	85	7	significant	significant	ADJ
dpc-4927	85	8	capillary	capillary	ADJ
dpc-4927	85	9	anomalies	anomaly	NOUN
dpc-4927	85	10	indicating	indicate	VERB
dpc-4927	85	11	microvascular	microvascular	ADJ
dpc-4927	85	12	damage	damage	NOUN
dpc-4927	85	13	was	be	AUX
dpc-4927	85	14	detected	detect	VERB
dpc-4927	85	15	in	in	ADP
dpc-4927	85	16	the	the	DET
dpc-4927	85	17	patients	patient	NOUN
dpc-4927	85	18	.	.	PUNCT
dpc-4927	86	1	in	in	ADP
dpc-4927	86	2	the	the	DET
dpc-4927	86	3	initial	initial	ADJ
dpc-4927	86	4	evaluation	evaluation	NOUN
dpc-4927	86	5	,	,	PUNCT
dpc-4927	86	6	the	the	DET
dpc-4927	86	7	capillary	capillary	ADJ
dpc-4927	86	8	architecture	architecture	NOUN
dpc-4927	86	9	was	be	AUX
dpc-4927	86	10	disorganized	disorganize	VERB
dpc-4927	86	11	in	in	ADP
dpc-4927	86	12	six	six	NUM
dpc-4927	86	13	out	out	ADP
dpc-4927	86	14	of	of	ADP
dpc-4927	86	15	27	27	NUM
dpc-4927	86	16	patients	patient	NOUN
dpc-4927	86	17	,	,	PUNCT
dpc-4927	86	18	but	but	CCONJ
dpc-4927	86	19	all	all	PRON
dpc-4927	86	20	showed	show	VERB
dpc-4927	86	21	organized	organized	ADJ
dpc-4927	86	22	architecture	architecture	NOUN
dpc-4927	86	23	in	in	ADP
dpc-4927	86	24	the	the	DET
dpc-4927	86	25	follow	follow	NOUN
dpc-4927	86	26	-	-	PUNCT
dpc-4927	86	27	up	up	NOUN
dpc-4927	86	28	.	.	PUNCT
dpc-4927	87	1	in	in	ADP
dpc-4927	87	2	four	four	NUM
dpc-4927	87	3	of	of	ADP
dpc-4927	87	4	these	these	DET
dpc-4927	87	5	patients	patient	NOUN
dpc-4927	87	6	,	,	PUNCT
dpc-4927	87	7	the	the	DET
dpc-4927	87	8	ramified	ramify	VERB
dpc-4927	87	9	capillary	capillary	NOUN
dpc-4927	87	10	was	be	AUX
dpc-4927	87	11	initially	initially	ADV
dpc-4927	87	12	present	present	ADJ
dpc-4927	87	13	but	but	CCONJ
dpc-4927	87	14	disappeared	disappear	VERB
dpc-4927	87	15	,	,	PUNCT
dpc-4927	87	16	and	and	CCONJ
dpc-4927	87	17	in	in	ADP
dpc-4927	87	18	one	one	NUM
dpc-4927	87	19	patient	patient	NOUN
dpc-4927	87	20	,	,	PUNCT
dpc-4927	87	21	the	the	DET
dpc-4927	87	22	ramified	ramified	ADJ
dpc-4927	87	23	capillary	capillary	NOUN
dpc-4927	87	24	appeared	appear	VERB
dpc-4927	87	25	at	at	ADP
dpc-4927	87	26	the	the	DET
dpc-4927	87	27	second	second	ADJ
dpc-4927	87	28	evaluation	evaluation	NOUN
dpc-4927	87	29	.	.	PUNCT
dpc-4927	88	1	during	during	ADP
dpc-4927	88	2	the	the	DET
dpc-4927	88	3	follow	follow	NOUN
dpc-4927	88	4	-	-	PUNCT
dpc-4927	88	5	up	up	NOUN
dpc-4927	88	6	,	,	PUNCT
dpc-4927	88	7	microhemorrhage	microhemorrhage	NOUN
dpc-4927	88	8	was	be	AUX
dpc-4927	88	9	initially	initially	ADV
dpc-4927	88	10	present	present	ADJ
dpc-4927	88	11	in	in	ADP
dpc-4927	88	12	10	10	NUM
dpc-4927	88	13	patients	patient	NOUN
dpc-4927	88	14	but	but	CCONJ
dpc-4927	88	15	disappeared	disappear	VERB
dpc-4927	88	16	in	in	ADP
dpc-4927	88	17	nine	nine	NUM
dpc-4927	88	18	of	of	ADP
dpc-4927	88	19	them	they	PRON
dpc-4927	88	20	;	;	PUNCT
dpc-4927	88	21	it	it	PRON
dpc-4927	88	22	appeared	appear	VERB
dpc-4927	88	23	in	in	ADP
dpc-4927	88	24	one	one	NUM
dpc-4927	88	25	patient	patient	NOUN
dpc-4927	88	26	at	at	ADP
dpc-4927	88	27	the	the	DET
dpc-4927	88	28	second	second	ADJ
dpc-4927	88	29	evaluation	evaluation	NOUN
dpc-4927	88	30	.	.	PUNCT
dpc-4927	89	1	avascular	avascular	ADJ
dpc-4927	89	2	areas	area	NOUN
dpc-4927	89	3	were	be	AUX
dpc-4927	89	4	present	present	ADJ
dpc-4927	89	5	in	in	ADP
dpc-4927	89	6	seven	seven	NUM
dpc-4927	89	7	of	of	ADP
dpc-4927	89	8	27	27	NUM
dpc-4927	89	9	patients	patient	NOUN
dpc-4927	89	10	,	,	PUNCT
dpc-4927	89	11	all	all	PRON
dpc-4927	89	12	of	of	ADP
dpc-4927	89	13	which	which	PRON
dpc-4927	89	14	had	have	AUX
dpc-4927	89	15	resolved	resolve	VERB
dpc-4927	89	16	by	by	ADP
dpc-4927	89	17	follow	follow	NOUN
dpc-4927	89	18	-	-	PUNCT
dpc-4927	89	19	up	up	NOUN
dpc-4927	89	20	(	(	PUNCT
dpc-4927	89	21	figure	figure	NOUN
dpc-4927	89	22	3b	3b	NUM
dpc-4927	89	23	)	)	PUNCT
dpc-4927	89	24	.	.	PUNCT
dpc-4927	90	1	we	we	PRON
dpc-4927	90	2	did	do	AUX
dpc-4927	90	3	not	not	PART
dpc-4927	90	4	detect	detect	VERB
dpc-4927	90	5	any	any	DET
dpc-4927	90	6	significant	significant	ADJ
dpc-4927	90	7	difference	difference	NOUN
dpc-4927	90	8	between	between	ADP
dpc-4927	90	9	covid-19	covid-19	PROPN
dpc-4927	90	10	patients	patient	NOUN
dpc-4927	90	11	with	with	ADP
dpc-4927	90	12	mild	mild	ADJ
dpc-4927	90	13	and	and	CCONJ
dpc-4927	90	14	moderate	moderate	ADJ
dpc-4927	90	15	disease	disease	NOUN
dpc-4927	90	16	in	in	ADP
dpc-4927	90	17	all	all	DET
dpc-4927	90	18	examinations	examination	NOUN
dpc-4927	90	19	.	.	PUNCT
dpc-4927	91	1	figure	figure	NOUN
dpc-4927	91	2	1	1	NUM
dpc-4927	91	3	.	.	PUNCT
dpc-4927	91	4	red	red	ADJ
dpc-4927	91	5	half	half	ADJ
dpc-4927	91	6	-	-	PUNCT
dpc-4927	91	7	moon	moon	NOUN
dpc-4927	91	8	nail	nail	NOUN
dpc-4927	91	9	sign	sign	NOUN
dpc-4927	91	10	.	.	PUNCT
dpc-4927	92	1	(	(	PUNCT
dpc-4927	92	2	a	a	X
dpc-4927	92	3	)	)	PUNCT
dpc-4927	92	4	the	the	DET
dpc-4927	92	5	distal	distal	ADJ
dpc-4927	92	6	margin	margin	NOUN
dpc-4927	92	7	of	of	ADP
dpc-4927	92	8	the	the	DET
dpc-4927	92	9	lunula	lunula	NOUN
dpc-4927	92	10	is	be	AUX
dpc-4927	92	11	surrounded	surround	VERB
dpc-4927	92	12	by	by	ADP
dpc-4927	92	13	distally	distally	ADV
dpc-4927	92	14	convex	convex	VERB
dpc-4927	92	15	half	half	ADV
dpc-4927	92	16	-	-	PUNCT
dpc-4927	92	17	moonshaped	moonshape	VERB
dpc-4927	92	18	red	red	ADJ
dpc-4927	92	19	bands	band	NOUN
dpc-4927	92	20	.	.	PUNCT
dpc-4927	93	1	(	(	PUNCT
dpc-4927	93	2	b	b	X
dpc-4927	93	3	)	)	PUNCT
dpc-4927	93	4	on	on	ADP
dpc-4927	93	5	dermoscopy	dermoscopy	NOUN
dpc-4927	93	6	,	,	PUNCT
dpc-4927	93	7	the	the	DET
dpc-4927	93	8	lunula	lunula	NOUN
dpc-4927	93	9	was	be	AUX
dpc-4927	93	10	blurred	blur	VERB
dpc-4927	93	11	and	and	CCONJ
dpc-4927	93	12	indistinct	indistinct	ADJ
dpc-4927	93	13	.	.	PUNCT
dpc-4927	94	1	figure	figure	NOUN
dpc-4927	94	2	2	2	NUM
dpc-4927	94	3	.	.	PUNCT
dpc-4927	94	4	nailfold	nailfold	PROPN
dpc-4927	94	5	capillaries	capillary	NOUN
dpc-4927	94	6	in	in	ADP
dpc-4927	94	7	a	a	DET
dpc-4927	94	8	healthy	healthy	ADJ
dpc-4927	94	9	control	control	NOUN
dpc-4927	94	10	.	.	PUNCT
dpc-4927	95	1	in	in	ADP
dpc-4927	95	2	healthy	healthy	ADJ
dpc-4927	95	3	individuals	individual	NOUN
dpc-4927	95	4	,	,	PUNCT
dpc-4927	95	5	the	the	DET
dpc-4927	95	6	capillaries	capillary	NOUN
dpc-4927	95	7	in	in	ADP
dpc-4927	95	8	the	the	DET
dpc-4927	95	9	proximal	proximal	ADJ
dpc-4927	95	10	nail	nail	NOUN
dpc-4927	95	11	fold	fold	NOUN
dpc-4927	95	12	are	be	AUX
dpc-4927	95	13	loop	loop	NOUN
dpc-4927	95	14	-	-	PUNCT
dpc-4927	95	15	shaped	shape	VERB
dpc-4927	95	16	and	and	CCONJ
dpc-4927	95	17	run	run	VERB
dpc-4927	95	18	parallel	parallel	ADJ
dpc-4927	95	19	to	to	ADP
dpc-4927	95	20	the	the	DET
dpc-4927	95	21	skin	skin	NOUN
dpc-4927	95	22	(	(	PUNCT
dpc-4927	95	23	×20	×20	PROPN
dpc-4927	95	24	)	)	PUNCT
dpc-4927	95	25	.	.	PUNCT
dpc-4927	96	1	4	4	NUM
dpc-4927	96	2	original	original	ADJ
dpc-4927	96	3	article	article	NOUN
dpc-4927	96	4	|	|	ADV
dpc-4927	96	5	dermatol	dermatol	ADJ
dpc-4927	96	6	pract	pract	NOUN
dpc-4927	96	7	concept	concept	NOUN
dpc-4927	96	8	.	.	PUNCT
dpc-4927	97	1	2025;15(1):4927	2025;15(1):4927	NUM
dpc-4927	97	2	hospitalized	hospitalize	VERB
dpc-4927	97	3	covid-19	covid-19	PROPN
dpc-4927	97	4	patients	patient	NOUN
dpc-4927	97	5	,	,	PUNCT
dpc-4927	97	6	about	about	ADV
dpc-4927	97	7	60	60	NUM
dpc-4927	97	8	%	%	NOUN
dpc-4927	97	9	showed	show	VERB
dpc-4927	97	10	enlarged	enlarge	VERB
dpc-4927	97	11	capillaries	capillary	NOUN
dpc-4927	97	12	and	and	CCONJ
dpc-4927	97	13	around	around	ADV
dpc-4927	97	14	50	50	NUM
dpc-4927	97	15	%	%	NOUN
dpc-4927	97	16	had	have	VERB
dpc-4927	97	17	meandering	meander	VERB
dpc-4927	97	18	capillaries	capillary	NOUN
dpc-4927	97	19	and	and	CCONJ
dpc-4927	97	20	reduced	reduce	VERB
dpc-4927	97	21	capillary	capillary	ADJ
dpc-4927	97	22	density	density	NOUN
dpc-4927	97	23	[	[	X
dpc-4927	97	24	12,15	12,15	NUM
dpc-4927	97	25	]	]	X
dpc-4927	97	26	.	.	PUNCT
dpc-4927	98	1	in	in	ADP
dpc-4927	98	2	the	the	DET
dpc-4927	98	3	study	study	NOUN
dpc-4927	98	4	by	by	ADP
dpc-4927	98	5	karahan	karahan	PROPN
dpc-4927	98	6	et	et	PROPN
dpc-4927	98	7	al	al	PROPN
dpc-4927	98	8	.	.	PROPN
dpc-4927	98	9	involving	involve	VERB
dpc-4927	98	10	covid-19	covid-19	PROPN
dpc-4927	98	11	patients	patient	NOUN
dpc-4927	98	12	in	in	ADP
dpc-4927	98	13	need	need	NOUN
dpc-4927	98	14	of	of	ADP
dpc-4927	98	15	intensive	intensive	ADJ
dpc-4927	98	16	care	care	NOUN
dpc-4927	98	17	,	,	PUNCT
dpc-4927	98	18	a	a	DET
dpc-4927	98	19	similarly	similarly	ADV
dpc-4927	98	20	high	high	ADJ
dpc-4927	98	21	rate	rate	NOUN
dpc-4927	98	22	of	of	ADP
dpc-4927	98	23	dilated	dilated	ADJ
dpc-4927	98	24	capillaries	capillary	NOUN
dpc-4927	98	25	(	(	PUNCT
dpc-4927	98	26	43.8	43.8	NUM
dpc-4927	98	27	%	%	NOUN
dpc-4927	98	28	)	)	PUNCT
dpc-4927	98	29	and	and	CCONJ
dpc-4927	98	30	meandering	meander	VERB
dpc-4927	98	31	capillaries	capillary	NOUN
dpc-4927	98	32	(	(	PUNCT
dpc-4927	98	33	56.2	56.2	NUM
dpc-4927	98	34	%	%	NOUN
dpc-4927	98	35	)	)	PUNCT
dpc-4927	98	36	were	be	AUX
dpc-4927	98	37	reported	report	VERB
dpc-4927	98	38	[	[	X
dpc-4927	98	39	14	14	NUM
dpc-4927	98	40	]	]	PUNCT
dpc-4927	98	41	.	.	PUNCT
dpc-4927	99	1	our	our	PRON
dpc-4927	99	2	study	study	NOUN
dpc-4927	99	3	findings	finding	NOUN
dpc-4927	99	4	revealed	reveal	VERB
dpc-4927	99	5	significant	significant	ADJ
dpc-4927	99	6	microvascular	microvascular	ADJ
dpc-4927	99	7	abnormalities	abnormality	NOUN
dpc-4927	99	8	in	in	ADP
dpc-4927	99	9	mild	mild	ADJ
dpc-4927	99	10	-	-	PUNCT
dpc-4927	99	11	to	to	ADP
dpc-4927	99	12	-	-	PUNCT
dpc-4927	99	13	moderate	moderate	ADJ
dpc-4927	99	14	covid-19	covid-19	PROPN
dpc-4927	99	15	patients	patient	NOUN
dpc-4927	99	16	,	,	PUNCT
dpc-4927	99	17	with	with	ADP
dpc-4927	99	18	39.1	39.1	NUM
dpc-4927	99	19	%	%	NOUN
dpc-4927	99	20	showing	showing	NOUN
dpc-4927	99	21	decreased	decrease	VERB
dpc-4927	99	22	capillary	capillary	ADJ
dpc-4927	99	23	density	density	NOUN
dpc-4927	99	24	,	,	PUNCT
dpc-4927	99	25	23.9	23.9	NUM
dpc-4927	99	26	%	%	NOUN
dpc-4927	99	27	exhibiting	exhibit	VERB
dpc-4927	99	28	enlarged	enlarged	ADJ
dpc-4927	99	29	capillaries	capillary	NOUN
dpc-4927	99	30	,	,	PUNCT
dpc-4927	99	31	34.8	34.8	NUM
dpc-4927	99	32	%	%	NOUN
dpc-4927	99	33	microhemorrhage	microhemorrhage	NOUN
dpc-4927	99	34	,	,	PUNCT
dpc-4927	99	35	and	and	CCONJ
dpc-4927	99	36	19.6	19.6	NUM
dpc-4927	99	37	%	%	NOUN
dpc-4927	99	38	meandering	meander	VERB
dpc-4927	99	39	capillaries	capillary	NOUN
dpc-4927	99	40	.	.	PUNCT
dpc-4927	100	1	a	a	DET
dpc-4927	100	2	close	close	ADJ
dpc-4927	100	3	relationship	relationship	NOUN
dpc-4927	100	4	between	between	ADP
dpc-4927	100	5	endothelial	endothelial	ADJ
dpc-4927	100	6	dysfunction	dysfunction	NOUN
dpc-4927	100	7	and	and	CCONJ
dpc-4927	100	8	proximal	proximal	ADJ
dpc-4927	100	9	nailfold	nailfold	ADJ
dpc-4927	100	10	capillary	capillary	ADJ
dpc-4927	100	11	density	density	NOUN
dpc-4927	100	12	has	have	AUX
dpc-4927	100	13	been	be	AUX
dpc-4927	100	14	demonstrated	demonstrate	VERB
dpc-4927	100	15	in	in	ADP
dpc-4927	100	16	several	several	ADJ
dpc-4927	100	17	diseases	disease	NOUN
dpc-4927	100	18	including	include	VERB
dpc-4927	100	19	scleroderma	scleroderma	NOUN
dpc-4927	100	20	,	,	PUNCT
dpc-4927	100	21	diabetes	diabetes	NOUN
dpc-4927	100	22	mellitus	mellitus	NOUN
dpc-4927	100	23	,	,	PUNCT
dpc-4927	100	24	and	and	CCONJ
dpc-4927	100	25	essential	essential	ADJ
dpc-4927	100	26	hypertension	hypertension	NOUN
dpc-4927	100	27	[	[	X
dpc-4927	100	28	27	27	NUM
dpc-4927	100	29	]	]	PUNCT
dpc-4927	100	30	.	.	PUNCT
dpc-4927	101	1	sars	sar	NOUN
dpc-4927	101	2	-	-	PUNCT
dpc-4927	101	3	cov-2	cov-2	PART
dpc-4927	101	4	uses	use	VERB
dpc-4927	101	5	the	the	DET
dpc-4927	101	6	ace2	ace2	PROPN
dpc-4927	101	7	receptor	receptor	NOUN
dpc-4927	101	8	expressed	express	VERB
dpc-4927	101	9	by	by	ADP
dpc-4927	101	10	pneumocytes	pneumocyte	NOUN
dpc-4927	101	11	in	in	ADP
dpc-4927	101	12	the	the	DET
dpc-4927	101	13	epithelial	epithelial	ADJ
dpc-4927	101	14	alveolar	alveolar	ADJ
dpc-4927	101	15	lining	lining	NOUN
dpc-4927	101	16	to	to	PART
dpc-4927	101	17	infect	infect	VERB
dpc-4927	101	18	the	the	DET
dpc-4927	101	19	host	host	NOUN
dpc-4927	101	20	,	,	PUNCT
dpc-4927	101	21	and	and	CCONJ
dpc-4927	101	22	the	the	DET
dpc-4927	101	23	ace2	ace2	NOUN
dpc-4927	101	24	receptor	receptor	NOUN
dpc-4927	101	25	is	be	AUX
dpc-4927	101	26	also	also	ADV
dpc-4927	101	27	widely	widely	ADV
dpc-4927	101	28	expressed	express	VERB
dpc-4927	101	29	in	in	ADP
dpc-4927	101	30	endothelial	endothelial	ADJ
dpc-4927	101	31	cells	cell	NOUN
dpc-4927	101	32	.	.	PUNCT
dpc-4927	102	1	direct	direct	ADJ
dpc-4927	102	2	viral	viral	ADJ
dpc-4927	102	3	infection	infection	NOUN
dpc-4927	102	4	of	of	ADP
dpc-4927	102	5	the	the	DET
dpc-4927	102	6	endothelium	endothelium	NOUN
dpc-4927	102	7	and	and	CCONJ
dpc-4927	102	8	subsequent	subsequent	ADJ
dpc-4927	102	9	inflammation	inflammation	NOUN
dpc-4927	102	10	can	can	AUX
dpc-4927	102	11	lead	lead	VERB
dpc-4927	102	12	to	to	ADP
dpc-4927	102	13	apoptosis	apoptosis	NOUN
dpc-4927	102	14	and	and	CCONJ
dpc-4927	102	15	widespread	widespread	ADJ
dpc-4927	102	16	endothelial	endothelial	ADJ
dpc-4927	102	17	dysfunction	dysfunction	NOUN
dpc-4927	102	18	[	[	X
dpc-4927	102	19	28	28	NUM
dpc-4927	102	20	]	]	PUNCT
dpc-4927	102	21	.	.	PUNCT
dpc-4927	103	1	reduced	reduce	VERB
dpc-4927	103	2	capillary	capillary	ADJ
dpc-4927	103	3	density	density	NOUN
dpc-4927	103	4	is	be	AUX
dpc-4927	103	5	likely	likely	ADJ
dpc-4927	103	6	to	to	PART
dpc-4927	103	7	reflect	reflect	VERB
dpc-4927	103	8	endothelial	endothelial	ADJ
dpc-4927	103	9	dysfunction	dysfunction	NOUN
dpc-4927	103	10	in	in	ADP
dpc-4927	103	11	covid-19	covid-19	PROPN
dpc-4927	103	12	.	.	PUNCT
dpc-4927	104	1	the	the	DET
dpc-4927	104	2	impairment	impairment	NOUN
dpc-4927	104	3	of	of	ADP
dpc-4927	104	4	microvascular	microvascular	ADJ
dpc-4927	104	5	tone	tone	NOUN
dpc-4927	104	6	causes	cause	VERB
dpc-4927	104	7	the	the	DET
dpc-4927	104	8	opening	opening	NOUN
dpc-4927	104	9	of	of	ADP
dpc-4927	104	10	endothelial	endothelial	ADJ
dpc-4927	104	11	junctions	junction	NOUN
dpc-4927	104	12	,	,	PUNCT
dpc-4927	104	13	which	which	PRON
dpc-4927	104	14	increases	increase	VERB
dpc-4927	104	15	microvascular	microvascular	ADJ
dpc-4927	104	16	permeability	permeability	NOUN
dpc-4927	104	17	and	and	CCONJ
dpc-4927	104	18	leads	lead	VERB
dpc-4927	104	19	to	to	ADP
dpc-4927	104	20	progressive	progressive	ADJ
dpc-4927	104	21	leakage	leakage	NOUN
dpc-4927	104	22	,	,	PUNCT
dpc-4927	104	23	resulting	result	VERB
dpc-4927	104	24	in	in	ADP
dpc-4927	104	25	microhemorrhages	microhemorrhage	NOUN
dpc-4927	104	26	[	[	X
dpc-4927	104	27	29	29	NUM
dpc-4927	104	28	]	]	PUNCT
dpc-4927	104	29	.	.	PUNCT
dpc-4927	105	1	additionally	additionally	ADV
dpc-4927	105	2	,	,	PUNCT
dpc-4927	105	3	it	it	PRON
dpc-4927	105	4	has	have	AUX
dpc-4927	105	5	been	be	AUX
dpc-4927	105	6	suggested	suggest	VERB
dpc-4927	105	7	that	that	SCONJ
dpc-4927	105	8	hypoxia	hypoxia	NOUN
dpc-4927	105	9	and	and	CCONJ
dpc-4927	105	10	inflammation	inflammation	NOUN
dpc-4927	105	11	that	that	PRON
dpc-4927	105	12	develop	develop	VERB
dpc-4927	105	13	during	during	ADP
dpc-4927	105	14	covid-19	covid-19	PROPN
dpc-4927	105	15	may	may	AUX
dpc-4927	105	16	stimulate	stimulate	VERB
dpc-4927	105	17	neoangiogenesis	neoangiogenesis	NOUN
dpc-4927	105	18	in	in	ADP
dpc-4927	105	19	the	the	DET
dpc-4927	105	20	proximal	proximal	ADJ
dpc-4927	105	21	nail	nail	NOUN
dpc-4927	105	22	fold	fold	NOUN
dpc-4927	106	1	[	[	X
dpc-4927	106	2	16	16	NUM
dpc-4927	106	3	]	]	PUNCT
dpc-4927	106	4	.	.	PUNCT
dpc-4927	107	1	the	the	DET
dpc-4927	107	2	meandering	meander	VERB
dpc-4927	107	3	capillaries	capillary	NOUN
dpc-4927	107	4	observed	observe	VERB
dpc-4927	107	5	in	in	ADP
dpc-4927	107	6	dermoscopy	dermoscopy	NOUN
dpc-4927	107	7	are	be	AUX
dpc-4927	107	8	representative	representative	ADJ
dpc-4927	107	9	of	of	ADP
dpc-4927	107	10	neoangiogenesis	neoangiogenesis	NOUN
dpc-4927	107	11	.	.	PUNCT
dpc-4927	108	1	furthermore	furthermore	ADV
dpc-4927	108	2	,	,	PUNCT
dpc-4927	108	3	local	local	ADJ
dpc-4927	108	4	endothelial	endothelial	ADJ
dpc-4927	108	5	cells	cell	NOUN
dpc-4927	108	6	secrete	secrete	VERB
dpc-4927	108	7	vasodilator	vasodilator	NOUN
dpc-4927	108	8	agents	agent	NOUN
dpc-4927	108	9	,	,	PUNCT
dpc-4927	108	10	such	such	ADJ
dpc-4927	108	11	as	as	ADP
dpc-4927	108	12	prostacyclin	prostacyclin	ADJ
dpc-4927	108	13	and	and	CCONJ
dpc-4927	108	14	nitric	nitric	ADJ
dpc-4927	108	15	oxide	oxide	NOUN
dpc-4927	108	16	(	(	PUNCT
dpc-4927	108	17	no	no	NOUN
dpc-4927	108	18	)	)	PUNCT
dpc-4927	108	19	,	,	PUNCT
dpc-4927	108	20	in	in	ADP
dpc-4927	108	21	response	response	NOUN
dpc-4927	108	22	to	to	ADP
dpc-4927	108	23	hypoxia	hypoxia	NOUN
dpc-4927	108	24	,	,	PUNCT
dpc-4927	108	25	which	which	PRON
dpc-4927	108	26	explains	explain	VERB
dpc-4927	108	27	the	the	DET
dpc-4927	108	28	presence	presence	NOUN
dpc-4927	108	29	of	of	ADP
dpc-4927	108	30	dilated	dilated	ADJ
dpc-4927	108	31	capillaries	capillary	NOUN
dpc-4927	108	32	[	[	X
dpc-4927	108	33	30	30	NUM
dpc-4927	108	34	]	]	PUNCT
dpc-4927	108	35	.	.	PUNCT
dpc-4927	109	1	although	although	SCONJ
dpc-4927	109	2	the	the	DET
dpc-4927	109	3	relatively	relatively	ADV
dpc-4927	109	4	higher	high	ADJ
dpc-4927	109	5	rates	rate	NOUN
dpc-4927	109	6	of	of	ADP
dpc-4927	109	7	pathological	pathological	ADJ
dpc-4927	109	8	nvc	nvc	NOUN
dpc-4927	109	9	findings	finding	NOUN
dpc-4927	109	10	in	in	ADP
dpc-4927	109	11	previous	previous	ADJ
dpc-4927	109	12	studies	study	NOUN
dpc-4927	109	13	suggest	suggest	VERB
dpc-4927	109	14	that	that	SCONJ
dpc-4927	109	15	disease	disease	NOUN
dpc-4927	109	16	severity	severity	NOUN
dpc-4927	109	17	may	may	AUX
dpc-4927	109	18	have	have	VERB
dpc-4927	109	19	an	an	DET
dpc-4927	109	20	impact	impact	NOUN
dpc-4927	109	21	on	on	ADP
dpc-4927	109	22	capillaroscopic	capillaroscopic	ADJ
dpc-4927	109	23	findings	finding	NOUN
dpc-4927	109	24	,	,	PUNCT
dpc-4927	109	25	in	in	ADP
dpc-4927	109	26	the	the	DET
dpc-4927	109	27	study	study	NOUN
dpc-4927	109	28	by	by	ADP
dpc-4927	109	29	sulli	sulli	PROPN
dpc-4927	109	30	et	et	PROPN
dpc-4927	109	31	al	al	PROPN
dpc-4927	109	32	.	.	PROPN
dpc-4927	109	33	,	,	PUNCT
dpc-4927	109	34	no	no	DET
dpc-4927	109	35	difference	difference	NOUN
dpc-4927	109	36	was	be	AUX
dpc-4927	109	37	found	find	VERB
dpc-4927	109	38	in	in	ADP
dpc-4927	109	39	terms	term	NOUN
dpc-4927	109	40	of	of	ADP
dpc-4927	109	41	nvc	nvc	PROPN
dpc-4927	109	42	findings	finding	NOUN
dpc-4927	109	43	between	between	ADP
dpc-4927	109	44	severe	severe	ADJ
dpc-4927	109	45	disease	disease	NOUN
dpc-4927	109	46	and	and	CCONJ
dpc-4927	109	47	mild	mild	ADJ
dpc-4927	109	48	-	-	PUNCT
dpc-4927	109	49	moderate	moderate	ADJ
dpc-4927	109	50	disease	disease	NOUN
dpc-4927	109	51	[	[	X
dpc-4927	109	52	11	11	NUM
dpc-4927	109	53	]	]	PUNCT
dpc-4927	109	54	.	.	PUNCT
dpc-4927	110	1	technical	technical	ADJ
dpc-4927	110	2	differences	difference	NOUN
dpc-4927	110	3	certainly	certainly	ADV
dpc-4927	110	4	contribute	contribute	VERB
dpc-4927	110	5	to	to	ADP
dpc-4927	110	6	our	our	PRON
dpc-4927	110	7	relatively	relatively	ADV
dpc-4927	110	8	lower	low	ADJ
dpc-4927	110	9	discussion	discussion	NOUN
dpc-4927	110	10	capillaroscopy	capillaroscopy	NOUN
dpc-4927	110	11	of	of	ADP
dpc-4927	110	12	the	the	DET
dpc-4927	110	13	proximal	proximal	ADJ
dpc-4927	110	14	nailfold	nailfold	NOUN
dpc-4927	110	15	provides	provide	VERB
dpc-4927	110	16	important	important	ADJ
dpc-4927	110	17	clues	clue	NOUN
dpc-4927	110	18	for	for	ADP
dpc-4927	110	19	the	the	DET
dpc-4927	110	20	early	early	ADJ
dpc-4927	110	21	detection	detection	NOUN
dpc-4927	110	22	of	of	ADP
dpc-4927	110	23	microcirculation	microcirculation	NOUN
dpc-4927	110	24	changes	change	NOUN
dpc-4927	110	25	[	[	X
dpc-4927	110	26	22	22	NUM
dpc-4927	110	27	]	]	PUNCT
dpc-4927	110	28	.	.	PUNCT
dpc-4927	111	1	nailfold	nailfold	PROPN
dpc-4927	111	2	capillaroscopic	capillaroscopic	PROPN
dpc-4927	111	3	abnormalities	abnormality	NOUN
dpc-4927	111	4	have	have	AUX
dpc-4927	111	5	been	be	AUX
dpc-4927	111	6	found	find	VERB
dpc-4927	111	7	in	in	ADP
dpc-4927	111	8	conditions	condition	NOUN
dpc-4927	111	9	linked	link	VERB
dpc-4927	111	10	to	to	ADP
dpc-4927	111	11	microvascular	microvascular	ADJ
dpc-4927	111	12	changes	change	NOUN
dpc-4927	111	13	,	,	PUNCT
dpc-4927	111	14	such	such	ADJ
dpc-4927	111	15	as	as	ADP
dpc-4927	111	16	connective	connective	ADJ
dpc-4927	111	17	tissue	tissue	NOUN
dpc-4927	111	18	diseases	disease	NOUN
dpc-4927	111	19	,	,	PUNCT
dpc-4927	111	20	hypertension	hypertension	NOUN
dpc-4927	111	21	,	,	PUNCT
dpc-4927	111	22	and	and	CCONJ
dpc-4927	111	23	diabetes	diabetes	NOUN
dpc-4927	111	24	[	[	X
dpc-4927	111	25	20,23	20,23	NUM
dpc-4927	111	26	-	-	SYM
dpc-4927	111	27	25	25	NUM
dpc-4927	111	28	]	]	PUNCT
dpc-4927	111	29	.	.	PUNCT
dpc-4927	112	1	the	the	DET
dpc-4927	112	2	videocapillaroscope	videocapillaroscope	NOUN
dpc-4927	112	3	is	be	AUX
dpc-4927	112	4	the	the	DET
dpc-4927	112	5	main	main	ADJ
dpc-4927	112	6	tool	tool	NOUN
dpc-4927	112	7	for	for	ADP
dpc-4927	112	8	capillaroscopic	capillaroscopic	ADJ
dpc-4927	112	9	analysis	analysis	NOUN
dpc-4927	112	10	,	,	PUNCT
dpc-4927	112	11	but	but	CCONJ
dpc-4927	112	12	a	a	DET
dpc-4927	112	13	dermoscope	dermoscope	NOUN
dpc-4927	112	14	,	,	PUNCT
dpc-4927	112	15	ophthalmoscope	ophthalmoscope	NOUN
dpc-4927	112	16	,	,	PUNCT
dpc-4927	112	17	or	or	CCONJ
dpc-4927	112	18	wide	wide	ADJ
dpc-4927	112	19	-	-	PUNCT
dpc-4927	112	20	field	field	NOUN
dpc-4927	112	21	microscope	microscope	NOUN
dpc-4927	112	22	can	can	AUX
dpc-4927	112	23	also	also	ADV
dpc-4927	112	24	be	be	AUX
dpc-4927	112	25	effective	effective	ADJ
dpc-4927	112	26	alternatives	alternative	NOUN
dpc-4927	112	27	[	[	X
dpc-4927	112	28	22	22	NUM
dpc-4927	112	29	]	]	PUNCT
dpc-4927	112	30	.	.	PUNCT
dpc-4927	113	1	dermoscopic	dermoscopic	PROPN
dpc-4927	113	2	findings	finding	NOUN
dpc-4927	113	3	of	of	ADP
dpc-4927	113	4	the	the	DET
dpc-4927	113	5	nailfold	nailfold	NOUN
dpc-4927	113	6	have	have	AUX
dpc-4927	113	7	been	be	AUX
dpc-4927	113	8	reported	report	VERB
dpc-4927	113	9	in	in	ADP
dpc-4927	113	10	hemolytic	hemolytic	ADJ
dpc-4927	113	11	uremic	uremic	ADJ
dpc-4927	113	12	syndrome	syndrome	NOUN
dpc-4927	113	13	,	,	PUNCT
dpc-4927	113	14	psoriatic	psoriatic	ADJ
dpc-4927	113	15	arthritis	arthritis	NOUN
dpc-4927	113	16	,	,	PUNCT
dpc-4927	113	17	rheumatoid	rheumatoid	NOUN
dpc-4927	113	18	arthritis	arthritis	NOUN
dpc-4927	113	19	,	,	PUNCT
dpc-4927	113	20	and	and	CCONJ
dpc-4927	113	21	connective	connective	ADJ
dpc-4927	113	22	tissue	tissue	NOUN
dpc-4927	113	23	diseases	disease	NOUN
dpc-4927	113	24	[	[	X
dpc-4927	113	25	26	26	NUM
dpc-4927	113	26	-	-	SYM
dpc-4927	113	27	29	29	NUM
dpc-4927	113	28	]	]	PUNCT
dpc-4927	113	29	.	.	PUNCT
dpc-4927	114	1	the	the	DET
dpc-4927	114	2	current	current	ADJ
dpc-4927	114	3	study	study	NOUN
dpc-4927	114	4	used	use	VERB
dpc-4927	114	5	dermoscopy	dermoscopy	NOUN
dpc-4927	114	6	to	to	PART
dpc-4927	114	7	evaluate	evaluate	VERB
dpc-4927	114	8	proximal	proximal	ADJ
dpc-4927	114	9	nailfold	nailfold	NOUN
dpc-4927	114	10	capillaries	capillary	NOUN
dpc-4927	114	11	in	in	ADP
dpc-4927	114	12	early	early	ADJ
dpc-4927	114	13	and	and	CCONJ
dpc-4927	114	14	long	long	ADJ
dpc-4927	114	15	-	-	PUNCT
dpc-4927	114	16	term	term	NOUN
dpc-4927	114	17	follow	follow	NOUN
dpc-4927	114	18	-	-	PUNCT
dpc-4927	114	19	up	up	NOUN
dpc-4927	114	20	of	of	ADP
dpc-4927	114	21	covid-19	covid-19	PROPN
dpc-4927	114	22	patients	patient	NOUN
dpc-4927	114	23	.	.	PUNCT
dpc-4927	115	1	it	it	PRON
dpc-4927	115	2	is	be	AUX
dpc-4927	115	3	now	now	ADV
dpc-4927	115	4	well	well	ADV
dpc-4927	115	5	-	-	PUNCT
dpc-4927	115	6	known	know	VERB
dpc-4927	115	7	that	that	SCONJ
dpc-4927	115	8	endothelial	endothelial	ADJ
dpc-4927	115	9	dysfunction	dysfunction	NOUN
dpc-4927	115	10	plays	play	VERB
dpc-4927	115	11	a	a	DET
dpc-4927	115	12	crucial	crucial	ADJ
dpc-4927	115	13	role	role	NOUN
dpc-4927	115	14	in	in	ADP
dpc-4927	115	15	the	the	DET
dpc-4927	115	16	pathogenesis	pathogenesis	NOUN
dpc-4927	115	17	of	of	ADP
dpc-4927	115	18	covid-19	covid-19	PROPN
dpc-4927	116	1	[	[	X
dpc-4927	116	2	30	30	NUM
dpc-4927	116	3	]	]	PUNCT
dpc-4927	116	4	.	.	PUNCT
dpc-4927	117	1	microvascular	microvascular	ADJ
dpc-4927	117	2	changes	change	NOUN
dpc-4927	117	3	due	due	ADJ
dpc-4927	117	4	to	to	ADP
dpc-4927	117	5	endothelial	endothelial	ADJ
dpc-4927	117	6	dysfunction	dysfunction	NOUN
dpc-4927	117	7	in	in	ADP
dpc-4927	117	8	covid-19	covid-19	PROPN
dpc-4927	117	9	patients	patient	NOUN
dpc-4927	117	10	have	have	AUX
dpc-4927	117	11	been	be	AUX
dpc-4927	117	12	reported	report	VERB
dpc-4927	117	13	in	in	ADP
dpc-4927	117	14	a	a	DET
dpc-4927	117	15	few	few	ADJ
dpc-4927	117	16	studies	study	NOUN
dpc-4927	117	17	with	with	ADP
dpc-4927	117	18	nvc	nvc	PROPN
dpc-4927	117	19	[	[	X
dpc-4927	117	20	10	10	NUM
dpc-4927	117	21	-	-	SYM
dpc-4927	117	22	16	16	NUM
dpc-4927	117	23	]	]	PUNCT
dpc-4927	117	24	.	.	PUNCT
dpc-4927	118	1	these	these	DET
dpc-4927	118	2	studies	study	NOUN
dpc-4927	118	3	included	include	VERB
dpc-4927	118	4	patients	patient	NOUN
dpc-4927	118	5	with	with	ADP
dpc-4927	118	6	varying	vary	VERB
dpc-4927	118	7	disease	disease	NOUN
dpc-4927	118	8	severity	severity	NOUN
dpc-4927	118	9	,	,	PUNCT
dpc-4927	118	10	and	and	CCONJ
dpc-4927	118	11	pathological	pathological	ADJ
dpc-4927	118	12	capillaroscopy	capillaroscopy	NOUN
dpc-4927	118	13	findings	finding	NOUN
dpc-4927	118	14	were	be	AUX
dpc-4927	118	15	reported	report	VERB
dpc-4927	118	16	at	at	ADP
dpc-4927	118	17	different	different	ADJ
dpc-4927	118	18	rates	rate	NOUN
dpc-4927	118	19	.	.	PUNCT
dpc-4927	119	1	in	in	ADP
dpc-4927	119	2	two	two	NUM
dpc-4927	119	3	studies	study	NOUN
dpc-4927	119	4	on	on	ADP
dpc-4927	119	5	figure	figure	NOUN
dpc-4927	119	6	3	3	NUM
dpc-4927	119	7	.	.	PUNCT
dpc-4927	119	8	architecture	architecture	NOUN
dpc-4927	119	9	and	and	CCONJ
dpc-4927	119	10	density	density	NOUN
dpc-4927	119	11	evaluation	evaluation	NOUN
dpc-4927	119	12	of	of	ADP
dpc-4927	119	13	proximal	proximal	ADJ
dpc-4927	119	14	nailfold	nailfold	NOUN
dpc-4927	119	15	capillaries	capillary	NOUN
dpc-4927	119	16	.	.	PUNCT
dpc-4927	120	1	(	(	PUNCT
dpc-4927	120	2	a	a	X
dpc-4927	120	3	)	)	PUNCT
dpc-4927	120	4	dermoscopic	dermoscopic	ADJ
dpc-4927	120	5	image	image	NOUN
dpc-4927	120	6	of	of	ADP
dpc-4927	120	7	covid-19	covid-19	PROPN
dpc-4927	120	8	patient	patient	NOUN
dpc-4927	120	9	showing	show	VERB
dpc-4927	120	10	avascular	avascular	ADJ
dpc-4927	120	11	regions	region	NOUN
dpc-4927	120	12	,	,	PUNCT
dpc-4927	120	13	reduced	reduce	VERB
dpc-4927	120	14	capillary	capillary	ADJ
dpc-4927	120	15	density	density	NOUN
dpc-4927	120	16	,	,	PUNCT
dpc-4927	120	17	and	and	CCONJ
dpc-4927	120	18	disorganized	disorganized	ADJ
dpc-4927	120	19	capillaries	capillary	NOUN
dpc-4927	120	20	in	in	ADP
dpc-4927	120	21	the	the	DET
dpc-4927	120	22	acute	acute	ADJ
dpc-4927	120	23	stage	stage	NOUN
dpc-4927	120	24	(	(	PUNCT
dpc-4927	120	25	×	×	NOUN
dpc-4927	120	26	20	20	NUM
dpc-4927	120	27	)	)	PUNCT
dpc-4927	120	28	.	.	PUNCT
dpc-4927	121	1	(	(	PUNCT
dpc-4927	121	2	b	b	X
dpc-4927	121	3	)	)	PUNCT
dpc-4927	121	4	in	in	ADP
dpc-4927	121	5	the	the	DET
dpc-4927	121	6	long	long	ADJ
dpc-4927	121	7	-	-	PUNCT
dpc-4927	121	8	term	term	NOUN
dpc-4927	121	9	follow	follow	NOUN
dpc-4927	121	10	-	-	PUNCT
dpc-4927	121	11	up	up	NOUN
dpc-4927	121	12	of	of	ADP
dpc-4927	121	13	the	the	DET
dpc-4927	121	14	same	same	ADJ
dpc-4927	121	15	patient	patient	NOUN
dpc-4927	121	16	,	,	PUNCT
dpc-4927	121	17	neovascularization	neovascularization	NOUN
dpc-4927	121	18	was	be	AUX
dpc-4927	121	19	observed	observe	VERB
dpc-4927	121	20	,	,	PUNCT
dpc-4927	121	21	and	and	CCONJ
dpc-4927	121	22	avascular	avascular	ADJ
dpc-4927	121	23	areas	area	NOUN
dpc-4927	121	24	and	and	CCONJ
dpc-4927	121	25	irregularities	irregularity	NOUN
dpc-4927	121	26	disappeared	disappear	VERB
dpc-4927	121	27	(	(	PUNCT
dpc-4927	121	28	×	×	NOUN
dpc-4927	121	29	20	20	NUM
dpc-4927	121	30	)	)	PUNCT
dpc-4927	121	31	.	.	PUNCT
dpc-4927	122	1	figure	figure	VERB
dpc-4927	122	2	4	4	NUM
dpc-4927	122	3	.	.	PUNCT
dpc-4927	122	4	meandering	meander	VERB
dpc-4927	122	5	capillaries	capillary	NOUN
dpc-4927	122	6	in	in	ADP
dpc-4927	122	7	a	a	DET
dpc-4927	122	8	covid-19	covid-19	PROPN
dpc-4927	122	9	patient	patient	NOUN
dpc-4927	122	10	.	.	PUNCT
dpc-4927	123	1	meandering	meander	VERB
dpc-4927	123	2	capillaries	capillary	NOUN
dpc-4927	123	3	were	be	AUX
dpc-4927	123	4	more	more	ADV
dpc-4927	123	5	common	common	ADJ
dpc-4927	123	6	in	in	ADP
dpc-4927	123	7	covid-19	covid-19	PROPN
dpc-4927	123	8	patients	patient	NOUN
dpc-4927	123	9	than	than	ADP
dpc-4927	123	10	healthy	healthy	ADJ
dpc-4927	123	11	controls	control	NOUN
dpc-4927	123	12	(	(	PUNCT
dpc-4927	123	13	p	p	X
dpc-4927	123	14	=	=	NOUN
dpc-4927	123	15	0.016	0.016	NUM
dpc-4927	123	16	)	)	PUNCT
dpc-4927	123	17	(	(	PUNCT
dpc-4927	123	18	×	×	NOUN
dpc-4927	123	19	20	20	NUM
dpc-4927	123	20	)	)	PUNCT
dpc-4927	123	21	.	.	PUNCT
dpc-4927	124	1	original	original	ADJ
dpc-4927	124	2	article	article	NOUN
dpc-4927	124	3	|	|	ADV
dpc-4927	124	4	dermatol	dermatol	ADJ
dpc-4927	124	5	pract	pract	NOUN
dpc-4927	124	6	concept	concept	NOUN
dpc-4927	124	7	.	.	PUNCT
dpc-4927	125	1	2025;15(1):4927	2025;15(1):4927	NUM
dpc-4927	125	2	5	5	NUM
dpc-4927	125	3	changes	change	NOUN
dpc-4927	125	4	as	as	ADP
dpc-4927	125	5	those	those	PRON
dpc-4927	125	6	in	in	ADP
dpc-4927	125	7	our	our	PRON
dpc-4927	125	8	study	study	NOUN
dpc-4927	125	9	.	.	PUNCT
dpc-4927	126	1	this	this	PRON
dpc-4927	126	2	reinforces	reinforce	VERB
dpc-4927	126	3	the	the	DET
dpc-4927	126	4	notion	notion	NOUN
dpc-4927	126	5	that	that	SCONJ
dpc-4927	126	6	patient	patient	ADJ
dpc-4927	126	7	outcomes	outcome	NOUN
dpc-4927	126	8	are	be	AUX
dpc-4927	126	9	influenced	influence	VERB
dpc-4927	126	10	by	by	ADP
dpc-4927	126	11	their	their	PRON
dpc-4927	126	12	age	age	NOUN
dpc-4927	126	13	and	and	CCONJ
dpc-4927	126	14	comorbidities	comorbiditie	NOUN
dpc-4927	126	15	.	.	PUNCT
dpc-4927	127	1	in	in	ADP
dpc-4927	127	2	the	the	DET
dpc-4927	127	3	study	study	NOUN
dpc-4927	127	4	,	,	PUNCT
dpc-4927	127	5	it	it	PRON
dpc-4927	127	6	was	be	AUX
dpc-4927	127	7	found	find	VERB
dpc-4927	127	8	that	that	SCONJ
dpc-4927	127	9	22.5	22.5	NUM
dpc-4927	127	10	%	%	NOUN
dpc-4927	127	11	of	of	ADP
dpc-4927	127	12	the	the	DET
dpc-4927	127	13	patients	patient	NOUN
dpc-4927	127	14	had	have	VERB
dpc-4927	127	15	microhemorrhage	microhemorrhage	NOUN
dpc-4927	127	16	,	,	PUNCT
dpc-4927	127	17	29	29	NUM
dpc-4927	127	18	%	%	NOUN
dpc-4927	127	19	had	have	VERB
dpc-4927	127	20	branched	branched	ADJ
dpc-4927	127	21	capillaries	capillary	NOUN
dpc-4927	127	22	,	,	PUNCT
dpc-4927	127	23	and	and	CCONJ
dpc-4927	127	24	38.7	38.7	NUM
dpc-4927	127	25	%	%	NOUN
dpc-4927	127	26	had	have	VERB
dpc-4927	127	27	dilated	dilate	VERB
dpc-4927	127	28	capillaries	capillary	NOUN
dpc-4927	127	29	[	[	X
dpc-4927	127	30	16	16	NUM
dpc-4927	127	31	]	]	PUNCT
dpc-4927	127	32	.	.	PUNCT
dpc-4927	128	1	microvascular	microvascular	ADJ
dpc-4927	128	2	alterations	alteration	NOUN
dpc-4927	128	3	have	have	AUX
dpc-4927	128	4	been	be	AUX
dpc-4927	128	5	a	a	DET
dpc-4927	128	6	topic	topic	NOUN
dpc-4927	128	7	of	of	ADP
dpc-4927	128	8	interest	interest	NOUN
dpc-4927	128	9	throughout	throughout	ADP
dpc-4927	128	10	the	the	DET
dpc-4927	128	11	covid-19	covid-19	PROPN
dpc-4927	128	12	pandemic	pandemic	NOUN
dpc-4927	128	13	,	,	PUNCT
dpc-4927	128	14	aimed	aim	VERB
dpc-4927	128	15	at	at	ADP
dpc-4927	128	16	understanding	understand	VERB
dpc-4927	128	17	the	the	DET
dpc-4927	128	18	pathogenesis	pathogenesis	NOUN
dpc-4927	128	19	and	and	CCONJ
dpc-4927	128	20	at	at	ADP
dpc-4927	128	21	developing	develop	VERB
dpc-4927	128	22	treatments	treatment	NOUN
dpc-4927	128	23	[	[	X
dpc-4927	128	24	3,10,3133	3,10,3133	NUM
dpc-4927	128	25	]	]	PUNCT
dpc-4927	128	26	.	.	PUNCT
dpc-4927	129	1	the	the	DET
dpc-4927	129	2	long	long	ADJ
dpc-4927	129	3	-	-	PUNCT
dpc-4927	129	4	term	term	NOUN
dpc-4927	129	5	consequences	consequence	NOUN
dpc-4927	129	6	of	of	ADP
dpc-4927	129	7	acute	acute	ADJ
dpc-4927	129	8	endothelial	endothelial	ADJ
dpc-4927	129	9	damage	damage	NOUN
dpc-4927	129	10	have	have	AUX
dpc-4927	129	11	been	be	AUX
dpc-4927	129	12	the	the	DET
dpc-4927	129	13	subject	subject	NOUN
dpc-4927	129	14	of	of	ADP
dpc-4927	129	15	a	a	DET
dpc-4927	129	16	few	few	ADJ
dpc-4927	129	17	studies	study	NOUN
dpc-4927	129	18	[	[	X
dpc-4927	129	19	3,31,32	3,31,32	NUM
dpc-4927	129	20	]	]	PUNCT
dpc-4927	129	21	.	.	PUNCT
dpc-4927	130	1	some	some	DET
dpc-4927	130	2	studies	study	NOUN
dpc-4927	130	3	rate	rate	NOUN
dpc-4927	130	4	of	of	ADP
dpc-4927	130	5	pathological	pathological	ADJ
dpc-4927	130	6	capillaroscopic	capillaroscopic	NOUN
dpc-4927	130	7	findings	finding	NOUN
dpc-4927	130	8	,	,	PUNCT
dpc-4927	130	9	but	but	CCONJ
dpc-4927	130	10	we	we	PRON
dpc-4927	130	11	believe	believe	VERB
dpc-4927	130	12	the	the	DET
dpc-4927	130	13	patient	patient	ADJ
dpc-4927	130	14	population	population	NOUN
dpc-4927	130	15	included	include	VERB
dpc-4927	130	16	in	in	ADP
dpc-4927	130	17	the	the	DET
dpc-4927	130	18	studies	study	NOUN
dpc-4927	130	19	plays	play	VERB
dpc-4927	130	20	a	a	DET
dpc-4927	130	21	greater	great	ADJ
dpc-4927	130	22	role	role	NOUN
dpc-4927	130	23	.	.	PUNCT
dpc-4927	131	1	in	in	ADP
dpc-4927	131	2	other	other	ADJ
dpc-4927	131	3	studies	study	NOUN
dpc-4927	131	4	,	,	PUNCT
dpc-4927	131	5	involving	involve	VERB
dpc-4927	131	6	adult	adult	NOUN
dpc-4927	131	7	patients	patient	NOUN
dpc-4927	131	8	,	,	PUNCT
dpc-4927	131	9	the	the	DET
dpc-4927	131	10	average	average	ADJ
dpc-4927	131	11	age	age	NOUN
dpc-4927	131	12	was	be	AUX
dpc-4927	131	13	around	around	ADV
dpc-4927	131	14	60	60	NUM
dpc-4927	131	15	,	,	PUNCT
dpc-4927	131	16	whereas	whereas	SCONJ
dpc-4927	131	17	in	in	ADP
dpc-4927	131	18	our	our	PRON
dpc-4927	131	19	study	study	NOUN
dpc-4927	131	20	,	,	PUNCT
dpc-4927	131	21	it	it	PRON
dpc-4927	131	22	was	be	AUX
dpc-4927	131	23	34.15	34.15	NUM
dpc-4927	131	24	±	±	NUM
dpc-4927	131	25	11.35	11.35	NUM
dpc-4927	131	26	.	.	PUNCT
dpc-4927	132	1	furthermore	furthermore	ADV
dpc-4927	132	2	,	,	PUNCT
dpc-4927	132	3	unlike	unlike	ADP
dpc-4927	132	4	previous	previous	ADJ
dpc-4927	132	5	studies	study	NOUN
dpc-4927	132	6	which	which	PRON
dpc-4927	132	7	included	include	VERB
dpc-4927	132	8	patients	patient	NOUN
dpc-4927	132	9	with	with	ADP
dpc-4927	132	10	underlying	underlie	VERB
dpc-4927	132	11	conditions	condition	NOUN
dpc-4927	132	12	such	such	ADJ
dpc-4927	132	13	as	as	ADP
dpc-4927	132	14	hypertension	hypertension	NOUN
dpc-4927	132	15	,	,	PUNCT
dpc-4927	132	16	diabetes	diabetes	NOUN
dpc-4927	132	17	,	,	PUNCT
dpc-4927	132	18	and	and	CCONJ
dpc-4927	132	19	smoking	smoking	NOUN
dpc-4927	132	20	,	,	PUNCT
dpc-4927	132	21	which	which	PRON
dpc-4927	132	22	can	can	AUX
dpc-4927	132	23	lead	lead	VERB
dpc-4927	132	24	to	to	ADP
dpc-4927	132	25	microvascular	microvascular	ADJ
dpc-4927	132	26	changes	change	NOUN
dpc-4927	132	27	,	,	PUNCT
dpc-4927	132	28	our	our	PRON
dpc-4927	132	29	study	study	NOUN
dpc-4927	132	30	specifically	specifically	ADV
dpc-4927	132	31	excluded	exclude	VERB
dpc-4927	132	32	individuals	individual	NOUN
dpc-4927	132	33	with	with	ADP
dpc-4927	132	34	these	these	DET
dpc-4927	132	35	comorbidities	comorbiditie	NOUN
dpc-4927	132	36	.	.	PUNCT
dpc-4927	133	1	in	in	ADP
dpc-4927	133	2	their	their	PRON
dpc-4927	133	3	assessment	assessment	NOUN
dpc-4927	133	4	of	of	ADP
dpc-4927	133	5	nvc	nvc	NOUN
dpc-4927	133	6	in	in	ADP
dpc-4927	133	7	pediatric	pediatric	ADJ
dpc-4927	133	8	patients	patient	NOUN
dpc-4927	133	9	,	,	PUNCT
dpc-4927	133	10	çakmak	çakmak	PROPN
dpc-4927	133	11	et	et	PROPN
dpc-4927	133	12	al	al	PROPN
dpc-4927	133	13	.	.	PROPN
dpc-4927	133	14	found	find	VERB
dpc-4927	133	15	similar	similar	ADJ
dpc-4927	133	16	rates	rate	NOUN
dpc-4927	133	17	of	of	ADP
dpc-4927	133	18	microvascular	microvascular	ADJ
dpc-4927	133	19	figure	figure	NOUN
dpc-4927	133	20	6	6	NUM
dpc-4927	133	21	.	.	PUNCT
dpc-4927	133	22	enlarged	enlarge	VERB
dpc-4927	133	23	capillaries	capillary	NOUN
dpc-4927	133	24	.	.	PUNCT
dpc-4927	134	1	enlarged	enlarge	VERB
dpc-4927	134	2	capillaries	capillary	NOUN
dpc-4927	134	3	were	be	AUX
dpc-4927	134	4	detected	detect	VERB
dpc-4927	134	5	significantly	significantly	ADV
dpc-4927	134	6	more	more	ADV
dpc-4927	134	7	often	often	ADV
dpc-4927	134	8	in	in	ADP
dpc-4927	134	9	covid-19	covid-19	PROPN
dpc-4927	134	10	patients	patient	NOUN
dpc-4927	134	11	(	(	PUNCT
dpc-4927	134	12	p	p	X
dpc-4927	134	13	=	=	NOUN
dpc-4927	134	14	0.009	0.009	NUM
dpc-4927	134	15	)	)	PUNCT
dpc-4927	134	16	.	.	PUNCT
dpc-4927	135	1	(	(	PUNCT
dpc-4927	135	2	a	a	X
dpc-4927	135	3	)	)	PUNCT
dpc-4927	135	4	×	×	NOUN
dpc-4927	135	5	20	20	NUM
dpc-4927	135	6	.	.	PUNCT
dpc-4927	136	1	(	(	PUNCT
dpc-4927	136	2	b	b	NOUN
dpc-4927	136	3	)	)	PUNCT
dpc-4927	136	4	.	.	PUNCT
dpc-4927	137	1	×	×	PROPN
dpc-4927	137	2	70	70	NUM
dpc-4927	137	3	.	.	PUNCT
dpc-4927	138	1	figure	figure	NOUN
dpc-4927	138	2	5	5	NUM
dpc-4927	138	3	.	.	PUNCT
dpc-4927	139	1	microhemorrhages	microhemorrhage	NOUN
dpc-4927	139	2	were	be	AUX
dpc-4927	139	3	more	more	ADV
dpc-4927	139	4	common	common	ADJ
dpc-4927	139	5	in	in	ADP
dpc-4927	139	6	covid-19	covid-19	PROPN
dpc-4927	139	7	patients	patient	NOUN
dpc-4927	139	8	than	than	ADP
dpc-4927	139	9	healthy	healthy	ADJ
dpc-4927	139	10	controls	control	NOUN
dpc-4927	139	11	:	:	PUNCT
dpc-4927	139	12	(	(	PUNCT
dpc-4927	139	13	a	a	X
dpc-4927	139	14	)	)	PUNCT
dpc-4927	139	15	microhemorrhages	microhemorrhage	NOUN
dpc-4927	139	16	(	(	PUNCT
dpc-4927	139	17	stars	star	NOUN
dpc-4927	139	18	)	)	PUNCT
dpc-4927	139	19	and	and	CCONJ
dpc-4927	139	20	enlarged	enlarge	VERB
dpc-4927	139	21	capillaries	capillary	NOUN
dpc-4927	139	22	(	(	PUNCT
dpc-4927	139	23	circle	circle	NOUN
dpc-4927	139	24	)	)	PUNCT
dpc-4927	139	25	in	in	ADP
dpc-4927	139	26	a	a	DET
dpc-4927	139	27	covid-19	covid-19	PROPN
dpc-4927	139	28	patient	patient	NOUN
dpc-4927	139	29	(	(	PUNCT
dpc-4927	139	30	×	×	NOUN
dpc-4927	139	31	20	20	NUM
dpc-4927	139	32	)	)	PUNCT
dpc-4927	139	33	.	.	PUNCT
dpc-4927	140	1	(	(	PUNCT
dpc-4927	140	2	b	b	X
dpc-4927	140	3	)	)	PUNCT
dpc-4927	140	4	microhemorrhages	microhemorrhage	NOUN
dpc-4927	140	5	(	(	PUNCT
dpc-4927	140	6	stars	star	NOUN
dpc-4927	140	7	)	)	PUNCT
dpc-4927	140	8	and	and	CCONJ
dpc-4927	140	9	meandering	meander	VERB
dpc-4927	140	10	capillaries	capillary	NOUN
dpc-4927	140	11	(	(	PUNCT
dpc-4927	140	12	arrow	arrow	NOUN
dpc-4927	140	13	)	)	PUNCT
dpc-4927	140	14	in	in	ADP
dpc-4927	140	15	a	a	DET
dpc-4927	140	16	covid-19	covid-19	PROPN
dpc-4927	140	17	patient	patient	NOUN
dpc-4927	140	18	.	.	PUNCT
dpc-4927	141	1	table	table	NOUN
dpc-4927	141	2	1	1	NUM
dpc-4927	141	3	.	.	PUNCT
dpc-4927	141	4	dermoscopic	dermoscopic	PROPN
dpc-4927	141	5	findings	finding	NOUN
dpc-4927	141	6	observed	observe	VERB
dpc-4927	141	7	in	in	ADP
dpc-4927	141	8	proximal	proximal	ADJ
dpc-4927	141	9	nailfold	nailfold	NOUN
dpc-4927	141	10	and	and	CCONJ
dpc-4927	141	11	nail	nail	NOUN
dpc-4927	141	12	bed	bed	NOUN
dpc-4927	141	13	.	.	PUNCT
dpc-4927	142	1	covid-19	covid-19	PROPN
dpc-4927	142	2	patients	patient	NOUN
dpc-4927	142	3	n	n	CCONJ
dpc-4927	142	4	(	(	PUNCT
dpc-4927	142	5	%	%	INTJ
dpc-4927	142	6	)	)	PUNCT
dpc-4927	142	7	healthy	healthy	ADJ
dpc-4927	142	8	controls	control	NOUN
dpc-4927	142	9	n	n	PROPN
dpc-4927	142	10	(	(	PUNCT
dpc-4927	142	11	%	%	NOUN
dpc-4927	142	12	)	)	PUNCT
dpc-4927	142	13	p	p	ADJ
dpc-4927	142	14	-	-	PUNCT
dpc-4927	142	15	value	value	NOUN
dpc-4927	142	16	avascular	avascular	ADJ
dpc-4927	142	17	area	area	NOUN
dpc-4927	142	18	15	15	NUM
dpc-4927	142	19	(	(	PUNCT
dpc-4927	142	20	32.6	32.6	NUM
dpc-4927	142	21	)	)	PUNCT
dpc-4927	142	22	4	4	NUM
dpc-4927	142	23	(	(	PUNCT
dpc-4927	142	24	6.4	6.4	NUM
dpc-4927	142	25	)	)	PUNCT
dpc-4927	142	26	p<0.001	p<0.001	NOUN
dpc-4927	142	27	*	*	PUNCT
dpc-4927	142	28	meandering	meander	VERB
dpc-4927	142	29	capillaries	capillary	NOUN
dpc-4927	142	30	9	9	NUM
dpc-4927	142	31	(	(	PUNCT
dpc-4927	142	32	19.6	19.6	NUM
dpc-4927	142	33	)	)	PUNCT
dpc-4927	142	34	3	3	NUM
dpc-4927	142	35	(	(	PUNCT
dpc-4927	142	36	4.8	4.8	NUM
dpc-4927	142	37	)	)	PUNCT
dpc-4927	142	38	p=0.016	p=0.016	NOUN
dpc-4927	142	39	*	*	PUNCT
dpc-4927	142	40	microhemorrhages	microhemorrhage	VERB
dpc-4927	142	41	16	16	NUM
dpc-4927	142	42	(	(	PUNCT
dpc-4927	142	43	34.8	34.8	NUM
dpc-4927	142	44	)	)	SYM
dpc-4927	142	45	8	8	NUM
dpc-4927	142	46	(	(	PUNCT
dpc-4927	142	47	12.9	12.9	NUM
dpc-4927	142	48	)	)	PUNCT
dpc-4927	142	49	p=0.007	p=0.007	VERB
dpc-4927	142	50	*	*	PUNCT
dpc-4927	142	51	tortuous	tortuous	ADJ
dpc-4927	142	52	capillaries	capillary	NOUN
dpc-4927	142	53	16	16	NUM
dpc-4927	142	54	(	(	PUNCT
dpc-4927	142	55	27.6	27.6	NUM
dpc-4927	142	56	)	)	SYM
dpc-4927	142	57	19	19	NUM
dpc-4927	142	58	(	(	PUNCT
dpc-4927	142	59	61.3	61.3	NUM
dpc-4927	142	60	)	)	PUNCT
dpc-4927	142	61	0.013	0.013	NUM
dpc-4927	142	62	*	*	PUNCT
dpc-4927	142	63	reduced	reduce	VERB
dpc-4927	142	64	capillary	capillary	ADJ
dpc-4927	142	65	density	density	NOUN
dpc-4927	142	66	18	18	NUM
dpc-4927	142	67	(	(	PUNCT
dpc-4927	142	68	39.1	39.1	NUM
dpc-4927	142	69	)	)	PUNCT
dpc-4927	142	70	5	5	NUM
dpc-4927	142	71	(	(	PUNCT
dpc-4927	142	72	8.1	8.1	NUM
dpc-4927	142	73	)	)	PUNCT
dpc-4927	142	74	p<0.001	p<0.001	PROPN
dpc-4927	142	75	*	*	PUNCT
dpc-4927	142	76	disorganized	disorganized	ADJ
dpc-4927	142	77	capillaries	capillary	NOUN
dpc-4927	142	78	12	12	NUM
dpc-4927	142	79	(	(	PUNCT
dpc-4927	142	80	26.1	26.1	NUM
dpc-4927	142	81	)	)	PUNCT
dpc-4927	142	82	3	3	NUM
dpc-4927	142	83	(	(	PUNCT
dpc-4927	142	84	4.8	4.8	NUM
dpc-4927	142	85	)	)	PUNCT
dpc-4927	142	86	p=0.002	p=0.002	NOUN
dpc-4927	142	87	*	*	PUNCT
dpc-4927	142	88	enlarged	enlarge	VERB
dpc-4927	142	89	capillaries	capillary	NOUN
dpc-4927	142	90	11	11	NUM
dpc-4927	142	91	(	(	PUNCT
dpc-4927	142	92	23.9	23.9	NUM
dpc-4927	142	93	)	)	PUNCT
dpc-4927	142	94	4	4	NUM
dpc-4927	142	95	(	(	PUNCT
dpc-4927	142	96	6.4	6.4	NUM
dpc-4927	142	97	)	)	PUNCT
dpc-4927	142	98	0.009	0.009	NUM
dpc-4927	142	99	*	*	NUM
dpc-4927	142	100	branched	branched	ADJ
dpc-4927	142	101	capillaries	capillary	NOUN
dpc-4927	142	102	11	11	NUM
dpc-4927	142	103	(	(	PUNCT
dpc-4927	142	104	23.9	23.9	NUM
dpc-4927	142	105	)	)	PUNCT
dpc-4927	142	106	7	7	NUM
dpc-4927	142	107	(	(	PUNCT
dpc-4927	142	108	11.3	11.3	NUM
dpc-4927	142	109	)	)	PUNCT
dpc-4927	142	110	0.082	0.082	NUM
dpc-4927	142	111	dilated	dilate	VERB
dpc-4927	142	112	nail	nail	NOUN
dpc-4927	142	113	bed	bed	NOUN
dpc-4927	142	114	capillaries	capillary	NOUN
dpc-4927	142	115	19	19	NUM
dpc-4927	142	116	(	(	PUNCT
dpc-4927	142	117	41.3	41.3	NUM
dpc-4927	142	118	)	)	PUNCT
dpc-4927	142	119	17	17	NUM
dpc-4927	142	120	(	(	PUNCT
dpc-4927	142	121	27.4	27.4	NUM
dpc-4927	142	122	)	)	PUNCT
dpc-4927	142	123	0.130	0.130	NOUN
dpc-4927	142	124	*	*	PUNCT
dpc-4927	142	125	p	p	NOUN
dpc-4927	142	126	-	-	PUNCT
dpc-4927	142	127	values	value	NOUN
dpc-4927	142	128	with	with	ADP
dpc-4927	142	129	p<0.05	p<0.05	NOUN
dpc-4927	142	130	are	be	AUX
dpc-4927	142	131	written	write	VERB
dpc-4927	142	132	in	in	ADP
dpc-4927	142	133	bold	bold	ADJ
dpc-4927	142	134	.	.	PUNCT
dpc-4927	143	1	6	6	NUM
dpc-4927	143	2	original	original	ADJ
dpc-4927	143	3	article	article	NOUN
dpc-4927	143	4	|	|	ADV
dpc-4927	143	5	dermatol	dermatol	ADJ
dpc-4927	143	6	pract	pract	NOUN
dpc-4927	143	7	concept	concept	NOUN
dpc-4927	143	8	.	.	PUNCT
dpc-4927	144	1	2025;15(1):4927	2025;15(1):4927	NUM
dpc-4927	144	2	references	reference	NOUN
dpc-4927	144	3	1	1	NUM
dpc-4927	144	4	.	.	PUNCT
dpc-4927	144	5	pine	pine	PROPN
dpc-4927	144	6	ab	ab	PROPN
dpc-4927	144	7	,	,	PUNCT
dpc-4927	144	8	meizlish	meizlish	PROPN
dpc-4927	144	9	ml	ml	PROPN
dpc-4927	144	10	,	,	PUNCT
dpc-4927	144	11	goshua	goshua	PROPN
dpc-4927	144	12	g	g	PROPN
dpc-4927	144	13	,	,	PUNCT
dpc-4927	144	14	et	et	PROPN
dpc-4927	144	15	al	al	PROPN
dpc-4927	144	16	.	.	PUNCT
dpc-4927	144	17	circulating	circulate	VERB
dpc-4927	144	18	markers	marker	NOUN
dpc-4927	144	19	of	of	ADP
dpc-4927	144	20	angiogenesis	angiogenesis	NOUN
dpc-4927	144	21	and	and	CCONJ
dpc-4927	144	22	endotheliopathy	endotheliopathy	ADJ
dpc-4927	144	23	in	in	ADP
dpc-4927	144	24	covid-19	covid-19	PROPN
dpc-4927	144	25	.	.	PUNCT
dpc-4927	145	1	pulm	pulm	NOUN
dpc-4927	145	2	circ	circ	NOUN
dpc-4927	145	3	.	.	PUNCT
dpc-4927	146	1	2020;10(4):2045894020966547	2020;10(4):2045894020966547	NUM
dpc-4927	146	2	.	.	PUNCT
dpc-4927	147	1	doi	doi	NOUN
dpc-4927	147	2	:	:	PUNCT
dpc-4927	147	3	10.1177/2045894	10.1177/2045894	NUM
dpc-4927	147	4	020966547	020966547	NUM
dpc-4927	147	5	.	.	PUNCT
dpc-4927	148	1	pmid	pmid	NOUN
dpc-4927	148	2	:	:	PUNCT
dpc-4927	148	3	33282193	33282193	NUM
dpc-4927	148	4	2	2	NUM
dpc-4927	148	5	.	.	PUNCT
dpc-4927	148	6	xu	xu	PROPN
dpc-4927	148	7	sw	sw	PROPN
dpc-4927	148	8	,	,	PUNCT
dpc-4927	148	9	ilyas	ilyas	PROPN
dpc-4927	149	1	i	i	PRON
dpc-4927	149	2	,	,	PUNCT
dpc-4927	149	3	weng	weng	PROPN
dpc-4927	149	4	jp	jp	PROPN
dpc-4927	149	5	.	.	PUNCT
dpc-4927	150	1	endothelial	endothelial	ADJ
dpc-4927	150	2	dysfunction	dysfunction	NOUN
dpc-4927	150	3	in	in	ADP
dpc-4927	150	4	covid-19	covid-19	PROPN
dpc-4927	150	5	:	:	PUNCT
dpc-4927	150	6	an	an	DET
dpc-4927	150	7	overview	overview	NOUN
dpc-4927	150	8	of	of	ADP
dpc-4927	150	9	evidence	evidence	NOUN
dpc-4927	150	10	,	,	PUNCT
dpc-4927	150	11	biomarkers	biomarker	NOUN
dpc-4927	150	12	,	,	PUNCT
dpc-4927	150	13	mechanisms	mechanism	NOUN
dpc-4927	150	14	and	and	CCONJ
dpc-4927	150	15	potential	potential	ADJ
dpc-4927	150	16	therapies	therapy	NOUN
dpc-4927	150	17	.	.	PUNCT
dpc-4927	151	1	acta	acta	PROPN
dpc-4927	151	2	pharmacol	pharmacol	PROPN
dpc-4927	151	3	sin	sin	NOUN
dpc-4927	151	4	.	.	PUNCT
dpc-4927	152	1	2023;44(4):695	2023;44(4):695	NUM
dpc-4927	152	2	-	-	SYM
dpc-4927	152	3	709	709	NUM
dpc-4927	152	4	.	.	PUNCT
dpc-4927	152	5	doi	doi	NOUN
dpc-4927	152	6	:	:	PUNCT
dpc-4927	152	7	10.1038	10.1038	NUM
dpc-4927	152	8	/s41401	/s41401	NOUN
dpc-4927	152	9	-	-	PUNCT
dpc-4927	152	10	022	022	PROPN
dpc-4927	152	11	-	-	PUNCT
dpc-4927	152	12	00998	00998	NUM
dpc-4927	152	13	-	-	PUNCT
dpc-4927	152	14	0	0	NUM
dpc-4927	152	15	.	.	PUNCT
dpc-4927	153	1	pmid	pmid	NOUN
dpc-4927	153	2	:	:	PUNCT
dpc-4927	153	3	36253560	36253560	NUM
dpc-4927	153	4	.	.	PUNCT
dpc-4927	154	1	3	3	X
dpc-4927	154	2	.	.	X
dpc-4927	154	3	rovas	rovas	PROPN
dpc-4927	154	4	a	a	PRON
dpc-4927	154	5	,	,	PUNCT
dpc-4927	154	6	osiaevi	osiaevi	PROPN
dpc-4927	154	7	i	i	PROPN
dpc-4927	154	8	,	,	PUNCT
dpc-4927	154	9	buscher	buscher	PROPN
dpc-4927	154	10	k	k	PROPN
dpc-4927	154	11	,	,	PUNCT
dpc-4927	154	12	et	et	PROPN
dpc-4927	154	13	al	al	PROPN
dpc-4927	154	14	.	.	PUNCT
dpc-4927	155	1	microvascular	microvascular	ADJ
dpc-4927	155	2	dysfunction	dysfunction	NOUN
dpc-4927	155	3	in	in	ADP
dpc-4927	155	4	covid-19	covid-19	PROPN
dpc-4927	155	5	:	:	PUNCT
dpc-4927	155	6	the	the	DET
dpc-4927	155	7	mystic	mystic	ADJ
dpc-4927	155	8	study	study	NOUN
dpc-4927	155	9	.	.	PUNCT
dpc-4927	156	1	angiogenesis	angiogenesis	NOUN
dpc-4927	156	2	.	.	PUNCT
dpc-4927	157	1	2021;24(1	2021;24(1	NUM
dpc-4927	157	2	):	):	PUNCT
dpc-4927	157	3	145	145	NUM
dpc-4927	157	4	-	-	SYM
dpc-4927	157	5	157	157	NUM
dpc-4927	157	6	.	.	PUNCT
dpc-4927	158	1	doi	doi	NOUN
dpc-4927	158	2	:	:	PUNCT
dpc-4927	158	3	10.1007	10.1007	NUM
dpc-4927	158	4	/	/	SYM
dpc-4927	158	5	s10456	s10456	NOUN
dpc-4927	158	6	-	-	PUNCT
dpc-4927	158	7	020	020	NUM
dpc-4927	158	8	-	-	PUNCT
dpc-4927	158	9	09753	09753	NUM
dpc-4927	158	10	-	-	SYM
dpc-4927	158	11	7	7	NUM
dpc-4927	158	12	.	.	PUNCT
dpc-4927	159	1	pmid	pmid	NOUN
dpc-4927	159	2	:	:	PUNCT
dpc-4927	159	3	33058027	33058027	NUM
dpc-4927	159	4	4	4	NUM
dpc-4927	159	5	.	.	X
dpc-4927	160	1	andrianto	andrianto	NOUN
dpc-4927	160	2	,	,	PUNCT
dpc-4927	160	3	al	al	PROPN
dpc-4927	160	4	-	-	PUNCT
dpc-4927	160	5	farabi	farabi	PROPN
dpc-4927	160	6	mj	mj	PROPN
dpc-4927	160	7	,	,	PUNCT
dpc-4927	160	8	nugraha	nugraha	PROPN
dpc-4927	160	9	ra	ra	PROPN
dpc-4927	160	10	,	,	PUNCT
dpc-4927	160	11	marsudi	marsudi	PROPN
dpc-4927	160	12	ba	ba	PROPN
dpc-4927	160	13	,	,	PUNCT
dpc-4927	160	14	azmi	azmi	PROPN
dpc-4927	160	15	y.	y.	PROPN
dpc-4927	160	16	biomarkers	biomarker	NOUN
dpc-4927	160	17	of	of	ADP
dpc-4927	160	18	endothelial	endothelial	ADJ
dpc-4927	160	19	dysfunction	dysfunction	NOUN
dpc-4927	160	20	and	and	CCONJ
dpc-4927	160	21	outcomes	outcome	NOUN
dpc-4927	160	22	in	in	ADP
dpc-4927	160	23	coronavirus	coronavirus	NOUN
dpc-4927	160	24	disease	disease	NOUN
dpc-4927	160	25	2019	2019	NUM
dpc-4927	160	26	(	(	PUNCT
dpc-4927	160	27	covid-19	covid-19	PROPN
dpc-4927	160	28	)	)	PUNCT
dpc-4927	160	29	patients	patient	NOUN
dpc-4927	160	30	:	:	PUNCT
dpc-4927	160	31	a	a	DET
dpc-4927	160	32	systematic	systematic	ADJ
dpc-4927	160	33	review	review	NOUN
dpc-4927	160	34	and	and	CCONJ
dpc-4927	160	35	meta	meta	ADJ
dpc-4927	160	36	-	-	PUNCT
dpc-4927	160	37	analysis	analysis	NOUN
dpc-4927	160	38	.	.	PUNCT
dpc-4927	161	1	microvasc	microvasc	PROPN
dpc-4927	161	2	res	res	PROPN
dpc-4927	161	3	.	.	PUNCT
dpc-4927	162	1	2021;138:104224	2021;138:104224	NUM
dpc-4927	162	2	.	.	PUNCT
dpc-4927	163	1	doi	doi	NOUN
dpc-4927	163	2	:	:	PUNCT
dpc-4927	163	3	10.1016	10.1016	NUM
dpc-4927	163	4	/j.mvr.2021.104224	/j.mvr.2021.104224	PUNCT
dpc-4927	163	5	.	.	PUNCT
dpc-4927	164	1	pmid	pmid	NOUN
dpc-4927	164	2	:	:	PUNCT
dpc-4927	164	3	34273359	34273359	NUM
dpc-4927	164	4	5	5	NUM
dpc-4927	164	5	.	.	PUNCT
dpc-4927	164	6	cugno	cugno	PROPN
dpc-4927	164	7	m	m	PROPN
dpc-4927	164	8	,	,	PUNCT
dpc-4927	164	9	meroni	meroni	PROPN
dpc-4927	164	10	pl	pl	PROPN
dpc-4927	164	11	,	,	PUNCT
dpc-4927	164	12	gualtierotti	gualtierotti	ADJ
dpc-4927	164	13	r	r	NOUN
dpc-4927	164	14	,	,	PUNCT
dpc-4927	164	15	et	et	PROPN
dpc-4927	164	16	al	al	PROPN
dpc-4927	164	17	.	.	PROPN
dpc-4927	164	18	complement	complement	NOUN
dpc-4927	164	19	activation	activation	NOUN
dpc-4927	164	20	and	and	CCONJ
dpc-4927	164	21	endothelial	endothelial	NOUN
dpc-4927	164	22	perturbation	perturbation	NOUN
dpc-4927	164	23	parallel	parallel	ADJ
dpc-4927	164	24	covid-19	covid-19	PROPN
dpc-4927	164	25	severity	severity	NOUN
dpc-4927	164	26	and	and	CCONJ
dpc-4927	164	27	activity	activity	NOUN
dpc-4927	164	28	.	.	PUNCT
dpc-4927	165	1	j	j	PROPN
dpc-4927	165	2	autoimmun	autoimmun	PROPN
dpc-4927	165	3	.	.	PUNCT
dpc-4927	166	1	2021;116:102560	2021;116:102560	X
dpc-4927	166	2	.	.	PUNCT
dpc-4927	167	1	doi	doi	NOUN
dpc-4927	167	2	:	:	PUNCT
dpc-4927	167	3	10.1016	10.1016	NUM
dpc-4927	167	4	/j.jaut.2020.102560	/j.jaut.2020.102560	NOUN
dpc-4927	167	5	.	.	PUNCT
dpc-4927	168	1	pmid	pmid	NOUN
dpc-4927	168	2	:	:	PUNCT
dpc-4927	168	3	33139116	33139116	NUM
dpc-4927	168	4	.	.	PUNCT
dpc-4927	169	1	6	6	NUM
dpc-4927	169	2	.	.	X
dpc-4927	169	3	goshua	goshua	PROPN
dpc-4927	169	4	g	g	PROPN
dpc-4927	169	5	,	,	PUNCT
dpc-4927	169	6	pine	pine	PROPN
dpc-4927	169	7	ab	ab	PROPN
dpc-4927	169	8	,	,	PUNCT
dpc-4927	169	9	meizlish	meizlish	PROPN
dpc-4927	169	10	ml	ml	PROPN
dpc-4927	169	11	,	,	PUNCT
dpc-4927	169	12	et	et	PROPN
dpc-4927	169	13	al	al	PROPN
dpc-4927	169	14	.	.	PROPN
dpc-4927	169	15	endotheliopathy	endotheliopathy	PROPN
dpc-4927	169	16	in	in	ADP
dpc-4927	169	17	covid-19	covid-19	PROPN
dpc-4927	169	18	-	-	PUNCT
dpc-4927	169	19	associated	associate	VERB
dpc-4927	169	20	coagulopathy	coagulopathy	ADJ
dpc-4927	169	21	:	:	PUNCT
dpc-4927	169	22	evidence	evidence	NOUN
dpc-4927	169	23	from	from	ADP
dpc-4927	169	24	a	a	DET
dpc-4927	169	25	singlecentre	singlecentre	NOUN
dpc-4927	169	26	,	,	PUNCT
dpc-4927	169	27	cross	cross	ADJ
dpc-4927	169	28	-	-	ADJ
dpc-4927	169	29	sectional	sectional	ADJ
dpc-4927	169	30	study	study	NOUN
dpc-4927	169	31	.	.	PUNCT
dpc-4927	170	1	lancet	lancet	PROPN
dpc-4927	170	2	haematol	haematol	NOUN
dpc-4927	170	3	.	.	PUNCT
dpc-4927	171	1	2020;7(8):e575	2020;7(8):e575	NUM
dpc-4927	171	2	-	-	PUNCT
dpc-4927	171	3	e582	e582	PROPN
dpc-4927	171	4	.	.	PUNCT
dpc-4927	172	1	doi	doi	NOUN
dpc-4927	172	2	:	:	PUNCT
dpc-4927	172	3	10.1016	10.1016	NUM
dpc-4927	172	4	/	/	SYM
dpc-4927	172	5	s2352	s2352	PROPN
dpc-4927	172	6	-	-	PUNCT
dpc-4927	172	7	3026(20)30216	3026(20)30216	NUM
dpc-4927	172	8	-	-	PUNCT
dpc-4927	172	9	7	7	NUM
dpc-4927	172	10	.	.	PUNCT
dpc-4927	173	1	pmid	pmid	NOUN
dpc-4927	173	2	:	:	PUNCT
dpc-4927	173	3	32619411	32619411	NUM
dpc-4927	173	4	7	7	NUM
dpc-4927	173	5	.	.	PUNCT
dpc-4927	173	6	rosei	rosei	PROPN
dpc-4927	173	7	ca	ca	PROPN
dpc-4927	173	8	,	,	PUNCT
dpc-4927	173	9	gaggero	gaggero	VERB
dpc-4927	173	10	a	a	DET
dpc-4927	173	11	,	,	PUNCT
dpc-4927	173	12	famà	famà	NOUN
dpc-4927	173	13	f	f	PROPN
dpc-4927	173	14	,	,	PUNCT
dpc-4927	173	15	malerba	malerba	NOUN
dpc-4927	173	16	p	p	NOUN
dpc-4927	173	17	,	,	PUNCT
dpc-4927	173	18	chiarini	chiarini	NOUN
dpc-4927	173	19	g	g	NOUN
dpc-4927	173	20	,	,	PUNCT
dpc-4927	173	21	nardin	nardin	NOUN
dpc-4927	173	22	m	m	PROPN
dpc-4927	173	23	,	,	PUNCT
dpc-4927	173	24	brami	brami	NOUN
dpc-4927	173	25	v	v	NOUN
dpc-4927	173	26	,	,	PUNCT
dpc-4927	173	27	rossini	rossini	PROPN
dpc-4927	173	28	c	c	PROPN
dpc-4927	173	29	,	,	PUNCT
dpc-4927	173	30	coschignano	coschignano	PROPN
dpc-4927	173	31	ma	ma	PROPN
dpc-4927	173	32	,	,	PUNCT
dpc-4927	173	33	porteri	porteri	NOUN
dpc-4927	173	34	e	e	PROPN
dpc-4927	173	35	,	,	PUNCT
dpc-4927	173	36	salvetti	salvetti	PROPN
dpc-4927	173	37	m	m	PROPN
dpc-4927	173	38	,	,	PUNCT
dpc-4927	173	39	muiesan	muiesan	PROPN
dpc-4927	173	40	ml	ml	NOUN
dpc-4927	173	41	,	,	PUNCT
dpc-4927	173	42	rizzoni	rizzoni	PROPN
dpc-4927	173	43	d	d	PROPN
dpc-4927	173	44	,	,	PUNCT
dpc-4927	173	45	de	de	PROPN
dpc-4927	173	46	ciuceis	ciuceis	PROPN
dpc-4927	173	47	c.	c.	PROPN
dpc-4927	173	48	skin	skin	NOUN
dpc-4927	173	49	capillary	capillary	ADJ
dpc-4927	173	50	alterations	alteration	NOUN
dpc-4927	173	51	in	in	ADP
dpc-4927	173	52	patients	patient	NOUN
dpc-4927	173	53	with	with	ADP
dpc-4927	173	54	acute	acute	ADJ
dpc-4927	173	55	sarscov2	sarscov2	NOUN
dpc-4927	173	56	infection	infection	NOUN
dpc-4927	173	57	.	.	PUNCT
dpc-4927	174	1	j	j	PROPN
dpc-4927	174	2	hypertens	hyperten	NOUN
dpc-4927	174	3	.	.	PUNCT
dpc-4927	175	1	2022	2022	NUM
dpc-4927	175	2	;	;	PUNCT
dpc-4927	175	3	40(12):2385	40(12):2385	X
dpc-4927	175	4	-	-	SYM
dpc-4927	175	5	2393	2393	NUM
dpc-4927	175	6	.	.	PUNCT
dpc-4927	176	1	doi	doi	NOUN
dpc-4927	176	2	:	:	PUNCT
dpc-4927	176	3	10.1097	10.1097	NUM
dpc-4927	176	4	/	/	SYM
dpc-4927	176	5	hjh.0000000000003271	hjh.0000000000003271	PROPN
dpc-4927	176	6	.	.	PUNCT
dpc-4927	177	1	pmid	pmid	NOUN
dpc-4927	177	2	:	:	PUNCT
dpc-4927	177	3	35983856	35983856	NUM
dpc-4927	177	4	.	.	PUNCT
dpc-4927	178	1	8	8	X
dpc-4927	178	2	.	.	PUNCT
dpc-4927	179	1	sulli	sulli	PROPN
dpc-4927	179	2	a	a	PROPN
dpc-4927	179	3	,	,	PUNCT
dpc-4927	179	4	gotelli	gotelli	PROPN
dpc-4927	179	5	e	e	PROPN
dpc-4927	179	6	,	,	PUNCT
dpc-4927	179	7	bica	bica	PROPN
dpc-4927	179	8	pf	pf	PROPN
dpc-4927	179	9	,	,	PUNCT
dpc-4927	179	10	et	et	PROPN
dpc-4927	179	11	al	al	PROPN
dpc-4927	179	12	.	.	PUNCT
dpc-4927	180	1	detailed	detail	VERB
dpc-4927	180	2	videocapillaroscopic	videocapillaroscopic	ADJ
dpc-4927	180	3	microvascular	microvascular	NOUN
dpc-4927	180	4	changes	change	NOUN
dpc-4927	180	5	detectable	detectable	ADJ
dpc-4927	180	6	in	in	ADP
dpc-4927	180	7	adult	adult	NOUN
dpc-4927	180	8	covid-19	covid-19	PROPN
dpc-4927	180	9	survivors	survivor	NOUN
dpc-4927	180	10	.	.	PUNCT
dpc-4927	181	1	microvasc	microvasc	PROPN
dpc-4927	181	2	res	re	NOUN
dpc-4927	181	3	.	.	PUNCT
dpc-4927	182	1	2022;142:104361	2022;142:104361	X
dpc-4927	182	2	.	.	PUNCT
dpc-4927	183	1	doi	doi	NOUN
dpc-4927	183	2	:	:	PUNCT
dpc-4927	183	3	10.1016	10.1016	NUM
dpc-4927	183	4	/	/	SYM
dpc-4927	183	5	j.mvr	j.mvr	PROPN
dpc-4927	183	6	.2022.104361	.2022.104361	PROPN
dpc-4927	183	7	.	.	PUNCT
dpc-4927	184	1	pmid	pmid	NOUN
dpc-4927	184	2	:	:	PUNCT
dpc-4927	184	3	35339493	35339493	NUM
dpc-4927	184	4	9	9	NUM
dpc-4927	184	5	.	.	PUNCT
dpc-4927	185	1	natalello	natalello	PROPN
dpc-4927	185	2	g	g	PROPN
dpc-4927	185	3	,	,	PUNCT
dpc-4927	185	4	de	de	X
dpc-4927	185	5	luca	luca	PROPN
dpc-4927	185	6	g	g	PROPN
dpc-4927	185	7	,	,	PUNCT
dpc-4927	185	8	gigante	gigante	PROPN
dpc-4927	185	9	l	l	PROPN
dpc-4927	185	10	,	,	PUNCT
dpc-4927	185	11	campochiaro	campochiaro	NOUN
dpc-4927	185	12	c	c	NOUN
dpc-4927	185	13	,	,	PUNCT
dpc-4927	185	14	de	de	X
dpc-4927	185	15	lorenzis	lorenzis	X
dpc-4927	185	16	e	e	NOUN
dpc-4927	185	17	,	,	PUNCT
dpc-4927	185	18	verardi	verardi	NOUN
dpc-4927	185	19	l	l	NOUN
dpc-4927	185	20	,	,	PUNCT
dpc-4927	185	21	paglionico	paglionico	NOUN
dpc-4927	185	22	a	a	DET
dpc-4927	185	23	,	,	PUNCT
dpc-4927	185	24	petricca	petricca	ADJ
dpc-4927	185	25	l	l	NOUN
dpc-4927	185	26	,	,	PUNCT
dpc-4927	185	27	martone	martone	NOUN
dpc-4927	185	28	am	am	NOUN
dpc-4927	185	29	,	,	PUNCT
dpc-4927	185	30	calvisi	calvisi	PROPN
dpc-4927	185	31	s	s	PROPN
dpc-4927	185	32	,	,	PUNCT
dpc-4927	185	33	ripa	ripa	PROPN
dpc-4927	185	34	m	m	PROPN
dpc-4927	185	35	,	,	PUNCT
dpc-4927	185	36	cavalli	cavalli	PROPN
dpc-4927	185	37	g	g	PROPN
dpc-4927	185	38	,	,	PUNCT
dpc-4927	185	39	della	della	PROPN
dpc-4927	185	40	-	-	PUNCT
dpc-4927	185	41	torre	torre	PROPN
dpc-4927	185	42	e	e	PROPN
dpc-4927	185	43	,	,	PUNCT
dpc-4927	185	44	tresoldi	tresoldi	PROPN
dpc-4927	185	45	m	m	PROPN
dpc-4927	185	46	,	,	PUNCT
dpc-4927	185	47	landi	landi	PROPN
dpc-4927	185	48	f	f	PROPN
dpc-4927	185	49	,	,	PUNCT
dpc-4927	185	50	bosello	bosello	PROPN
dpc-4927	185	51	sl	sl	PROPN
dpc-4927	185	52	,	,	PUNCT
dpc-4927	185	53	gremese	gremese	ADJ
dpc-4927	185	54	e	e	NOUN
dpc-4927	185	55	,	,	PUNCT
dpc-4927	185	56	dagna	dagna	PROPN
dpc-4927	185	57	l.	l.	PROPN
dpc-4927	185	58	nailfold	nailfold	PROPN
dpc-4927	185	59	capillaroscopy	capillaroscopy	VERB
dpc-4927	185	60	findings	finding	NOUN
dpc-4927	185	61	in	in	ADP
dpc-4927	185	62	patients	patient	NOUN
dpc-4927	185	63	with	with	ADP
dpc-4927	185	64	coronavirus	coronavirus	NOUN
dpc-4927	185	65	disease	disease	NOUN
dpc-4927	185	66	2019	2019	NUM
dpc-4927	185	67	:	:	PUNCT
dpc-4927	185	68	broadening	broaden	VERB
dpc-4927	185	69	the	the	DET
dpc-4927	185	70	spectrum	spectrum	NOUN
dpc-4927	185	71	of	of	ADP
dpc-4927	185	72	covid-19	covid-19	PROPN
dpc-4927	185	73	microvascular	microvascular	ADJ
dpc-4927	185	74	involvement	involvement	NOUN
dpc-4927	185	75	.	.	PUNCT
dpc-4927	186	1	microvasc	microvasc	PROPN
dpc-4927	186	2	res	res	PROPN
dpc-4927	186	3	.	.	PUNCT
dpc-4927	187	1	2021;133:104071	2021;133:104071	NUM
dpc-4927	187	2	.	.	PUNCT
dpc-4927	188	1	doi	doi	NOUN
dpc-4927	188	2	:	:	PUNCT
dpc-4927	188	3	10.1016	10.1016	NUM
dpc-4927	188	4	/	/	SYM
dpc-4927	188	5	j.mvr.2020.104071	j.mvr.2020.104071	PROPN
dpc-4927	188	6	.	.	PUNCT
dpc-4927	189	1	pmid	pmid	NOUN
dpc-4927	189	2	:	:	PUNCT
dpc-4927	189	3	32949574	32949574	NUM
dpc-4927	189	4	.	.	PUNCT
dpc-4927	190	1	report	report	VERB
dpc-4927	190	2	that	that	SCONJ
dpc-4927	190	3	in	in	ADP
dpc-4927	190	4	long	long	ADJ
dpc-4927	190	5	-	-	PUNCT
dpc-4927	190	6	term	term	NOUN
dpc-4927	190	7	follow	follow	NOUN
dpc-4927	190	8	-	-	PUNCT
dpc-4927	190	9	up	up	NOUN
dpc-4927	190	10	after	after	ADP
dpc-4927	190	11	covid-19	covid-19	PROPN
dpc-4927	190	12	,	,	PUNCT
dpc-4927	190	13	the	the	DET
dpc-4927	190	14	elevation	elevation	NOUN
dpc-4927	190	15	of	of	ADP
dpc-4927	190	16	endothelial	endothelial	ADJ
dpc-4927	190	17	biomarkers	biomarker	NOUN
dpc-4927	190	18	did	do	AUX
dpc-4927	190	19	not	not	PART
dpc-4927	190	20	continue	continue	VERB
dpc-4927	190	21	,	,	PUNCT
dpc-4927	190	22	and	and	CCONJ
dpc-4927	190	23	they	they	PRON
dpc-4927	190	24	found	find	VERB
dpc-4927	190	25	no	no	DET
dpc-4927	190	26	evidence	evidence	NOUN
dpc-4927	190	27	that	that	SCONJ
dpc-4927	190	28	endothelial	endothelial	ADJ
dpc-4927	190	29	dysfunction	dysfunction	NOUN
dpc-4927	190	30	persisted	persist	VERB
dpc-4927	190	31	[	[	X
dpc-4927	190	32	3,32	3,32	NUM
dpc-4927	190	33	]	]	PUNCT
dpc-4927	190	34	.	.	PUNCT
dpc-4927	191	1	however	however	ADV
dpc-4927	191	2	,	,	PUNCT
dpc-4927	191	3	fan	fan	PROPN
dpc-4927	191	4	et	et	PROPN
dpc-4927	191	5	al	al	PROPN
dpc-4927	191	6	.	.	PROPN
dpc-4927	191	7	reported	report	VERB
dpc-4927	191	8	that	that	SCONJ
dpc-4927	191	9	hypercoagulation	hypercoagulation	NOUN
dpc-4927	191	10	,	,	PUNCT
dpc-4927	191	11	endothelial	endothelial	ADJ
dpc-4927	191	12	dysfunction	dysfunction	NOUN
dpc-4927	191	13	,	,	PUNCT
dpc-4927	191	14	and	and	CCONJ
dpc-4927	191	15	inflammation	inflammation	NOUN
dpc-4927	191	16	could	could	AUX
dpc-4927	191	17	be	be	AUX
dpc-4927	191	18	detected	detect	VERB
dpc-4927	191	19	in	in	ADP
dpc-4927	191	20	some	some	DET
dpc-4927	191	21	patients	patient	NOUN
dpc-4927	191	22	approximately	approximately	ADV
dpc-4927	191	23	one	one	NUM
dpc-4927	191	24	year	year	NOUN
dpc-4927	191	25	after	after	ADP
dpc-4927	191	26	recovery	recovery	NOUN
dpc-4927	191	27	from	from	ADP
dpc-4927	191	28	covid-19	covid-19	PROPN
dpc-4927	192	1	[	[	X
dpc-4927	192	2	31	31	NUM
dpc-4927	192	3	]	]	PUNCT
dpc-4927	192	4	.	.	PUNCT
dpc-4927	193	1	in	in	ADP
dpc-4927	193	2	one	one	NUM
dpc-4927	193	3	of	of	ADP
dpc-4927	193	4	the	the	DET
dpc-4927	193	5	studies	study	NOUN
dpc-4927	193	6	on	on	ADP
dpc-4927	193	7	nvc	nvc	PROPN
dpc-4927	193	8	,	,	PUNCT
dpc-4927	193	9	the	the	DET
dpc-4927	193	10	follow	follow	VERB
dpc-4927	193	11	-	-	PUNCT
dpc-4927	193	12	up	up	NOUN
dpc-4927	193	13	capillaroscopy	capillaroscopy	NOUN
dpc-4927	193	14	findings	finding	NOUN
dpc-4927	193	15	of	of	ADP
dpc-4927	193	16	the	the	DET
dpc-4927	193	17	patients	patient	NOUN
dpc-4927	193	18	were	be	AUX
dpc-4927	193	19	reported	report	VERB
dpc-4927	193	20	.	.	PUNCT
dpc-4927	194	1	while	while	SCONJ
dpc-4927	194	2	rosei	rosei	PROPN
dpc-4927	194	3	et	et	PROPN
dpc-4927	194	4	al	al	PROPN
dpc-4927	194	5	.	.	PROPN
dpc-4927	194	6	detected	detect	VERB
dpc-4927	194	7	significant	significant	ADJ
dpc-4927	194	8	capillaroscopic	capillaroscopic	ADJ
dpc-4927	194	9	findings	finding	NOUN
dpc-4927	194	10	of	of	ADP
dpc-4927	194	11	microvascular	microvascular	ADJ
dpc-4927	194	12	impairment	impairment	NOUN
dpc-4927	194	13	in	in	ADP
dpc-4927	194	14	the	the	DET
dpc-4927	194	15	acute	acute	ADJ
dpc-4927	194	16	phase	phase	NOUN
dpc-4927	194	17	,	,	PUNCT
dpc-4927	194	18	they	they	PRON
dpc-4927	194	19	observed	observe	VERB
dpc-4927	194	20	that	that	SCONJ
dpc-4927	194	21	these	these	DET
dpc-4927	194	22	findings	finding	NOUN
dpc-4927	194	23	disappeared	disappear	VERB
dpc-4927	194	24	after	after	ADP
dpc-4927	194	25	three	three	NUM
dpc-4927	194	26	months	month	NOUN
dpc-4927	195	1	[	[	X
dpc-4927	195	2	10	10	NUM
dpc-4927	195	3	]	]	PUNCT
dpc-4927	195	4	.	.	PUNCT
dpc-4927	196	1	we	we	PRON
dpc-4927	196	2	reevaluated	reevaluate	VERB
dpc-4927	196	3	our	our	PRON
dpc-4927	196	4	patients	patient	NOUN
dpc-4927	196	5	at	at	ADP
dpc-4927	196	6	10–14	10–14	NUM
dpc-4927	196	7	months	month	NOUN
dpc-4927	196	8	and	and	CCONJ
dpc-4927	196	9	found	find	VERB
dpc-4927	196	10	resolution	resolution	NOUN
dpc-4927	196	11	of	of	ADP
dpc-4927	196	12	the	the	DET
dpc-4927	196	13	pathological	pathological	ADJ
dpc-4927	196	14	capillaroscopy	capillaroscopy	NOUN
dpc-4927	196	15	findings	finding	NOUN
dpc-4927	196	16	.	.	PUNCT
dpc-4927	197	1	the	the	DET
dpc-4927	197	2	relatively	relatively	ADV
dpc-4927	197	3	small	small	ADJ
dpc-4927	197	4	number	number	NOUN
dpc-4927	197	5	of	of	ADP
dpc-4927	197	6	patients	patient	NOUN
dpc-4927	197	7	and	and	CCONJ
dpc-4927	197	8	the	the	DET
dpc-4927	197	9	exclusion	exclusion	NOUN
dpc-4927	197	10	of	of	ADP
dpc-4927	197	11	patients	patient	NOUN
dpc-4927	197	12	with	with	ADP
dpc-4927	197	13	severe	severe	ADJ
dpc-4927	197	14	disease	disease	NOUN
dpc-4927	197	15	were	be	AUX
dpc-4927	197	16	limitations	limitation	NOUN
dpc-4927	197	17	of	of	ADP
dpc-4927	197	18	our	our	PRON
dpc-4927	197	19	study	study	NOUN
dpc-4927	197	20	.	.	PUNCT
dpc-4927	198	1	the	the	DET
dpc-4927	198	2	strengths	strength	NOUN
dpc-4927	198	3	of	of	ADP
dpc-4927	198	4	this	this	DET
dpc-4927	198	5	study	study	NOUN
dpc-4927	198	6	include	include	VERB
dpc-4927	198	7	its	its	PRON
dpc-4927	198	8	prospective	prospective	ADJ
dpc-4927	198	9	design	design	NOUN
dpc-4927	198	10	,	,	PUNCT
dpc-4927	198	11	healthy	healthy	ADJ
dpc-4927	198	12	comparator	comparator	NOUN
dpc-4927	198	13	groups	group	NOUN
dpc-4927	198	14	,	,	PUNCT
dpc-4927	198	15	and	and	CCONJ
dpc-4927	198	16	long	long	ADJ
dpc-4927	198	17	-	-	PUNCT
dpc-4927	198	18	term	term	NOUN
dpc-4927	198	19	follow	follow	NOUN
dpc-4927	198	20	-	-	PUNCT
dpc-4927	198	21	up	up	ADP
dpc-4927	198	22	data	datum	NOUN
dpc-4927	198	23	.	.	PUNCT
dpc-4927	199	1	conclusions	conclusion	NOUN
dpc-4927	199	2	despite	despite	SCONJ
dpc-4927	199	3	advances	advance	NOUN
dpc-4927	199	4	in	in	ADP
dpc-4927	199	5	vaccines	vaccine	NOUN
dpc-4927	199	6	,	,	PUNCT
dpc-4927	199	7	antiviral	antiviral	ADJ
dpc-4927	199	8	drugs	drug	NOUN
dpc-4927	199	9	,	,	PUNCT
dpc-4927	199	10	and	and	CCONJ
dpc-4927	199	11	preventive	preventive	ADJ
dpc-4927	199	12	measures	measure	NOUN
dpc-4927	199	13	,	,	PUNCT
dpc-4927	199	14	new	new	ADJ
dpc-4927	199	15	infections	infection	NOUN
dpc-4927	199	16	with	with	ADP
dpc-4927	199	17	sars	sar	NOUN
dpc-4927	199	18	-	-	PUNCT
dpc-4927	199	19	cov-2	cov-2	PART
dpc-4927	199	20	continue	continue	VERB
dpc-4927	199	21	[	[	X
dpc-4927	199	22	35	35	NUM
dpc-4927	199	23	]	]	PUNCT
dpc-4927	199	24	.	.	PUNCT
dpc-4927	200	1	the	the	DET
dpc-4927	200	2	virus	virus	NOUN
dpc-4927	200	3	continues	continue	VERB
dpc-4927	200	4	its	its	PRON
dpc-4927	200	5	life	life	NOUN
dpc-4927	200	6	with	with	ADP
dpc-4927	200	7	new	new	ADJ
dpc-4927	200	8	mutations	mutation	NOUN
dpc-4927	200	9	.	.	PUNCT
dpc-4927	201	1	in	in	ADP
dpc-4927	201	2	addition	addition	NOUN
dpc-4927	201	3	to	to	ADP
dpc-4927	201	4	the	the	DET
dpc-4927	201	5	significant	significant	ADJ
dpc-4927	201	6	complications	complication	NOUN
dpc-4927	201	7	associated	associate	VERB
dpc-4927	201	8	with	with	ADP
dpc-4927	201	9	covid-19	covid-19	PROPN
dpc-4927	201	10	,	,	PUNCT
dpc-4927	201	11	the	the	DET
dpc-4927	201	12	post	post	ADJ
dpc-4927	201	13	-	-	ADJ
dpc-4927	201	14	viral	viral	ADJ
dpc-4927	201	15	syndrome	syndrome	NOUN
dpc-4927	201	16	known	know	VERB
dpc-4927	201	17	as	as	ADP
dpc-4927	201	18	post	post	ADJ
dpc-4927	201	19	-	-	ADJ
dpc-4927	201	20	acute	acute	ADJ
dpc-4927	201	21	sequelae	sequelae	NOUN
dpc-4927	201	22	of	of	ADP
dpc-4927	201	23	sars	sar	NOUN
dpc-4927	201	24	-	-	PUNCT
dpc-4927	201	25	cov-2	cov-2	NOUN
dpc-4927	201	26	infection	infection	NOUN
dpc-4927	201	27	,	,	PUNCT
dpc-4927	201	28	or	or	CCONJ
dpc-4927	201	29	“	"	PUNCT
dpc-4927	201	30	long	long	ADJ
dpc-4927	201	31	covid-19	covid-19	PROPN
dpc-4927	201	32	,	,	PUNCT
dpc-4927	201	33	”	"	PUNCT
dpc-4927	201	34	continues	continue	VERB
dpc-4927	201	35	to	to	PART
dpc-4927	201	36	represent	represent	VERB
dpc-4927	201	37	a	a	DET
dpc-4927	201	38	significant	significant	ADJ
dpc-4927	201	39	public	public	ADJ
dpc-4927	201	40	health	health	NOUN
dpc-4927	201	41	concern	concern	NOUN
dpc-4927	201	42	[	[	X
dpc-4927	201	43	36	36	NUM
dpc-4927	201	44	]	]	PUNCT
dpc-4927	201	45	.	.	PUNCT
dpc-4927	202	1	our	our	PRON
dpc-4927	202	2	findings	finding	NOUN
dpc-4927	202	3	could	could	AUX
dpc-4927	202	4	lead	lead	VERB
dpc-4927	202	5	to	to	ADP
dpc-4927	202	6	new	new	ADJ
dpc-4927	202	7	research	research	NOUN
dpc-4927	202	8	aimed	aim	VERB
dpc-4927	202	9	at	at	ADP
dpc-4927	202	10	explaining	explain	VERB
dpc-4927	202	11	or	or	CCONJ
dpc-4927	202	12	predicting	predict	VERB
dpc-4927	202	13	complications	complication	NOUN
dpc-4927	202	14	related	relate	VERB
dpc-4927	202	15	to	to	ADP
dpc-4927	202	16	covid-19	covid-19	PROPN
dpc-4927	202	17	.	.	PUNCT
dpc-4927	203	1	we	we	PRON
dpc-4927	203	2	suggest	suggest	VERB
dpc-4927	203	3	that	that	SCONJ
dpc-4927	203	4	proximal	proximal	ADJ
dpc-4927	203	5	nailfold	nailfold	NOUN
dpc-4927	203	6	dermoscopy	dermoscopy	NOUN
dpc-4927	203	7	is	be	AUX
dpc-4927	203	8	an	an	DET
dpc-4927	203	9	easily	easily	ADV
dpc-4927	203	10	accessible	accessible	ADJ
dpc-4927	203	11	and	and	CCONJ
dpc-4927	203	12	cheaper	cheap	ADJ
dpc-4927	203	13	technique	technique	NOUN
dpc-4927	203	14	that	that	PRON
dpc-4927	203	15	can	can	AUX
dpc-4927	203	16	be	be	AUX
dpc-4927	203	17	used	use	VERB
dpc-4927	203	18	as	as	ADP
dpc-4927	203	19	an	an	DET
dpc-4927	203	20	alternative	alternative	NOUN
dpc-4927	203	21	to	to	ADP
dpc-4927	203	22	nvc	nvc	NOUN
dpc-4927	203	23	to	to	PART
dpc-4927	203	24	detect	detect	VERB
dpc-4927	203	25	microvascular	microvascular	ADJ
dpc-4927	203	26	changes	change	NOUN
dpc-4927	203	27	in	in	ADP
dpc-4927	203	28	covid-19	covid-19	PROPN
dpc-4927	203	29	patients	patient	NOUN
dpc-4927	203	30	.	.	PUNCT
dpc-4927	204	1	we	we	PRON
dpc-4927	204	2	hope	hope	VERB
dpc-4927	204	3	that	that	SCONJ
dpc-4927	204	4	early	early	ADJ
dpc-4927	204	5	detection	detection	NOUN
dpc-4927	204	6	of	of	ADP
dpc-4927	204	7	microvascular	microvascular	ADJ
dpc-4927	204	8	changes	change	NOUN
dpc-4927	204	9	and	and	CCONJ
dpc-4927	204	10	widespread	widespread	ADJ
dpc-4927	204	11	screening	screening	NOUN
dpc-4927	204	12	,	,	PUNCT
dpc-4927	204	13	especially	especially	ADV
dpc-4927	204	14	in	in	ADP
dpc-4927	204	15	atrisk	atrisk	PROPN
dpc-4927	204	16	patients	patient	NOUN
dpc-4927	204	17	,	,	PUNCT
dpc-4927	204	18	will	will	AUX
dpc-4927	204	19	protect	protect	VERB
dpc-4927	204	20	them	they	PRON
dpc-4927	204	21	from	from	ADP
dpc-4927	204	22	complications	complication	NOUN
dpc-4927	204	23	that	that	PRON
dpc-4927	204	24	can	can	AUX
dpc-4927	204	25	have	have	VERB
dpc-4927	204	26	dangerous	dangerous	ADJ
dpc-4927	204	27	consequences	consequence	NOUN
dpc-4927	204	28	.	.	PUNCT
dpc-4927	205	1	figure	figure	VERB
dpc-4927	205	2	7	7	NUM
dpc-4927	205	3	.	.	NUM
dpc-4927	205	4	dilated	dilate	VERB
dpc-4927	205	5	nail	nail	NOUN
dpc-4927	205	6	bed	bed	NOUN
dpc-4927	205	7	capillaries	capillary	NOUN
dpc-4927	205	8	.	.	PUNCT
dpc-4927	206	1	it	it	PRON
dpc-4927	206	2	was	be	AUX
dpc-4927	206	3	determined	determine	VERB
dpc-4927	206	4	that	that	SCONJ
dpc-4927	206	5	there	there	PRON
dpc-4927	206	6	were	be	VERB
dpc-4927	206	7	more	more	ADV
dpc-4927	206	8	dilated	dilated	ADJ
dpc-4927	206	9	capillaries	capillary	NOUN
dpc-4927	206	10	in	in	ADP
dpc-4927	206	11	the	the	DET
dpc-4927	206	12	nail	nail	NOUN
dpc-4927	206	13	bed	bed	NOUN
dpc-4927	206	14	in	in	ADP
dpc-4927	206	15	covid-19	covid-19	PROPN
dpc-4927	206	16	patients	patient	NOUN
dpc-4927	206	17	,	,	PUNCT
dpc-4927	206	18	but	but	CCONJ
dpc-4927	206	19	the	the	DET
dpc-4927	206	20	difference	difference	NOUN
dpc-4927	206	21	was	be	AUX
dpc-4927	206	22	not	not	PART
dpc-4927	206	23	statistically	statistically	ADV
dpc-4927	206	24	significant	significant	ADJ
dpc-4927	206	25	(	(	PUNCT
dpc-4927	206	26	p	p	X
dpc-4927	206	27	>	>	X
dpc-4927	206	28	0.05	0.05	NUM
dpc-4927	206	29	)	)	PUNCT
dpc-4927	206	30	.	.	PUNCT
dpc-4927	207	1	(	(	PUNCT
dpc-4927	207	2	a	a	X
dpc-4927	207	3	)	)	PUNCT
dpc-4927	207	4	×	×	NOUN
dpc-4927	207	5	20	20	NUM
dpc-4927	207	6	.	.	PUNCT
dpc-4927	208	1	(	(	PUNCT
dpc-4927	208	2	b	b	X
dpc-4927	208	3	)	)	PUNCT
dpc-4927	208	4	×	×	NOUN
dpc-4927	208	5	70	70	NUM
dpc-4927	208	6	.	.	PUNCT
dpc-4927	209	1	original	original	ADJ
dpc-4927	209	2	article	article	NOUN
dpc-4927	209	3	|	|	ADV
dpc-4927	209	4	dermatol	dermatol	ADJ
dpc-4927	209	5	pract	pract	NOUN
dpc-4927	209	6	concept	concept	NOUN
dpc-4927	209	7	.	.	PUNCT
dpc-4927	210	1	2025;15(1):4927	2025;15(1):4927	NUM
dpc-4927	210	2	7	7	NUM
dpc-4927	210	3	rheumatoid	rheumatoid	NOUN
dpc-4927	210	4	arthritis	arthritis	NOUN
dpc-4927	210	5	:	:	PUNCT
dpc-4927	210	6	role	role	NOUN
dpc-4927	210	7	of	of	ADP
dpc-4927	210	8	dermoscopy	dermoscopy	NOUN
dpc-4927	210	9	combined	combine	VERB
dpc-4927	210	10	with	with	ADP
dpc-4927	210	11	ultrasonography	ultrasonography	NOUN
dpc-4927	210	12	for	for	ADP
dpc-4927	210	13	differential	differential	ADJ
dpc-4927	210	14	diagnosis	diagnosis	NOUN
dpc-4927	210	15	.	.	PUNCT
dpc-4927	211	1	j	j	PROPN
dpc-4927	211	2	rheumatol	rheumatol	NOUN
dpc-4927	211	3	.	.	PUNCT
dpc-4927	212	1	2018;45(5):648	2018;45(5):648	NUM
dpc-4927	212	2	-	-	PUNCT
dpc-4927	212	3	654	654	NUM
dpc-4927	212	4	.	.	PUNCT
dpc-4927	213	1	doi	doi	NOUN
dpc-4927	213	2	:	:	PUNCT
dpc-4927	213	3	10.3899	10.3899	NUM
dpc-4927	213	4	/	/	SYM
dpc-4927	213	5	jrheum.170962	jrheum.170962	PROPN
dpc-4927	213	6	.	.	PUNCT
dpc-4927	214	1	pmid	pmid	NOUN
dpc-4927	214	2	:	:	PUNCT
dpc-4927	214	3	29449498	29449498	NUM
dpc-4927	214	4	.	.	PUNCT
dpc-4927	215	1	24	24	NUM
dpc-4927	215	2	.	.	PUNCT
dpc-4927	216	1	elmas	elmas	PROPN
dpc-4927	216	2	öf	öf	PROPN
dpc-4927	216	3	,	,	PUNCT
dpc-4927	216	4	okçu	okçu	PROPN
dpc-4927	216	5	m	m	PROPN
dpc-4927	216	6	,	,	PUNCT
dpc-4927	216	7	demirbaş	demirbaş	VERB
dpc-4927	216	8	a	a	DET
dpc-4927	216	9	,	,	PUNCT
dpc-4927	216	10	akdeniz	akdeniz	NOUN
dpc-4927	216	11	n.	n.	NOUN
dpc-4927	216	12	handheld	handheld	PROPN
dpc-4927	216	13	dermatoscopy	dermatoscopy	NOUN
dpc-4927	216	14	as	as	ADP
dpc-4927	216	15	an	an	DET
dpc-4927	216	16	easy	easy	ADJ
dpc-4927	216	17	-	-	PUNCT
dpc-4927	216	18	to	to	PART
dpc-4927	216	19	-	-	PUNCT
dpc-4927	216	20	use	use	VERB
dpc-4927	216	21	capillaroscopic	capillaroscopic	ADJ
dpc-4927	216	22	instrument	instrument	NOUN
dpc-4927	216	23	in	in	ADP
dpc-4927	216	24	rheumatoid	rheumatoid	NOUN
dpc-4927	216	25	arthritis	arthritis	NOUN
dpc-4927	216	26	:	:	PUNCT
dpc-4927	216	27	a	a	DET
dpc-4927	216	28	cross	cross	ADJ
dpc-4927	216	29	-	-	ADJ
dpc-4927	216	30	sectional	sectional	ADJ
dpc-4927	216	31	study	study	NOUN
dpc-4927	216	32	.	.	PUNCT
dpc-4927	217	1	turk	turk	PROPN
dpc-4927	217	2	j	j	PROPN
dpc-4927	217	3	med	med	PROPN
dpc-4927	217	4	sci	sci	PROPN
dpc-4927	217	5	.	.	PUNCT
dpc-4927	218	1	2020;50(6	2020;50(6	NUM
dpc-4927	218	2	):	):	PUNCT
dpc-4927	218	3	1540	1540	NUM
dpc-4927	218	4	-	-	SYM
dpc-4927	218	5	1545	1545	NUM
dpc-4927	218	6	.	.	PUNCT
dpc-4927	219	1	doi	doi	NOUN
dpc-4927	219	2	:	:	PUNCT
dpc-4927	219	3	10.3906	10.3906	NUM
dpc-4927	219	4	/	/	SYM
dpc-4927	219	5	sag-2006	sag-2006	NOUN
dpc-4927	219	6	-	-	PUNCT
dpc-4927	219	7	6	6	NUM
dpc-4927	219	8	.	.	PUNCT
dpc-4927	220	1	pmid	pmid	NOUN
dpc-4927	220	2	:	:	PUNCT
dpc-4927	220	3	32718130	32718130	NUM
dpc-4927	220	4	25	25	NUM
dpc-4927	220	5	.	.	PUNCT
dpc-4927	221	1	ghannem	ghannem	PROPN
dpc-4927	221	2	a	a	X
dpc-4927	221	3	,	,	PUNCT
dpc-4927	221	4	zaouak	zaouak	PROPN
dpc-4927	221	5	a	a	PRON
dpc-4927	221	6	,	,	PUNCT
dpc-4927	221	7	aydi	aydi	VERB
dpc-4927	221	8	z	z	PROPN
dpc-4927	221	9	,	,	PUNCT
dpc-4927	221	10	somai	somai	PROPN
dpc-4927	221	11	m	m	PROPN
dpc-4927	221	12	,	,	PUNCT
dpc-4927	221	13	hammami	hammami	ADJ
dpc-4927	221	14	h	h	NOUN
dpc-4927	221	15	,	,	PUNCT
dpc-4927	221	16	boussema	boussema	NOUN
dpc-4927	221	17	f	f	NOUN
dpc-4927	221	18	,	,	PUNCT
dpc-4927	221	19	fenniche	fenniche	PROPN
dpc-4927	221	20	s.	s.	PROPN
dpc-4927	221	21	nail	nail	PROPN
dpc-4927	221	22	involvement	involvement	NOUN
dpc-4927	221	23	in	in	ADP
dpc-4927	221	24	connective	connective	ADJ
dpc-4927	221	25	tissue	tissue	NOUN
dpc-4927	221	26	diseases	disease	NOUN
dpc-4927	221	27	:	:	PUNCT
dpc-4927	221	28	an	an	DET
dpc-4927	221	29	epidemiological	epidemiological	ADJ
dpc-4927	221	30	,	,	PUNCT
dpc-4927	221	31	clinical	clinical	ADJ
dpc-4927	221	32	,	,	PUNCT
dpc-4927	221	33	and	and	CCONJ
dpc-4927	221	34	dermoscopic	dermoscopic	NOUN
dpc-4927	221	35	study	study	NOUN
dpc-4927	221	36	.	.	PUNCT
dpc-4927	222	1	int	int	NOUN
dpc-4927	222	2	j	j	PROPN
dpc-4927	222	3	dermatol	dermatol	NOUN
dpc-4927	222	4	.	.	PUNCT
dpc-4927	223	1	2024;63(7):942	2024;63(7):942	NUM
dpc-4927	223	2	-	-	SYM
dpc-4927	223	3	946	946	NUM
dpc-4927	223	4	.	.	PUNCT
dpc-4927	224	1	doi	doi	NOUN
dpc-4927	224	2	:	:	PUNCT
dpc-4927	224	3	10.1111	10.1111	NUM
dpc-4927	224	4	/	/	SYM
dpc-4927	224	5	ijd.17113	ijd.17113	NOUN
dpc-4927	224	6	.	.	PUNCT
dpc-4927	225	1	pmid	pmid	NOUN
dpc-4927	225	2	:	:	PUNCT
dpc-4927	225	3	38426318	38426318	NUM
dpc-4927	225	4	.	.	PUNCT
dpc-4927	226	1	26	26	NUM
dpc-4927	226	2	.	.	PUNCT
dpc-4927	227	1	bonaventura	bonaventura	PROPN
dpc-4927	227	2	a	a	PRON
dpc-4927	227	3	,	,	PUNCT
dpc-4927	227	4	vecchié	vecchié	X
dpc-4927	227	5	a	a	PRON
dpc-4927	227	6	,	,	PUNCT
dpc-4927	227	7	dagna	dagna	PROPN
dpc-4927	227	8	l	l	NOUN
dpc-4927	227	9	,	,	PUNCT
dpc-4927	227	10	et	et	PROPN
dpc-4927	227	11	al	al	PROPN
dpc-4927	227	12	.	.	PUNCT
dpc-4927	228	1	endothelial	endothelial	ADJ
dpc-4927	228	2	dysfunction	dysfunction	NOUN
dpc-4927	228	3	and	and	CCONJ
dpc-4927	228	4	immunothrombosis	immunothrombosis	NOUN
dpc-4927	228	5	as	as	ADP
dpc-4927	228	6	key	key	ADJ
dpc-4927	228	7	pathogenic	pathogenic	ADJ
dpc-4927	228	8	mechanisms	mechanism	NOUN
dpc-4927	228	9	in	in	ADP
dpc-4927	228	10	covid-19	covid-19	PROPN
dpc-4927	228	11	.	.	PUNCT
dpc-4927	229	1	nat	nat	PROPN
dpc-4927	229	2	rev	rev	VERB
dpc-4927	229	3	immunol	immunol	NOUN
dpc-4927	229	4	.	.	PUNCT
dpc-4927	230	1	2021;21(5):319	2021;21(5):319	NUM
dpc-4927	230	2	-	-	PUNCT
dpc-4927	230	3	329	329	NUM
dpc-4927	230	4	.	.	PUNCT
dpc-4927	231	1	doi	doi	NOUN
dpc-4927	231	2	:	:	PUNCT
dpc-4927	231	3	10.1038	10.1038	NUM
dpc-4927	231	4	/	/	SYM
dpc-4927	231	5	s41577	s41577	PROPN
dpc-4927	231	6	-	-	PUNCT
dpc-4927	231	7	021	021	NUM
dpc-4927	231	8	-	-	PUNCT
dpc-4927	231	9	00536	00536	NUM
dpc-4927	231	10	-	-	SYM
dpc-4927	231	11	9	9	NUM
dpc-4927	231	12	.	.	PUNCT
dpc-4927	232	1	pmid	pmid	NOUN
dpc-4927	232	2	:	:	PUNCT
dpc-4927	232	3	33824483	33824483	NUM
dpc-4927	232	4	27	27	NUM
dpc-4927	232	5	.	.	PUNCT
dpc-4927	233	1	ciaffi	ciaffi	PROPN
dpc-4927	233	2	j	j	PROPN
dpc-4927	233	3	,	,	PUNCT
dpc-4927	233	4	ajasllari	ajasllari	NOUN
dpc-4927	233	5	n	n	CCONJ
dpc-4927	233	6	,	,	PUNCT
dpc-4927	233	7	mancarella	mancarella	PROPN
dpc-4927	233	8	l	l	PROPN
dpc-4927	233	9	,	,	PUNCT
dpc-4927	233	10	brusi	brusi	ADJ
dpc-4927	233	11	v	v	NOUN
dpc-4927	233	12	,	,	PUNCT
dpc-4927	233	13	meliconi	meliconi	NOUN
dpc-4927	233	14	r	r	NOUN
dpc-4927	233	15	,	,	PUNCT
dpc-4927	233	16	ursini	ursini	PROPN
dpc-4927	233	17	f.	f.	PROPN
dpc-4927	233	18	nailfold	nailfold	PROPN
dpc-4927	233	19	capillaroscopy	capillaroscopy	VERB
dpc-4927	233	20	in	in	ADP
dpc-4927	233	21	common	common	ADJ
dpc-4927	233	22	non	non	ADJ
dpc-4927	233	23	-	-	ADJ
dpc-4927	233	24	rheumatic	rheumatic	ADJ
dpc-4927	233	25	conditions	condition	NOUN
dpc-4927	233	26	:	:	PUNCT
dpc-4927	233	27	a	a	DET
dpc-4927	233	28	systematic	systematic	ADJ
dpc-4927	233	29	review	review	NOUN
dpc-4927	233	30	and	and	CCONJ
dpc-4927	233	31	applications	application	NOUN
dpc-4927	233	32	for	for	ADP
dpc-4927	233	33	clinical	clinical	ADJ
dpc-4927	233	34	practice	practice	NOUN
dpc-4927	233	35	.	.	PUNCT
dpc-4927	234	1	microvasc	microvasc	PROPN
dpc-4927	234	2	res	res	PROPN
dpc-4927	234	3	.	.	PUNCT
dpc-4927	234	4	2020;131:104036	2020;131:104036	NOUN
dpc-4927	234	5	.	.	PUNCT
dpc-4927	235	1	doi	doi	NOUN
dpc-4927	235	2	:	:	PUNCT
dpc-4927	235	3	10.1016	10.1016	NUM
dpc-4927	235	4	/	/	SYM
dpc-4927	235	5	j.mvr.2020.104036	j.mvr.2020.104036	PROPN
dpc-4927	235	6	.	.	PUNCT
dpc-4927	236	1	pmid	pmid	NOUN
dpc-4927	236	2	:	:	PUNCT
dpc-4927	236	3	32603698	32603698	NUM
dpc-4927	236	4	.	.	PUNCT
dpc-4927	237	1	28	28	NUM
dpc-4927	237	2	.	.	PUNCT
dpc-4927	238	1	varga	varga	PROPN
dpc-4927	238	2	z	z	PROPN
dpc-4927	238	3	,	,	PUNCT
dpc-4927	238	4	flammer	flammer	PROPN
dpc-4927	238	5	aj	aj	PROPN
dpc-4927	238	6	,	,	PUNCT
dpc-4927	238	7	steiger	steiger	PROPN
dpc-4927	238	8	p	p	PROPN
dpc-4927	238	9	,	,	PUNCT
dpc-4927	238	10	et	et	PROPN
dpc-4927	238	11	al	al	PROPN
dpc-4927	238	12	.	.	PUNCT
dpc-4927	238	13	endothelial	endothelial	ADJ
dpc-4927	238	14	cell	cell	NOUN
dpc-4927	238	15	infection	infection	NOUN
dpc-4927	238	16	and	and	CCONJ
dpc-4927	238	17	endotheliitis	endotheliitis	PRON
dpc-4927	238	18	in	in	ADP
dpc-4927	238	19	covid-19	covid-19	PROPN
dpc-4927	238	20	.	.	PUNCT
dpc-4927	239	1	lancet	lancet	PROPN
dpc-4927	239	2	.	.	PUNCT
dpc-4927	240	1	2020;395(10234	2020;395(10234	NUM
dpc-4927	240	2	):	):	PUNCT
dpc-4927	240	3	1417	1417	NUM
dpc-4927	240	4	-	-	SYM
dpc-4927	240	5	1418	1418	NUM
dpc-4927	240	6	.	.	PUNCT
dpc-4927	241	1	doi	doi	NOUN
dpc-4927	241	2	:	:	PUNCT
dpc-4927	241	3	10.1016	10.1016	NUM
dpc-4927	241	4	/	/	SYM
dpc-4927	241	5	s0140	s0140	PROPN
dpc-4927	241	6	-	-	PUNCT
dpc-4927	241	7	6736(20)30937	6736(20)30937	NUM
dpc-4927	241	8	-	-	SYM
dpc-4927	241	9	5	5	NUM
dpc-4927	241	10	.	.	PUNCT
dpc-4927	242	1	pmid	pmid	NOUN
dpc-4927	242	2	:	:	PUNCT
dpc-4927	242	3	32325026	32325026	NUM
dpc-4927	242	4	29	29	NUM
dpc-4927	242	5	.	.	PUNCT
dpc-4927	243	1	bruni	bruni	PROPN
dpc-4927	243	2	c	c	PROPN
dpc-4927	243	3	,	,	PUNCT
dpc-4927	243	4	frech	frech	PROPN
dpc-4927	243	5	t	t	PROPN
dpc-4927	243	6	,	,	PUNCT
dpc-4927	243	7	manetti	manetti	PROPN
dpc-4927	243	8	m	m	PROPN
dpc-4927	243	9	,	,	PUNCT
dpc-4927	243	10	et	et	PROPN
dpc-4927	243	11	al	al	PROPN
dpc-4927	243	12	.	.	PROPN
dpc-4927	243	13	vascular	vascular	ADJ
dpc-4927	243	14	leaking	leaking	NOUN
dpc-4927	243	15	,	,	PUNCT
dpc-4927	243	16	a	a	DET
dpc-4927	243	17	pivotal	pivotal	ADJ
dpc-4927	243	18	and	and	CCONJ
dpc-4927	243	19	early	early	ADJ
dpc-4927	243	20	pathogenetic	pathogenetic	ADJ
dpc-4927	243	21	event	event	NOUN
dpc-4927	243	22	in	in	ADP
dpc-4927	243	23	systemic	systemic	ADJ
dpc-4927	243	24	sclerosis	sclerosis	NOUN
dpc-4927	243	25	:	:	PUNCT
dpc-4927	243	26	should	should	AUX
dpc-4927	243	27	the	the	DET
dpc-4927	243	28	door	door	NOUN
dpc-4927	243	29	be	be	AUX
dpc-4927	243	30	closed	close	VERB
dpc-4927	243	31	?	?	PUNCT
dpc-4927	244	1	front	front	ADJ
dpc-4927	244	2	immunol	immunol	NOUN
dpc-4927	244	3	.	.	PUNCT
dpc-4927	245	1	2018;9:2045	2018;9:2045	ADJ
dpc-4927	245	2	.	.	PUNCT
dpc-4927	246	1	30	30	NUM
dpc-4927	246	2	.	.	X
dpc-4927	246	3	paparde	paparde	PROPN
dpc-4927	246	4	a	a	DET
dpc-4927	246	5	,	,	PUNCT
dpc-4927	246	6	nēringa	nēringa	ADV
dpc-4927	246	7	-	-	PUNCT
dpc-4927	246	8	martinsone	martinsone	NOUN
dpc-4927	246	9	k	k	PROPN
dpc-4927	246	10	,	,	PUNCT
dpc-4927	246	11	plakane	plakane	PROPN
dpc-4927	246	12	l	l	NOUN
dpc-4927	246	13	,	,	PUNCT
dpc-4927	246	14	aivars	aivar	VERB
dpc-4927	246	15	ji	ji	PROPN
dpc-4927	246	16	.	.	PROPN
dpc-4927	246	17	nail	nail	PROPN
dpc-4927	246	18	fold	fold	ADJ
dpc-4927	246	19	capillary	capillary	ADJ
dpc-4927	246	20	diameter	diameter	NOUN
dpc-4927	246	21	changes	change	NOUN
dpc-4927	246	22	in	in	ADP
dpc-4927	246	23	acute	acute	ADJ
dpc-4927	246	24	systemic	systemic	ADJ
dpc-4927	246	25	hypoxia	hypoxia	NOUN
dpc-4927	246	26	.	.	PUNCT
dpc-4927	247	1	microvasc	microvasc	PROPN
dpc-4927	247	2	res	re	NOUN
dpc-4927	247	3	.	.	PUNCT
dpc-4927	248	1	2014;93:30	2014;93:30	NUM
dpc-4927	248	2	-	-	SYM
dpc-4927	248	3	3	3	NUM
dpc-4927	248	4	.	.	PUNCT
dpc-4927	248	5	doi	doi	NOUN
dpc-4927	248	6	:	:	PUNCT
dpc-4927	248	7	10.1016	10.1016	NUM
dpc-4927	248	8	/	/	SYM
dpc-4927	248	9	j.mvr.2014.02.013	j.mvr.2014.02.013	PROPN
dpc-4927	248	10	.	.	PUNCT
dpc-4927	249	1	pmid	pmid	NOUN
dpc-4927	249	2	:	:	PUNCT
dpc-4927	249	3	24607833	24607833	NUM
dpc-4927	249	4	.	.	PUNCT
dpc-4927	250	1	31	31	NUM
dpc-4927	250	2	.	.	PUNCT
dpc-4927	251	1	kozłowski	kozłowski	PROPN
dpc-4927	251	2	p	p	X
dpc-4927	251	3	,	,	PUNCT
dpc-4927	251	4	śmiarowski	śmiarowski	PROPN
dpc-4927	251	5	m	m	PROPN
dpc-4927	251	6	,	,	PUNCT
dpc-4927	251	7	przyborska	przyborska	PROPN
dpc-4927	251	8	w	w	PROPN
dpc-4927	251	9	,	,	PUNCT
dpc-4927	251	10	et	et	PROPN
dpc-4927	251	11	al	al	PROPN
dpc-4927	251	12	.	.	PUNCT
dpc-4927	252	1	mild	mild	PROPN
dpc-4927	252	2	-	-	PUNCT
dpc-4927	252	3	to	to	PART
dpc-4927	252	4	moderate	moderate	ADJ
dpc-4927	252	5	covid-19	covid-19	PROPN
dpc-4927	252	6	convalescents	convalescent	NOUN
dpc-4927	252	7	may	may	AUX
dpc-4927	252	8	present	present	VERB
dpc-4927	252	9	pro	pro	ADJ
dpc-4927	252	10	-	-	ADJ
dpc-4927	252	11	longed	long	VERB
dpc-4927	252	12	endothelium	endothelium	NOUN
dpc-4927	252	13	injury	injury	NOUN
dpc-4927	252	14	.	.	PUNCT
dpc-4927	253	1	j	j	PROPN
dpc-4927	253	2	clin	clin	PROPN
dpc-4927	253	3	med	med	PROPN
dpc-4927	253	4	.	.	PUNCT
dpc-4927	254	1	2022;11(21):6461	2022;11(21):6461	NUM
dpc-4927	254	2	.	.	X
dpc-4927	254	3	doi	doi	NOUN
dpc-4927	254	4	:	:	PUNCT
dpc-4927	254	5	10.3390	10.3390	NUM
dpc-4927	254	6	/jcm11216461	/jcm11216461	SYM
dpc-4927	254	7	.	.	PUNCT
dpc-4927	255	1	pmid	pmid	NOUN
dpc-4927	255	2	:	:	PUNCT
dpc-4927	255	3	36362687	36362687	NUM
dpc-4927	255	4	.	.	PUNCT
dpc-4927	256	1	32	32	NUM
dpc-4927	256	2	.	.	PUNCT
dpc-4927	257	1	fan	fan	PROPN
dpc-4927	257	2	be	be	PROPN
dpc-4927	257	3	,	,	PUNCT
dpc-4927	257	4	wong	wong	PROPN
dpc-4927	257	5	sw	sw	PROPN
dpc-4927	257	6	,	,	PUNCT
dpc-4927	257	7	sum	sum	PROPN
dpc-4927	257	8	cll	cll	PROPN
dpc-4927	257	9	,	,	PUNCT
dpc-4927	257	10	et	et	PROPN
dpc-4927	257	11	al	al	PROPN
dpc-4927	257	12	.	.	PUNCT
dpc-4927	258	1	covid-19	covid-19	PROPN
dpc-4927	258	2	clotting	clotting	NOUN
dpc-4927	258	3	and	and	CCONJ
dpc-4927	258	4	bleeding	bleed	VERB
dpc-4927	258	5	investigators	investigator	NOUN
dpc-4927	258	6	.	.	PUNCT
dpc-4927	259	1	hypercoagulability	hypercoagulability	NOUN
dpc-4927	259	2	,	,	PUNCT
dpc-4927	259	3	endotheliopathy	endotheliopathy	ADJ
dpc-4927	259	4	,	,	PUNCT
dpc-4927	259	5	and	and	CCONJ
dpc-4927	259	6	inflammation	inflammation	NOUN
dpc-4927	259	7	approximating	approximate	VERB
dpc-4927	259	8	1	1	NUM
dpc-4927	259	9	year	year	NOUN
dpc-4927	259	10	after	after	ADP
dpc-4927	259	11	recovery	recovery	NOUN
dpc-4927	259	12	:	:	PUNCT
dpc-4927	259	13	assessing	assess	VERB
dpc-4927	259	14	the	the	DET
dpc-4927	259	15	long	long	ADJ
dpc-4927	259	16	-	-	PUNCT
dpc-4927	259	17	term	term	NOUN
dpc-4927	259	18	outcomes	outcome	NOUN
dpc-4927	259	19	in	in	ADP
dpc-4927	259	20	covid-19	covid-19	PROPN
dpc-4927	259	21	patients	patient	NOUN
dpc-4927	259	22	.	.	PUNCT
dpc-4927	260	1	am	be	AUX
dpc-4927	260	2	j	j	PROPN
dpc-4927	260	3	hematol	hematol	NOUN
dpc-4927	260	4	.	.	PUNCT
dpc-4927	261	1	2022;97(7):915	2022;97(7):915	NUM
dpc-4927	261	2	-	-	SYM
dpc-4927	261	3	923	923	NUM
dpc-4927	261	4	.	.	PUNCT
dpc-4927	262	1	doi	doi	NOUN
dpc-4927	262	2	:	:	PUNCT
dpc-4927	262	3	10.1002	10.1002	NUM
dpc-4927	262	4	/	/	SYM
dpc-4927	262	5	ajh.26575	ajh.26575	PROPN
dpc-4927	262	6	.	.	PUNCT
dpc-4927	263	1	pmid	pmid	NOUN
dpc-4927	263	2	:	:	PUNCT
dpc-4927	263	3	35477923	35477923	NUM
dpc-4927	263	4	33	33	NUM
dpc-4927	263	5	.	.	PUNCT
dpc-4927	264	1	tong	tong	PROPN
dpc-4927	264	2	m	m	PROPN
dpc-4927	264	3	,	,	PUNCT
dpc-4927	264	4	yan	yan	PROPN
dpc-4927	264	5	x	x	X
dpc-4927	264	6	,	,	PUNCT
dpc-4927	264	7	jiang	jiang	PROPN
dpc-4927	264	8	y	y	PROPN
dpc-4927	264	9	,	,	PUNCT
dpc-4927	264	10	et	et	PROPN
dpc-4927	264	11	al	al	PROPN
dpc-4927	264	12	.	.	PUNCT
dpc-4927	264	13	endothelial	endothelial	ADJ
dpc-4927	264	14	biomarkers	biomarker	NOUN
dpc-4927	264	15	in	in	ADP
dpc-4927	264	16	patients	patient	NOUN
dpc-4927	264	17	recovered	recover	VERB
dpc-4927	264	18	from	from	ADP
dpc-4927	264	19	covid-19	covid-19	PROPN
dpc-4927	264	20	one	one	NUM
dpc-4927	264	21	year	year	NOUN
dpc-4927	264	22	after	after	ADP
dpc-4927	264	23	hospital	hospital	NOUN
dpc-4927	264	24	discharge	discharge	NOUN
dpc-4927	264	25	:	:	PUNCT
dpc-4927	264	26	a	a	DET
dpc-4927	264	27	cross	cross	ADJ
dpc-4927	264	28	-	-	ADJ
dpc-4927	264	29	sectional	sectional	ADJ
dpc-4927	264	30	study	study	NOUN
dpc-4927	264	31	.	.	PUNCT
dpc-4927	265	1	mediterr	mediterr	PROPN
dpc-4927	265	2	j	j	PROPN
dpc-4927	265	3	hematol	hematol	PROPN
dpc-4927	265	4	infect	infect	VERB
dpc-4927	265	5	dis	dis	PROPN
dpc-4927	265	6	.	.	PUNCT
dpc-4927	266	1	2022;14(1):e2022033	2022;14(1):e2022033	NUM
dpc-4927	266	2	.	.	X
dpc-4927	266	3	doi	doi	NOUN
dpc-4927	266	4	:	:	PUNCT
dpc-4927	266	5	10.4084	10.4084	NUM
dpc-4927	266	6	/	/	SYM
dpc-4927	266	7	mjhid.2022.033	mjhid.2022.033	PROPN
dpc-4927	266	8	.	.	PUNCT
dpc-4927	267	1	pmid	pmid	NOUN
dpc-4927	267	2	:	:	PUNCT
dpc-4927	267	3	35615329	35615329	NUM
dpc-4927	267	4	.	.	PUNCT
dpc-4927	268	1	34	34	NUM
dpc-4927	268	2	.	.	X
dpc-4927	269	1	boccatonda	boccatonda	ADP
dpc-4927	269	2	a	a	DET
dpc-4927	269	3	,	,	PUNCT
dpc-4927	269	4	campello	campello	ADJ
dpc-4927	269	5	e	e	NOUN
dpc-4927	269	6	,	,	PUNCT
dpc-4927	269	7	simion	simion	NOUN
dpc-4927	269	8	c	c	NOUN
dpc-4927	269	9	,	,	PUNCT
dpc-4927	269	10	simioni	simioni	ADJ
dpc-4927	269	11	p.	p.	NOUN
dpc-4927	269	12	long	long	ADJ
dpc-4927	269	13	-	-	PUNCT
dpc-4927	269	14	term	term	NOUN
dpc-4927	269	15	hypercoagulability	hypercoagulability	NOUN
dpc-4927	269	16	,	,	PUNCT
dpc-4927	269	17	endotheliopathy	endotheliopathy	ADJ
dpc-4927	269	18	and	and	CCONJ
dpc-4927	269	19	inflammation	inflammation	NOUN
dpc-4927	269	20	following	follow	VERB
dpc-4927	269	21	acute	acute	ADJ
dpc-4927	269	22	sars	sar	NOUN
dpc-4927	269	23	-	-	PUNCT
dpc-4927	269	24	cov-2	cov-2	NOUN
dpc-4927	269	25	infection	infection	NOUN
dpc-4927	269	26	.	.	PUNCT
dpc-4927	270	1	expert	expert	NOUN
dpc-4927	270	2	rev	rev	PROPN
dpc-4927	270	3	hematol	hematol	NOUN
dpc-4927	270	4	.	.	PUNCT
dpc-4927	271	1	2023;16(12	2023;16(12	NUM
dpc-4927	271	2	):	):	PUNCT
dpc-4927	271	3	1035	1035	NUM
dpc-4927	271	4	-	-	SYM
dpc-4927	271	5	1048	1048	NUM
dpc-4927	271	6	.	.	PUNCT
dpc-4927	272	1	doi	doi	NOUN
dpc-4927	272	2	:	:	PUNCT
dpc-4927	272	3	10.1080/17474086.2023.2288154	10.1080/17474086.2023.2288154	NUM
dpc-4927	272	4	.	.	PUNCT
dpc-4927	273	1	pmid	pmid	NOUN
dpc-4927	273	2	:	:	PUNCT
dpc-4927	273	3	38018136	38018136	NUM
dpc-4927	273	4	.	.	PUNCT
dpc-4927	274	1	35	35	NUM
dpc-4927	274	2	.	.	PUNCT
dpc-4927	275	1	world	world	PROPN
dpc-4927	275	2	health	health	PROPN
dpc-4927	275	3	organization	organization	NOUN
dpc-4927	275	4	.	.	PUNCT
dpc-4927	276	1	covid-19	covid-19	PROPN
dpc-4927	276	2	epidemiological	epidemiological	ADJ
dpc-4927	276	3	update	update	NOUN
dpc-4927	276	4	.	.	PUNCT
dpc-4927	277	1	no	no	INTJ
dpc-4927	277	2	.	.	NOUN
dpc-4927	278	1	168	168	NUM
dpc-4927	278	2	.	.	PUNCT
dpc-4927	279	1	june	june	PROPN
dpc-4927	279	2	17	17	NUM
dpc-4927	279	3	,	,	PUNCT
dpc-4927	279	4	2024	2024	NUM
dpc-4927	279	5	(	(	PUNCT
dpc-4927	279	6	https://www.who.int/publications/m	https://www.who.int/publications/m	X
dpc-4927	279	7	/item	/item	PROPN
dpc-4927	279	8	/	/	SYM
dpc-4927	279	9	covid-19	covid-19	PROPN
dpc-4927	279	10	-	-	PUNCT
dpc-4927	279	11	epidemiological	epidemiological	ADJ
dpc-4927	279	12	-	-	PUNCT
dpc-4927	279	13	update	update	NOUN
dpc-4927	279	14	-	-	PUNCT
dpc-4927	279	15	edition-168	edition-168	NOUN
dpc-4927	279	16	)	)	PUNCT
dpc-4927	279	17	.	.	PUNCT
dpc-4927	280	1	36	36	NUM
dpc-4927	280	2	.	.	PUNCT
dpc-4927	281	1	rosen	rosen	PROPN
dpc-4927	281	2	cj	cj	PROPN
dpc-4927	281	3	.	.	PUNCT
dpc-4927	282	1	viral	viral	ADJ
dpc-4927	282	2	variants	variant	NOUN
dpc-4927	282	3	,	,	PUNCT
dpc-4927	282	4	vaccinations	vaccination	NOUN
dpc-4927	282	5	,	,	PUNCT
dpc-4927	282	6	and	and	CCONJ
dpc-4927	282	7	long	long	ADV
dpc-4927	282	8	covid	covid	VERB
dpc-4927	282	9	new	new	ADJ
dpc-4927	282	10	insights	insight	NOUN
dpc-4927	282	11	.	.	PUNCT
dpc-4927	283	1	n	n	PROPN
dpc-4927	283	2	engl	engl	PROPN
dpc-4927	283	3	j	j	PROPN
dpc-4927	283	4	med	med	PROPN
dpc-4927	283	5	.	.	PUNCT
dpc-4927	284	1	2024;391(6):561	2024;391(6):561	NUM
dpc-4927	284	2	-	-	PUNCT
dpc-4927	284	3	562	562	NUM
dpc-4927	284	4	.	.	PUNCT
dpc-4927	285	1	doi	doi	NOUN
dpc-4927	285	2	:	:	PUNCT
dpc-4927	285	3	10.1056	10.1056	NUM
dpc-4927	285	4	/nejme2407575	/nejme2407575	PUNCT
dpc-4927	285	5	.	.	PUNCT
dpc-4927	286	1	pmid	pmid	NOUN
dpc-4927	286	2	:	:	PUNCT
dpc-4927	286	3	39018529	39018529	NUM
dpc-4927	286	4	.	.	PUNCT
dpc-4927	287	1	10	10	NUM
dpc-4927	287	2	.	.	PUNCT
dpc-4927	288	1	mostmans	mostmans	PROPN
dpc-4927	288	2	y	y	PROPN
dpc-4927	288	3	,	,	PUNCT
dpc-4927	288	4	smith	smith	PROPN
dpc-4927	288	5	v	v	PROPN
dpc-4927	288	6	,	,	PUNCT
dpc-4927	288	7	cutolo	cutolo	PROPN
dpc-4927	288	8	m	m	PROPN
dpc-4927	288	9	,	,	PUNCT
dpc-4927	288	10	et	et	PROPN
dpc-4927	288	11	al	al	PROPN
dpc-4927	288	12	.	.	PROPN
dpc-4927	288	13	nailfold	nailfold	PROPN
dpc-4927	288	14	videocapillaroscopy	videocapillaroscopy	NOUN
dpc-4927	288	15	and	and	CCONJ
dpc-4927	288	16	serum	serum	VERB
dpc-4927	288	17	vascular	vascular	ADJ
dpc-4927	288	18	endothelial	endothelial	ADJ
dpc-4927	288	19	growth	growth	NOUN
dpc-4927	288	20	factor	factor	NOUN
dpc-4927	288	21	in	in	ADP
dpc-4927	288	22	probable	probable	ADJ
dpc-4927	288	23	covid-19	covid-19	PROPN
dpc-4927	288	24	-	-	PUNCT
dpc-4927	288	25	induced	induce	VERB
dpc-4927	288	26	chilblains	chilblain	NOUN
dpc-4927	288	27	:	:	PUNCT
dpc-4927	288	28	a	a	DET
dpc-4927	288	29	cross	cross	ADJ
dpc-4927	288	30	-	-	ADJ
dpc-4927	288	31	sectional	sectional	ADJ
dpc-4927	288	32	study	study	NOUN
dpc-4927	288	33	to	to	PART
dpc-4927	288	34	assess	assess	VERB
dpc-4927	288	35	microvascular	microvascular	ADJ
dpc-4927	288	36	impairment	impairment	NOUN
dpc-4927	288	37	.	.	PUNCT
dpc-4927	289	1	br	br	PROPN
dpc-4927	289	2	j	j	PROPN
dpc-4927	289	3	dermatol	dermatol	NOUN
dpc-4927	289	4	.	.	PUNCT
dpc-4927	290	1	2022;187(6	2022;187(6	NUM
dpc-4927	290	2	):	):	PUNCT
dpc-4927	290	3	1017	1017	NUM
dpc-4927	290	4	-	-	SYM
dpc-4927	290	5	1019	1019	NUM
dpc-4927	290	6	.	.	PUNCT
dpc-4927	291	1	doi	doi	NOUN
dpc-4927	291	2	:	:	PUNCT
dpc-4927	291	3	10.1111	10.1111	NUM
dpc-4927	291	4	/	/	SYM
dpc-4927	291	5	bjd.21785	bjd.21785	NUM
dpc-4927	291	6	.	.	PUNCT
dpc-4927	292	1	pmid	pmid	NOUN
dpc-4927	292	2	:	:	PUNCT
dpc-4927	292	3	35916189	35916189	NUM
dpc-4927	292	4	11	11	NUM
dpc-4927	292	5	.	.	PUNCT
dpc-4927	293	1	karahan	karahan	PROPN
dpc-4927	293	2	s	s	PROPN
dpc-4927	293	3	,	,	PUNCT
dpc-4927	293	4	aydin	aydin	VERB
dpc-4927	293	5	k	k	PROPN
dpc-4927	293	6	,	,	PUNCT
dpc-4927	293	7	cetinkaya	cetinkaya	PROPN
dpc-4927	293	8	a	a	X
dpc-4927	293	9	,	,	PUNCT
dpc-4927	293	10	sirakaya	sirakaya	PROPN
dpc-4927	293	11	ha	ha	INTJ
dpc-4927	293	12	.	.	PROPN
dpc-4927	293	13	nailfold	nailfold	PROPN
dpc-4927	293	14	videocapillaroscopy	videocapillaroscopy	NOUN
dpc-4927	293	15	in	in	ADP
dpc-4927	293	16	patients	patient	NOUN
dpc-4927	293	17	with	with	ADP
dpc-4927	293	18	covid-19	covid-19	PROPN
dpc-4927	293	19	-	-	PUNCT
dpc-4927	293	20	associated	associate	VERB
dpc-4927	293	21	pneumonia	pneumonia	NOUN
dpc-4927	293	22	in	in	ADP
dpc-4927	293	23	intensive	intensive	ADJ
dpc-4927	293	24	care	care	NOUN
dpc-4927	293	25	units	unit	NOUN
dpc-4927	293	26	.	.	PUNCT
dpc-4927	294	1	j	j	PROPN
dpc-4927	294	2	coll	coll	PROPN
dpc-4927	294	3	physicians	physicians	PROPN
dpc-4927	294	4	surg	surg	PROPN
dpc-4927	294	5	pak	pak	PROPN
dpc-4927	294	6	.	.	PUNCT
dpc-4927	295	1	2022;32(4	2022;32(4	NUM
dpc-4927	295	2	):	):	PUNCT
dpc-4927	295	3	455	455	NUM
dpc-4927	295	4	-	-	SYM
dpc-4927	295	5	460	460	NUM
dpc-4927	295	6	.	.	PUNCT
dpc-4927	296	1	doi	doi	NOUN
dpc-4927	296	2	:	:	PUNCT
dpc-4927	296	3	10.29271	10.29271	NUM
dpc-4927	296	4	/	/	SYM
dpc-4927	296	5	jcpsp.2022.04.455	jcpsp.2022.04.455	NOUN
dpc-4927	296	6	.	.	PUNCT
dpc-4927	297	1	pmid	pmid	NOUN
dpc-4927	297	2	:	:	PUNCT
dpc-4927	297	3	35330517	35330517	NUM
dpc-4927	297	4	.	.	PUNCT
dpc-4927	298	1	12	12	NUM
dpc-4927	298	2	.	.	PUNCT
dpc-4927	299	1	gualtierotti	gualtierotti	ADJ
dpc-4927	299	2	r	r	NOUN
dpc-4927	299	3	,	,	PUNCT
dpc-4927	299	4	fox	fox	PROPN
dpc-4927	299	5	se	se	X
dpc-4927	299	6	,	,	PUNCT
dpc-4927	299	7	da	da	PROPN
dpc-4927	299	8	silva	silva	PROPN
dpc-4927	299	9	lameira	lameira	PROPN
dpc-4927	299	10	f	f	PROPN
dpc-4927	299	11	,	,	PUNCT
dpc-4927	299	12	et	et	PROPN
dpc-4927	299	13	al	al	PROPN
dpc-4927	299	14	.	.	PROPN
dpc-4927	300	1	on	on	ADP
dpc-4927	300	2	behalf	behalf	NOUN
dpc-4927	300	3	of	of	ADP
dpc-4927	300	4	the	the	DET
dpc-4927	300	5	capcovid	capcovid	PROPN
dpc-4927	300	6	study	study	NOUN
dpc-4927	300	7	group	group	NOUN
dpc-4927	300	8	.	.	PUNCT
dpc-4927	301	1	nailfold	nailfold	PROPN
dpc-4927	301	2	videocapillaroscopic	videocapillaroscopic	PROPN
dpc-4927	301	3	alterations	alteration	NOUN
dpc-4927	301	4	as	as	ADP
dpc-4927	301	5	markers	marker	NOUN
dpc-4927	301	6	of	of	ADP
dpc-4927	301	7	microangiopathy	microangiopathy	PROPN
dpc-4927	301	8	in	in	ADP
dpc-4927	301	9	covid-19	covid-19	PROPN
dpc-4927	301	10	patients	patient	NOUN
dpc-4927	301	11	.	.	PUNCT
dpc-4927	302	1	j	j	PROPN
dpc-4927	302	2	clin	clin	PROPN
dpc-4927	302	3	med	med	PROPN
dpc-4927	302	4	.	.	PUNCT
dpc-4927	303	1	2023;12(11):3727	2023;12(11):3727	X
dpc-4927	303	2	.	.	PUNCT
dpc-4927	304	1	doi	doi	NOUN
dpc-4927	304	2	:	:	PUNCT
dpc-4927	304	3	10.3390	10.3390	NUM
dpc-4927	304	4	/	/	SYM
dpc-4927	304	5	jcm	jcm	PROPN
dpc-4927	304	6	12113727	12113727	NUM
dpc-4927	304	7	.	.	PUNCT
dpc-4927	305	1	pmid	pmid	NOUN
dpc-4927	305	2	:	:	PUNCT
dpc-4927	305	3	37297922	37297922	NUM
dpc-4927	305	4	13	13	NUM
dpc-4927	305	5	.	.	PUNCT
dpc-4927	306	1	çakmak	çakmak	PROPN
dpc-4927	306	2	f	f	PROPN
dpc-4927	306	3	,	,	PUNCT
dpc-4927	306	4	demirbuga	demirbuga	VERB
dpc-4927	306	5	a	a	PRON
dpc-4927	306	6	,	,	PUNCT
dpc-4927	306	7	demirkol	demirkol	PROPN
dpc-4927	306	8	d	d	PROPN
dpc-4927	306	9	,	,	PUNCT
dpc-4927	306	10	et	et	PROPN
dpc-4927	306	11	al	al	PROPN
dpc-4927	306	12	.	.	PROPN
dpc-4927	306	13	nailfold	nailfold	PROPN
dpc-4927	306	14	capillaroscopy	capillaroscopy	PROPN
dpc-4927	306	15	:	:	PUNCT
dpc-4927	306	16	a	a	DET
dpc-4927	306	17	sensitive	sensitive	ADJ
dpc-4927	306	18	method	method	NOUN
dpc-4927	306	19	for	for	ADP
dpc-4927	306	20	evaluating	evaluate	VERB
dpc-4927	306	21	microvascular	microvascular	ADJ
dpc-4927	306	22	involvement	involvement	NOUN
dpc-4927	306	23	in	in	ADP
dpc-4927	306	24	children	child	NOUN
dpc-4927	306	25	with	with	ADP
dpc-4927	306	26	sars	sar	NOUN
dpc-4927	306	27	-	-	PUNCT
dpc-4927	306	28	cov-2	cov-2	PART
dpc-4927	306	29	infection	infection	NOUN
dpc-4927	306	30	.	.	PUNCT
dpc-4927	307	1	microvasc	microvasc	PROPN
dpc-4927	307	2	res	res	PROPN
dpc-4927	307	3	.	.	PUNCT
dpc-4927	307	4	2021;138:104196	2021;138:104196	NUM
dpc-4927	307	5	.	.	PUNCT
dpc-4927	308	1	doi	doi	NOUN
dpc-4927	308	2	:	:	PUNCT
dpc-4927	308	3	10.1016	10.1016	NUM
dpc-4927	308	4	/	/	SYM
dpc-4927	308	5	j.mvr.2021.104196	j.mvr.2021.104196	NOUN
dpc-4927	308	6	.	.	PUNCT
dpc-4927	309	1	pmid	pmid	NOUN
dpc-4927	309	2	:	:	PUNCT
dpc-4927	309	3	34097919	34097919	NUM
dpc-4927	309	4	.	.	PUNCT
dpc-4927	310	1	14	14	NUM
dpc-4927	310	2	.	.	PUNCT
dpc-4927	311	1	hughes	hughes	PROPN
dpc-4927	311	2	m	m	PROPN
dpc-4927	311	3	,	,	PUNCT
dpc-4927	311	4	moore	moore	PROPN
dpc-4927	311	5	t	t	PROPN
dpc-4927	311	6	,	,	PUNCT
dpc-4927	311	7	o’leary	o’leary	PROPN
dpc-4927	311	8	n	n	CCONJ
dpc-4927	311	9	,	,	PUNCT
dpc-4927	311	10	et	et	PROPN
dpc-4927	311	11	al	al	PROPN
dpc-4927	311	12	.	.	PUNCT
dpc-4927	312	1	a	a	DET
dpc-4927	312	2	study	study	NOUN
dpc-4927	312	3	comparing	compare	VERB
dpc-4927	312	4	videocapillaroscopy	videocapillaroscopy	NOUN
dpc-4927	312	5	and	and	CCONJ
dpc-4927	312	6	dermoscopy	dermoscopy	VERB
dpc-4927	312	7	in	in	ADP
dpc-4927	312	8	the	the	DET
dpc-4927	312	9	assessment	assessment	NOUN
dpc-4927	312	10	of	of	ADP
dpc-4927	312	11	nailfold	nailfold	ADJ
dpc-4927	312	12	capillaries	capillary	NOUN
dpc-4927	312	13	in	in	ADP
dpc-4927	312	14	patients	patient	NOUN
dpc-4927	312	15	with	with	ADP
dpc-4927	312	16	systemic	systemic	ADJ
dpc-4927	312	17	sclerosis	sclerosis	NOUN
dpc-4927	312	18	-	-	PUNCT
dpc-4927	312	19	spectrum	spectrum	NOUN
dpc-4927	312	20	disorders	disorder	NOUN
dpc-4927	312	21	.	.	PUNCT
dpc-4927	313	1	rheumatology	rheumatology	NOUN
dpc-4927	313	2	(	(	PUNCT
dpc-4927	313	3	oxford	oxford	PROPN
dpc-4927	313	4	)	)	PUNCT
dpc-4927	313	5	.	.	PUNCT
dpc-4927	314	1	2015;54(8):1435	2015;54(8):1435	NUM
dpc-4927	314	2	-	-	SYM
dpc-4927	314	3	42	42	NUM
dpc-4927	314	4	.	.	PUNCT
dpc-4927	315	1	doi	doi	NOUN
dpc-4927	315	2	:	:	PUNCT
dpc-4927	315	3	10.1093	10.1093	NUM
dpc-4927	315	4	/rheumatology	/rheumatology	SYM
dpc-4927	315	5	/	/	SYM
dpc-4927	315	6	keu533	keu533	PROPN
dpc-4927	315	7	.	.	PUNCT
dpc-4927	316	1	pmid	pmid	NOUN
dpc-4927	316	2	:	:	PUNCT
dpc-4927	316	3	25749623	25749623	NUM
dpc-4927	316	4	.	.	PUNCT
dpc-4927	317	1	15	15	NUM
dpc-4927	317	2	.	.	PUNCT
dpc-4927	317	3	world	world	PROPN
dpc-4927	317	4	health	health	PROPN
dpc-4927	317	5	organization	organization	PROPN
dpc-4927	317	6	.	.	PUNCT
dpc-4927	318	1	who	who	PRON
dpc-4927	318	2	western	western	ADJ
dpc-4927	318	3	pacific	pacific	PROPN
dpc-4927	318	4	covid-19	covid-19	PROPN
dpc-4927	318	5	symptoms	symptom	NOUN
dpc-4927	318	6	and	and	CCONJ
dpc-4927	318	7	severity.august	severity.august	NOUN
dpc-4927	318	8	2023	2023	NUM
dpc-4927	318	9	.	.	PUNCT
dpc-4927	319	1	available	available	ADJ
dpc-4927	319	2	from	from	ADP
dpc-4927	319	3	https://	https://	PROPN
dpc-4927	319	4	www.who.int/westernpacific/emergencies/covid-19/information	www.who.int/westernpacific/emergencies/covid-19/information	NOUN
dpc-4927	319	5	/asymptomatic	/asymptomatic	PROPN
dpc-4927	319	6	-	-	PUNCT
dpc-4927	319	7	covid-19	covid-19	PROPN
dpc-4927	319	8	.	.	PROPN
dpc-4927	319	9	16	16	NUM
dpc-4927	319	10	.	.	PUNCT
dpc-4927	320	1	smith	smith	PROPN
dpc-4927	320	2	v	v	PROPN
dpc-4927	320	3	,	,	PUNCT
dpc-4927	320	4	herrick	herrick	PROPN
dpc-4927	320	5	al	al	PROPN
dpc-4927	320	6	,	,	PUNCT
dpc-4927	320	7	ingegnoli	ingegnoli	PROPN
dpc-4927	320	8	f	f	PROPN
dpc-4927	320	9	,	,	PUNCT
dpc-4927	320	10	et	et	PROPN
dpc-4927	320	11	al	al	PROPN
dpc-4927	320	12	;	;	PUNCT
dpc-4927	320	13	eular	eular	ADJ
dpc-4927	320	14	study	study	NOUN
dpc-4927	320	15	group	group	NOUN
dpc-4927	320	16	on	on	ADP
dpc-4927	320	17	microcirculation	microcirculation	NOUN
dpc-4927	320	18	in	in	ADP
dpc-4927	320	19	rheumatic	rheumatic	ADJ
dpc-4927	320	20	diseases	disease	NOUN
dpc-4927	320	21	and	and	CCONJ
dpc-4927	320	22	the	the	DET
dpc-4927	320	23	scleroderma	scleroderma	NOUN
dpc-4927	320	24	clinical	clinical	ADJ
dpc-4927	320	25	trials	trial	NOUN
dpc-4927	320	26	consortium	consortium	NOUN
dpc-4927	320	27	group	group	NOUN
dpc-4927	320	28	on	on	ADP
dpc-4927	320	29	capillaroscopy	capillaroscopy	NOUN
dpc-4927	320	30	.	.	PUNCT
dpc-4927	321	1	standardisation	standardisation	NOUN
dpc-4927	321	2	of	of	ADP
dpc-4927	321	3	nailfold	nailfold	ADJ
dpc-4927	321	4	capillaroscopy	capillaroscopy	NOUN
dpc-4927	321	5	for	for	ADP
dpc-4927	321	6	the	the	DET
dpc-4927	321	7	assessment	assessment	NOUN
dpc-4927	321	8	of	of	ADP
dpc-4927	321	9	patients	patient	NOUN
dpc-4927	321	10	with	with	ADP
dpc-4927	321	11	raynaud	raynaud	PROPN
dpc-4927	321	12	’s	’s	PART
dpc-4927	321	13	phenomenon	phenomenon	NOUN
dpc-4927	321	14	and	and	CCONJ
dpc-4927	321	15	systemic	systemic	ADJ
dpc-4927	321	16	sclerosis	sclerosis	NOUN
dpc-4927	321	17	.	.	PUNCT
dpc-4927	322	1	autoimmun	autoimmun	PROPN
dpc-4927	322	2	rev	rev	PROPN
dpc-4927	322	3	.	.	PUNCT
dpc-4927	323	1	2020;19(3):102458	2020;19(3):102458	NUM
dpc-4927	323	2	.	.	PUNCT
dpc-4927	324	1	doi	doi	NOUN
dpc-4927	324	2	:	:	PUNCT
dpc-4927	324	3	10.1016	10.1016	NUM
dpc-4927	324	4	/	/	SYM
dpc-4927	324	5	j.autrev.2020.102458	j.autrev.2020.102458	NOUN
dpc-4927	324	6	.	.	PUNCT
dpc-4927	325	1	pmid	pmid	NOUN
dpc-4927	325	2	:	:	PUNCT
dpc-4927	325	3	31927087	31927087	NUM
dpc-4927	325	4	.	.	PUNCT
dpc-4927	326	1	17	17	NUM
dpc-4927	326	2	.	.	PUNCT
dpc-4927	327	1	rennie	rennie	PROPN
dpc-4927	327	2	d.	d.	PROPN
dpc-4927	327	3	nailfold	nailfold	PROPN
dpc-4927	327	4	dermatoscopy	dermatoscopy	VERB
dpc-4927	327	5	in	in	ADP
dpc-4927	327	6	general	general	ADJ
dpc-4927	327	7	practice	practice	NOUN
dpc-4927	327	8	.	.	PUNCT
dpc-4927	328	1	aust	aust	PROPN
dpc-4927	328	2	fam	fam	PROPN
dpc-4927	328	3	physician	physician	NOUN
dpc-4927	328	4	.	.	PUNCT
dpc-4927	329	1	2015;44(11):809	2015;44(11):809	NUM
dpc-4927	329	2	-	-	SYM
dpc-4927	329	3	12	12	NUM
dpc-4927	329	4	.	.	PUNCT
dpc-4927	330	1	pmid	pmid	NOUN
dpc-4927	330	2	:	:	PUNCT
dpc-4927	330	3	26590619	26590619	NUM
dpc-4927	330	4	.	.	PUNCT
dpc-4927	331	1	18	18	NUM
dpc-4927	331	2	.	.	X
dpc-4927	331	3	etehad	etehad	PROPN
dpc-4927	331	4	tavakol	tavakol	PROPN
dpc-4927	331	5	m	m	PROPN
dpc-4927	331	6	,	,	PUNCT
dpc-4927	331	7	fatemi	fatemi	PROPN
dpc-4927	331	8	a	a	PROPN
dpc-4927	331	9	,	,	PUNCT
dpc-4927	331	10	karbalaie	karbalaie	PROPN
dpc-4927	331	11	a	a	NOUN
dpc-4927	331	12	,	,	PUNCT
dpc-4927	331	13	emrani	emrani	PROPN
dpc-4927	332	1	z	z	PROPN
dpc-4927	332	2	,	,	PUNCT
dpc-4927	332	3	erlandsson	erlandsson	PROPN
dpc-4927	332	4	be	be	VERB
dpc-4927	332	5	.	.	PUNCT
dpc-4927	333	1	nailfold	nailfold	PROPN
dpc-4927	333	2	capillaroscopy	capillaroscopy	VERB
dpc-4927	333	3	in	in	ADP
dpc-4927	333	4	rheumatic	rheumatic	ADJ
dpc-4927	333	5	diseases	disease	NOUN
dpc-4927	333	6	:	:	PUNCT
dpc-4927	333	7	which	which	PRON
dpc-4927	333	8	parameters	parameter	NOUN
dpc-4927	333	9	should	should	AUX
dpc-4927	333	10	be	be	AUX
dpc-4927	333	11	evaluated	evaluate	VERB
dpc-4927	333	12	?	?	PUNCT
dpc-4927	334	1	biomed	biome	VERB
dpc-4927	334	2	res	re	NOUN
dpc-4927	334	3	int	int	NOUN
dpc-4927	334	4	.	.	PUNCT
dpc-4927	335	1	2015;2015:974530	2015;2015:974530	NUM
dpc-4927	335	2	.	.	PUNCT
dpc-4927	336	1	doi	doi	NOUN
dpc-4927	336	2	:	:	PUNCT
dpc-4927	336	3	10.1155/2015/974530	10.1155/2015/974530	NUM
dpc-4927	336	4	.	.	PUNCT
dpc-4927	337	1	pmid	pmid	NOUN
dpc-4927	337	2	:	:	PUNCT
dpc-4927	337	3	26421308	26421308	NUM
dpc-4927	337	4	19	19	NUM
dpc-4927	337	5	.	.	PUNCT
dpc-4927	338	1	triantafyllou	triantafyllou	PROPN
dpc-4927	338	2	a	a	PROPN
dpc-4927	338	3	,	,	PUNCT
dpc-4927	338	4	anyfanti	anyfanti	PROPN
dpc-4927	338	5	p	p	NOUN
dpc-4927	338	6	,	,	PUNCT
dpc-4927	338	7	pyrpasopoulou	pyrpasopoulou	NOUN
dpc-4927	338	8	a	a	PRON
dpc-4927	338	9	,	,	PUNCT
dpc-4927	338	10	triantafyllou	triantafyllou	PROPN
dpc-4927	338	11	g	g	PROPN
dpc-4927	338	12	,	,	PUNCT
dpc-4927	338	13	aslanidis	aslanidis	PROPN
dpc-4927	338	14	s	s	PROPN
dpc-4927	338	15	,	,	PUNCT
dpc-4927	338	16	douma	douma	PROPN
dpc-4927	338	17	s.	s.	PROPN
dpc-4927	338	18	capillary	capillary	ADJ
dpc-4927	338	19	rarefaction	rarefaction	NOUN
dpc-4927	338	20	as	as	ADP
dpc-4927	338	21	an	an	DET
dpc-4927	338	22	index	index	NOUN
dpc-4927	338	23	for	for	ADP
dpc-4927	338	24	the	the	DET
dpc-4927	338	25	microvascular	microvascular	ADJ
dpc-4927	338	26	assessment	assessment	NOUN
dpc-4927	338	27	of	of	ADP
dpc-4927	338	28	hypertensive	hypertensive	ADJ
dpc-4927	338	29	patients	patient	NOUN
dpc-4927	338	30	.	.	PUNCT
dpc-4927	339	1	curr	curr	PROPN
dpc-4927	339	2	hypertens	hypertens	PROPN
dpc-4927	339	3	rep	rep	PROPN
dpc-4927	339	4	.	.	PROPN
dpc-4927	339	5	2015;17(5):33	2015;17(5):33	PROPN
dpc-4927	339	6	.	.	PUNCT
dpc-4927	339	7	doi	doi	NOUN
dpc-4927	339	8	:	:	PUNCT
dpc-4927	339	9	10.1007	10.1007	NUM
dpc-4927	339	10	/	/	SYM
dpc-4927	339	11	s11906	s11906	NOUN
dpc-4927	339	12	-	-	PUNCT
dpc-4927	339	13	015	015	NUM
dpc-4927	339	14	-	-	PUNCT
dpc-4927	339	15	0543	0543	NUM
dpc-4927	339	16	-	-	SYM
dpc-4927	339	17	3	3	NUM
dpc-4927	339	18	.	.	PUNCT
dpc-4927	340	1	pmid	pmid	NOUN
dpc-4927	340	2	:	:	PUNCT
dpc-4927	340	3	25833455	25833455	NUM
dpc-4927	340	4	.	.	PUNCT
dpc-4927	341	1	20	20	NUM
dpc-4927	341	2	.	.	PUNCT
dpc-4927	342	1	maldonado	maldonado	PROPN
dpc-4927	342	2	g	g	PROPN
dpc-4927	342	3	,	,	PUNCT
dpc-4927	342	4	guerrero	guerrero	PROPN
dpc-4927	342	5	r	r	PROPN
dpc-4927	342	6	,	,	PUNCT
dpc-4927	342	7	paredes	parede	VERB
dpc-4927	342	8	c	c	PROPN
dpc-4927	342	9	,	,	PUNCT
dpc-4927	342	10	ríos	ríos	PROPN
dpc-4927	342	11	c.	c.	PROPN
dpc-4927	342	12	nailfold	nailfold	PROPN
dpc-4927	342	13	capillaroscopy	capillaroscopy	VERB
dpc-4927	342	14	in	in	ADP
dpc-4927	342	15	diabetes	diabetes	NOUN
dpc-4927	342	16	mellitus	mellitus	NOUN
dpc-4927	342	17	.	.	PUNCT
dpc-4927	343	1	microvasc	microvasc	PROPN
dpc-4927	343	2	res	res	PROPN
dpc-4927	343	3	.	.	PUNCT
dpc-4927	343	4	2017;112:41	2017;112:41	NUM
dpc-4927	343	5	-	-	SYM
dpc-4927	343	6	46	46	NUM
dpc-4927	343	7	.	.	PUNCT
dpc-4927	344	1	doi	doi	NOUN
dpc-4927	344	2	:	:	PUNCT
dpc-4927	344	3	10.1016	10.1016	NUM
dpc-4927	344	4	/	/	SYM
dpc-4927	344	5	j.mvr.2017.03.001	j.mvr.2017.03.001	PROPN
dpc-4927	344	6	.	.	PUNCT
dpc-4927	345	1	pmid	pmid	NOUN
dpc-4927	345	2	:	:	PUNCT
dpc-4927	345	3	28274735	28274735	NUM
dpc-4927	345	4	.	.	PUNCT
dpc-4927	346	1	21	21	NUM
dpc-4927	346	2	.	.	PUNCT
dpc-4927	347	1	mansueto	mansueto	PROPN
dpc-4927	347	2	n	n	PROPN
dpc-4927	347	3	,	,	PUNCT
dpc-4927	347	4	rotondo	rotondo	PROPN
dpc-4927	347	5	c	c	PROPN
dpc-4927	347	6	,	,	PUNCT
dpc-4927	347	7	corrado	corrado	PROPN
dpc-4927	347	8	a	a	DET
dpc-4927	347	9	,	,	PUNCT
dpc-4927	347	10	cantatore	cantatore	PROPN
dpc-4927	347	11	fp	fp	PROPN
dpc-4927	347	12	.	.	PROPN
dpc-4927	347	13	nailfold	nailfold	PROPN
dpc-4927	347	14	capillaroscopy	capillaroscopy	PROPN
dpc-4927	347	15	:	:	PUNCT
dpc-4927	347	16	a	a	DET
dpc-4927	347	17	comprehensive	comprehensive	ADJ
dpc-4927	347	18	review	review	NOUN
dpc-4927	347	19	on	on	ADP
dpc-4927	347	20	common	common	ADJ
dpc-4927	347	21	findings	finding	NOUN
dpc-4927	347	22	and	and	CCONJ
dpc-4927	347	23	clinical	clinical	ADJ
dpc-4927	347	24	usefulness	usefulness	NOUN
dpc-4927	347	25	in	in	ADP
dpc-4927	347	26	non	non	ADJ
dpc-4927	347	27	-	-	ADJ
dpc-4927	347	28	rheumatic	rheumatic	ADJ
dpc-4927	347	29	disease	disease	NOUN
dpc-4927	347	30	.	.	PUNCT
dpc-4927	348	1	j	j	PROPN
dpc-4927	348	2	med	med	PROPN
dpc-4927	348	3	invest	invest	ADV
dpc-4927	348	4	.	.	PUNCT
dpc-4927	349	1	2021;68(1.2):6	2021;68(1.2):6	X
dpc-4927	349	2	-	-	SYM
dpc-4927	349	3	14	14	NUM
dpc-4927	349	4	.	.	PUNCT
dpc-4927	350	1	doi	doi	NOUN
dpc-4927	350	2	:	:	PUNCT
dpc-4927	350	3	10.2152	10.2152	NUM
dpc-4927	350	4	/	/	SYM
dpc-4927	350	5	jmi.68.6	jmi.68.6	PROPN
dpc-4927	350	6	.	.	PUNCT
dpc-4927	351	1	pmid	pmid	NOUN
dpc-4927	351	2	:	:	PUNCT
dpc-4927	351	3	33994482	33994482	NUM
dpc-4927	351	4	.	.	PUNCT
dpc-4927	352	1	22	22	NUM
dpc-4927	352	2	.	.	PUNCT
dpc-4927	353	1	onder	onder	PROPN
dpc-4927	353	2	ena	ena	PROPN
dpc-4927	353	3	,	,	PUNCT
dpc-4927	353	4	gokyayla	gokyayla	NOUN
dpc-4927	353	5	e	e	NOUN
dpc-4927	353	6	,	,	PUNCT
dpc-4927	353	7	ermertcan	ermertcan	VERB
dpc-4927	353	8	at	at	ADP
dpc-4927	353	9	,	,	PUNCT
dpc-4927	353	10	ertan	ertan	PROPN
dpc-4927	353	11	p.	p.	NOUN
dpc-4927	353	12	the	the	DET
dpc-4927	353	13	nailfold	nailfold	NOUN
dpc-4927	353	14	dermoscopy	dermoscopy	VERB
dpc-4927	353	15	findings	finding	NOUN
dpc-4927	353	16	of	of	ADP
dpc-4927	353	17	patients	patient	NOUN
dpc-4927	353	18	with	with	ADP
dpc-4927	353	19	atypical	atypical	ADJ
dpc-4927	353	20	haemolytic	haemolytic	ADJ
dpc-4927	353	21	uremic	uremic	ADJ
dpc-4927	353	22	syndrome	syndrome	NOUN
dpc-4927	353	23	.	.	PUNCT
dpc-4927	354	1	microvasc	microvasc	PROPN
dpc-4927	354	2	res	res	PROPN
dpc-4927	354	3	.	.	PUNCT
dpc-4927	355	1	2023;148:104548	2023;148:104548	NUM
dpc-4927	355	2	.	.	PUNCT
dpc-4927	356	1	doi	doi	PROPN
dpc-4927	356	2	:	:	PUNCT
dpc-4927	356	3	10.1016	10.1016	NUM
dpc-4927	356	4	/j.mvr.2023.104548	/j.mvr.2023.104548	PUNCT
dpc-4927	356	5	.	.	PUNCT
dpc-4927	357	1	pmid	pmid	NOUN
dpc-4927	357	2	:	:	PUNCT
dpc-4927	357	3	37225057	37225057	NUM
dpc-4927	357	4	.	.	PUNCT
dpc-4927	358	1	23	23	NUM
dpc-4927	358	2	.	.	PUNCT
dpc-4927	359	1	zabotti	zabotti	VERB
dpc-4927	359	2	a	a	PRON
dpc-4927	359	3	,	,	PUNCT
dpc-4927	359	4	errichetti	errichetti	NOUN
dpc-4927	359	5	e	e	NOUN
dpc-4927	359	6	,	,	PUNCT
dpc-4927	359	7	zuliani	zuliani	PROPN
dpc-4927	359	8	f	f	PROPN
dpc-4927	359	9	,	,	PUNCT
dpc-4927	359	10	quartuccio	quartuccio	PROPN
dpc-4927	359	11	l	l	PROPN
dpc-4927	359	12	,	,	PUNCT
dpc-4927	359	13	sacco	sacco	PROPN
dpc-4927	359	14	s	s	PROPN
dpc-4927	359	15	,	,	PUNCT
dpc-4927	359	16	stinco	stinco	ADJ
dpc-4927	359	17	g	g	PROPN
dpc-4927	359	18	,	,	PUNCT
dpc-4927	359	19	de	de	X
dpc-4927	359	20	vita	vita	PROPN
dpc-4927	359	21	s.	s.	PROPN
dpc-4927	359	22	early	early	ADV
dpc-4927	359	23	psoriatic	psoriatic	ADJ
dpc-4927	359	24	arthritis	arthritis	NOUN
dpc-4927	359	25	versus	versus	ADP
dpc-4927	359	26	early	early	ADJ
dpc-4927	359	27	seronegative	seronegative	ADJ